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Abstract 
Hypercapnia is clinically defined as an arterial blood partial pressure of CO2 of above 40mm 
Hg and is a symptom of chronic lung disease. In renal epithelia, hypercapnia can reduce 
agonist-stimulated cAMP levels and impair regulation of cAMP-dependent ion transporters. 
In the airways, elevations in intracellular cAMP in serous cells of the submucosal glands, 
activates CFTR-mediated HCO3
-
 and fluid secretion, which contributes to airway surface 
liquid homeostasis. The aim of the current work was to investigate the effects of both acute 
and chronic hypercapnia on cAMP-regulated ion and fluid transport in Calu-3 cells, a model 
of human serous cells. 
Acute hypercapnia significantly reduced both forskolin-stimulated elevations in intracellular 
cAMP and forskolin-stimulated increase in short-circuit current, suggesting CO2 reduced 
cAMP-regulated, CFTR-dependent anion secretion. Stimulation of Calu-3 cells with cAMP 
agonists induced a reversible intracellular acidification that was a result of CFTR-dependent 
HCO3
-
 secretion. In acute hypercapnia, this intracellular acidification was significantly 
augmented yet neither CFTR-dependent HCO3
-
 efflux, nor NBC-dependent HCO3
-
 influx, 
were found to be CO2-sensitive. However, ouabain blocked the augmentation induced by 
hypercapnia implicating the Na
+
/K
+
-ATPase in mediating the effects of raised CO2 on 
cAMP-mediated cytosolic acidification. In addition, both BAPTA-AM and the phospholipase 
C inhibitor, U77312, also blocked the effect of hypercapnia, implying a role for PLC-
regulated Ca
2+
 mobilization in the pH response to hypercapnia. Although addition of 
exogenous ATP in normocapnia mimicked the effect of hypercapnia, there was little evidence 
that CO2-induced ATP release from Calu-3 cells, which therefore suggests the effect of 
hypercapnia is not due to ATP/Ca
2+
 signalling via purinergic receptors. 
Exposure of Calu-3 cells to 24 hours hypercapnia caused a significant reduction in the 
volume of fluid secreted but did not affect the HCO3
-
 or mucus content of this secreted fluid. 
These data suggest that transporters involved in regulating the volume of secreted fluid have 
differential CO2 sensitivity compared to transporters involved in regulating its composition.  
These findings reveal that both acute and chronic hypercapnia affected ion and fluid transport 
in human airway epithelial cells, and suggests hypercapnia could have pronounced effects on 
the properties of the airway surface liquid which would be predicted to have important  
consequences for the innate defence mechanisms of the lungs.  
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Chapter 1:   Introduction 
 
1.1.  Carbon dioxide acts as a cell signalling molecule in a variety of species 
Carbon dioxide is formed in all cells of the body as a waste product of respiration and is 
removed from the blood during ventilation. Normal arterial blood CO2 (PaCO2) is 
approximately 40mmHg (5% (v/v) CO2) in healthy individuals but in certain lung diseases, 
such as chronic obstructive pulmonary disease (COPD), in which gas exchange at the alveoli 
is impaired, the removal of CO2 can be inadequate causing PaCO2 levels to increase 
(Lourenco and Miranda, 1968). A PaCO2 of above 40mmHg is defined as hypercapnia and 
can lead to serious health problems. For instance, CO2 can displace oxygen binding to 
haemoglobin and therefore reduce the oxygen carrying capacity of red blood cells (Dahms et 
al., 1972; Kilmartin, 1976) whilst elevated PaCO2 also causes respiratory acidosis – a 
decrease in blood pH due to the reaction of CO2 with H2O to form carbonic acid. Respiratory 
acidosis has been reported to reduce ventricular myocyte contractility in both rats and dogs 
(Walley et al., 1990; Harrison et al., 1992) as well as decreasing diaphragm function in dogs 
(Yanos et al., 1993) with Harrison et al. (1992) suggesting that acidosis affected muscle 
contractile proteins as well as intracellular Ca
2+
 ([Ca
2+
]i) homeostasis in myocytes. Thus 
hypercapnia can have major implications for cardiovascular health in mammals. Perhaps 
unsurprisingly, given the toxic nature of this naturally occurring gas, the effect of elevated 
CO2 has been studied in a variety of species. Not only has it been shown that organisms are 
able to sense changes in environmental CO2 but CO2 can act as a cell signalling molecule to 
affect organism physiology. 
 
1.1.1. Drosophila 
The eukaryotic organism Drosophila melanogaster has been studied for its gas sensing 
behaviour, notably in hypoxia where its homolog of the mammalian transcription factor HIF-
1 acts to upregulate the expression of certain genes (Lavista-Llanos et al., 2002). Drosophila 
are also affected by changes in environmental CO2. Helenius et al. (2009) demonstrated that 
in hypercapnic conditions (13% CO2), both fertility and embryo development were both 
impaired. Hypercapnia also altered the gene expression profile of the organism with 
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substantial downregulation of antimicrobial peptide genes which compromised the 
organisms’ innate defences. Thus, for Drosophila, hypercapnia is detrimental to the organism 
and, as a result, being able to sense changes in environmental CO2 is of evolutionary 
importance. Drosophila are able to sense changes in CO2 due to the activation of CO2-
sensitive olfactory receptors Gr63a and Gr21a (Jones et al., 2007) which indicates that, in 
lower organisms at least, changes in CO2 trigger olfactory receptor-mediated responses, 
implicating CO2 as a signalling molecule in this instance.  
 
1.1.2 Caenorhabditis elegans  
Similar to Drosophila, Caenorhabditis elegans can also serve as a powerful model to 
investigate the effects of environmental factors on the organism’s physiology and genetics. 
Sharabi et al. (2009) demonstrated that C. elegans grown in a hypercapnic environment 
showed reduced production of eggs, reduced motility and deterioration in muscle morphology 
and an extension to lifespan. Animals grown in 19% CO2 demonstrated an 89% reduction in 
the amount of eggs laid compared to animals grown in normal air but also lived, on average, 
5.5 days longer than control animals. These effects of chronic hypercapnia were accompanied 
by major changes in gene expression which likely contributed to the altered phenotypes 
observed. As well as CO2 being able to cause long term changes in C. elegans physiology by 
inducing changes in gene expression, it has recently been shown that BAG neurones of 
C.elegans, located towards the head of the organism, respond to CO2 per se in a dose 
dependent fashion (Smith et al., 2013). Elevated CO2 led to the activation of BAG neurones, 
as measured by increases in [Ca
2+
]i, which show that C.elegans possess specific sensors for 
CO2. This work highlights the importance of being able to detect changes in environmental 
CO2 for these organisms, although whether changes in gene expression are due to a CO2-
transduced signal, or serve as an adaptive response to the environmental hypercapnia still 
remains to be determined. 
 
1.1.3. Mammals 
In mammalian cells, a wide range of effects of hypercapnia have been reported in a variety of 
different tissues. Work published from the group of Nicholas Dale particularly supports the 
notion that CO2 is a key signalling molecule in mammals. In 2010, Huckstepp et al. (2010b) 
3 
 
investigated the mechanism behind the increased respiratory drive displayed by animals in 
response to hypercapnia. They demonstrated that increasing CO2 from 35mmHg (4.6% CO2) 
to 55mmHg (7.2% CO2) and 70mmHg (9.2% CO2) triggered a dose-dependent release of 
ATP from cells located in the medulla oblongata of rats with 70mmHg increasing the amount 
of ATP released by ~0.9µM compared to control conditions. As the medulla oblongata is the 
site of the central chemoreceptors involved in controlling ventilation rates in response to 
changes in blood O2, CO2 and H
+
, it suggested a possible mechanism in which the medulla 
oblongata can sense changes in arterial blood CO2. The released ATP may act directly on 
purinergic receptors of local respiratory neurones, or be broken down into adenosine, to 
regulate ventilation rate in response to hypercapnia. Further experiments identified that 
pharmacological blockade of connexin hemichannels prevented the ATP release from the 
medulla oblongata and blocked the increased respiratory drive in response to hypercapnia. 
Connexin 26 (Cx26) was found to be expressed on the ventral surface of the medulla 
oblongata and was suggested as being the CO2-sensitive connexin mediating ATP release 
from these cells. Expression of Cx26 in HeLa cells induced a dose-dependent increase in 
whole cell conductance in response to CO2 which was also observed in Cx32 but not Cx30 or 
Cx43-expressing cells, implicating only certain members of the connexin family are sensitive 
to CO2 (Huckstepp et al., 2010a).  Huckstepp and Dale (2011) have also reported that CO2 
dose-dependently increased the open probability of a member of the inwardly rectifying 
family of K
+
 channels and highlights the ability of CO2 to influence ion transport in 
mammalian and human tissue .  
Human retinal pigment epithelia (RPE) play a major role in removing waste products from 
the subretinal space that surround nearby photoreceptors. Due to the high metabolic rate of 
photoreceptors, the apical membrane of RPE are exposed to high levels of CO2 and Adijanto 
et al. (2009) have demonstrated membrane transporter activity to be sensitive to this 
hypercapnic microenvironment. Exposure of RPE to 13% CO2 stimulated the activity of a 
basolateral Na
+
/HCO3
-
 cotransporter (NBC) which increased Na
+
 and HCO3
-
 uptake into the 
cell and contributed to ~80% observed increase in fluid reabsorption. Conversely, RPE cells 
exposed to 1% CO2 had reduced NBC activity and a ~64% decrease in fluid reabsorption. 
However, the data was limited by the fact that altering CO2 levels caused a change in the 
intracellular pH (pHi) of the RPEs and therefore determining whether the changes in 
basolateral NBC activity was due to CO2 per se or changes in pHi was difficult. These studies 
provide valuable indications that hypercapnia is able to modulate plasma membrane 
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transporter activity to bring about a change in ion and fluid transport in animals and indeed 
humans. Therefore, gaining further insights into the molecular mechanisms underlying this is 
of major interest in the field of epithelial membrane transport physiology.  
 
1.2. The effect of CO2 on cell signalling second messengers 
1.2.1. The adenylyl cyclase/cAMP signalling pathway  
Cyclic adenosine 3’,5’-monophosphate (cAMP) is a key cellular second messenger first 
discovered by Berthet et al. (1957). ATP is converted into cAMP by a reaction catalyzed by 
the enzyme adenylyl cyclase (AC). This enzyme was first purified from bovine brain in 1985 
(Pfeuffer et al., 1985) and the entire coding sequence for bovine brain AC was published four 
years later (Krupinski et al., 1989). There exists two forms of adenylyl cyclase: 
transmembrane adenylyl cyclase (tmAC) (of which nine isoforms exists) and soluble 
adenylyl cyclase (sAC).  Amino acid sequencing has revealed that each tmAC isoform 
contains two transmembrane spanning domains (Tm1 and Tm2), as well as two catalytic 
domains, namely C1 and C2 (fig. 1.01). Each catalytic domain contains an ATP binding site 
which, upon tmAC activation, is converted into cAMP (Cooper et al., 1995). cAMP has a 
host of downstream targets ranging from the activation of cAMP-dependent protein kinase A 
(PKA), to the activation of transcription factors such as cAMP response element binding 
protein (CREB), allowing it to regulate gene expression in cells. 
 
Figure 1.01: The structure of transmembrane adenylyl cyclase.  TmAC contains two 
transmembrane spanning domains (Tm1 and Tm2) joined by an intracellular catalytic domain which 
can be further divided into the highly conserved catalytic domains 1a (C1a) and 2a (C2a) with C1b 
and C2b being less conserved domains. This is the site for ATP binding for conversion into cAMP. 
Figure adapted from Cooper (2003).  
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1.2.2. CO2 can modulate adenylyl cyclase activity 
As previously discussed, there exists a great deal of evidence that implicates CO2 as a 
signalling molecule in a host of different organisms. One reason why cells are able to sense, 
and thus respond to, CO2 is due to a CO2 induced effect on key intracellular second 
messengers, notably cAMP and Ca
2+
. It was initially shown that adenylyl cyclase activity was 
modulated by inorganic carbon (Ci) and thus responsive to both CO2 and HCO3
-
. However, 
Hammer et al. (2006) showed that the activity of the prokaryotic class III adenylyl cyclase, 
Slr1991, isolated from Synechocystis PCC 6803, was increased by CO2 but not HCO3
-
, which 
gave an early indication that adenylyl cyclase was sensitive to CO2 rather than carbon per se . 
This work was followed by a publication from our laboratory in which the role of CO2 on 
adenylyl cyclase activity across different species was investigated (Townsend et al., 2009). In 
this study, a recombinant, catalytically active, mammalian, transmembrane adenylyl cyclase 
protein, named 7C1•2C2, was expressed in HEK 293T cells and it was found that 
isoproterenol-induced ATP to cAMP conversion was significantly higher in cells exposed to 
5% CO2 compared to those exposed to 0.03% CO2.  Interestingly, further increase of CO2 to 
10% CO2 caused 7C1•2C2 activity to plateau, thus highlighting that CO2 has dose-dependent 
effects on adenylyl cyclase activity. This was the first work to show that mammalian 
transmembrane adenylyl cyclases are sensitive to CO2. Parfenova and Leffler (1996) 
demonstrated that cultured microvascular smooth muscle cells release higher amounts of 
cAMP into the extracellular space in response to a 15 minute exposure to hypercapnia  
suggesting either a greater production of cAMP or perhaps an increased activity of cAMP 
transporters such as the multidrug resistance proteins (Jedlitschky et al., 2000; Chen et al., 
2001; Osycka-Salut et al., 2014). Finally, our laboratory has shown that incubating OK cells 
(a renal cell line that is a model for proximal tubule cells) in 10% CO2 caused a ~20% and 
~30% reduction in parathyroid hormone and forskolin-stimulated intracellular cAMP levels 
([cAMP]i) respectively, compared to cells incubated in 5% CO2 (Cook et al., 2012). This 
phenomenon was not observed in the presence of BAPTA-AM, the inositol 1,4,5-
trisphosphate (IP3) receptor blocker 2-aminoethoxydiphenyl borate (2-APB) or in DT40KO 
cells which do not express any of the three IP3 receptor subtypes, suggesting that CO2 
stimulated IP3-induced Ca
2+
 signalling which reduced tmAC activity and subsequent cAMP 
production. Furthermore, hypercapnia enhanced the activity of the Na
+
/H
+
 exchanger 3 
(NHE3) in OK cells, a transporter negatively regulated by cAMP/PKA. Thus, our laboratory 
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has shown hypercapnia can affect cAMP-regulated transporters although precisely how this 
occurs is not fully understood. 
1.2.3. CO2 can modulate intracellular Ca
2+
 levels 
As described in 1.2.2., Cook et al., (2012) demonstrated a role for a change in [Ca
2+
]i in the 
response of renal cell lines to hypercapnia , and Ca
2+
 is indeed another very important second 
messenger that can be affected by environmental CO2. When measuring [Ca
2+
]i levels in 
rabbit proximal tubule, Bouyer et al. (2003) found applying 5% CO2 to the basolateral 
membrane, but not the apical membrane, induced an increase in [Ca
2+
]i. This increase in 
[Ca
2+
]i was even further augmented in the presence of 20% basolateral CO2. The source of 
Ca
2+
 was found to be from intracellular stores but Ca
2+
 release was insensitive to 
thapsigargin, caffeine and retonone, suggesting the stores were not the endoplasmic reticulum 
or mitochindria but potentially could be lysosomal. Similar observations have been made by 
Briva et al., (2011) who demonstrated that [Ca
2+
]i levels increase in the presence of 10% CO2 
in alveolar type II cells. However, in this instance the increase in [Ca
2+
]i was due to Ca
2+
 
entry from the extracellular medium. Interestingly, in human endothelial cells, although 
hypercapnia induced a small increase in [Ca
2+
]i, the largest increase in [Ca
2+
]i was in response 
to hypocapnia (2% CO2) (Nishio et al., 2001). This change in [Ca
2+
]i was thapsigargin-
sensitive and shows that distinctly different mechanisms for CO2 sensing exist in mammalian 
endothelial cells compared to epithelial cells. 
 
1.3. CO2 signalling in mammalian airways 
In mammalian airways, fluid reabsorption is governed by the rate of Na
+
 transport across 
airway cells, which generates an osmotic gradient for water absorption. The epithelial Na
+
 
channel (ENaC), expressed on the apical membrane of absorptive lung epithelia, transports 
Na
+
 into the cell which is effluxed across the basolateral membrane and into the bloodstream 
via the Na
+
/K
+
-ATPase (Fang et al., 2002). Briva et al. (2007) demonstrated that exposing 
isolated rat lung tissue to hypercapnia (60mmHg CO2) decreased Na
+
/K
+
-ATPase activity and 
consequently reduced alveolar fluid reabsorption. This occurred due to a CO2-dependent 
translocation of PKC-α and PKC-ζ to the basolateral membrane of alveolar type II cells, 
which triggered the endocytosis of the α subunit of Na+/K+-ATPase and consequently 
reduced pump activity in these cells. Follow up studies showed that the CO2-induced 
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translocation of PKC to the basolateral membrane of rat ATII cells was dependent on a CO2-
induced rise in [Ca
2+
]i as well as CO2-dependent activation of extracellular signal regulated 
kinase (ERK) 1/2 and adenosine monophosphate kinase (AMPK) (Vadasz et al., 2008). 
These findings provide fascinating insights into the effect of CO2 on key components of 
intracellular signalling pathways. 
 
1.4. CO2 and airway disease 
Although it is often used as a marker for lung disease, hypercapnia is also associated with the 
treatment of the lung diseases Acute Respiratory Distress Syndrome (ARDS) and Acute Lung 
Injury (ALI). These are diseases of the lung caused by the release of proinflammatory 
cytokines at the alveoli which recruits neutrophils, and inflammation of the lungs occurs 
(Martin, 1999; Pierrakos et al., 2012). An X-Ray of ARDS lungs showing clearly visible lung 
inflammation is shown in figure 1.02 (right panel). Therapeutic strategies employed to treat 
ARDS and ALI involve reduction of ventilation by mechanical measures to produce a tidal 
volume of approximately 6ml/kg body mass. This was based on findings in mice that 
revealed a high tidal volume increases the release of inflammatory mediators such as TNF-α 
and IL-6 (von Bethmann et al., 1998). A trial into the effects of ventilation in ARDS patients 
revealed that patients with a tidal volume of 6.2ml/kg body mass had a significant reduction 
in mortality and organ failure compared to the control group with a tidal volume of 11.8ml/kg 
body mass (Network, 2000). These results supported earlier work by Amato et al. (1998) who 
also found that a reduction in tidal volume improved survival in ARDS patients. How this 
form of treatment is beneficial to ARDS patient is still not well understood but one 
explanation could be linked to the result of the hypercapnia that arises due to the nature of the 
therapy. Prin et al. (2002) reported a mean PaCO2 of 67 ± 9 mmHg for ARDS patients 
undergoing treatment . This “permissive hypercapnia” - so called in that it must be tolerated 
in order for the treatment to have any benefits to the patient - may contribute to the effects on 
survival seen when tidal volume is reduced. Laffey et al. (2000) demonstrated in an in vivo 
rabbit model of ALI, that hypercapnia caused a reduction in pulmonary microvascular 
permeability as well as a decrease in the level of the proinflammatory cytokine TNF-α, 
compared to the normocapnic control group, implicating hypercapnia to have anti-
inflammatory effects in response to lung injury. Similar findings were also reported by 
Sinclair et al. (2002) and De Smet et al. (2007).   
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These findings suggest hypercapnia can help reduce the inflammation associated with ARDS 
and ALI and so prevent progression of the disease. Although the current mechanism for how 
this occurs remains to be determined, it appears that hypercapnia can regulate the activity of 
NF-κB, a master regulator of genes involved in inflammation and repair. Hypercapnia has 
been shown to reduce NF-κB activation following stretch-induced injury of A459 cells, 
which was accompanied by a fall in the level of the proinflammatory cytokine IL-8 and an 
increase in cell viability (Contreras et al., 2012). Similarly, Oliver et al. (2012) demonstrated 
that hypercapnia induced RelB (a member of the NF-κB family) cleavage and nuclear 
translocation, in both A459 cells and in an in vivo rat model of lung injury, which 
corresponded with a reduction in the levels of TNF- α. These results suggest that CO2 
modulates NF-κB signalling and consequentially expression of proinflammatory genes. In the 
lungs of newborn mice, Li et al. (2006) showed that hypercapnia induced downregulation of 
many genes involved in immune responses and supports the idea that hypercapnia can act as 
an anti-inflammatory agent to reduce progression of ARDS/ALI. These results were 
interesting in that mild hypercapnia (8% CO2) had much more pronounced effects than severe 
hypercapnia (12% CO2) suggesting cells are highly sensitive to the degree of CO2 in which 
they are exposed. 
Although there exists several studies which support the idea of hypercapnia as an anti-
inflammatory agent, it is worth noting that other studies have reported that increasing CO2 
levels can actually trigger pulmonary inflammation. Murine lung tissue exposed to 
hypercapnia for one hour demonstrated an upregulation and increased secretion of the 
proinflammatory cytokines IL-6, IL-8 and MIP-2 (Abolhassani et al., 2009). Interestingly, 
this was thought to be due to a CO2-induced nuclear translocation of p65 (a member of the 
NF-κB family) and not RelB as shown by Oliver et al., (2012). MUC5AC protein levels, 
another marker of pulmonary inflammation, were also increased in hypercapnia. These 
findings provide fascinating insights and promote interesting debates into whether permissive 
hypercapnia does slow disease progression in ARDS/ALI. Given the contradictory nature of 
the findings, it reinforces the importance of fully understanding the effects of CO2, 
particularly as a potential beneficial signalling molecule.  
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Figure 1.02: Chest X Rays to show the effects of ARDS on the lungs.  Left image is of a healthy 
individual and was obtained from Karippacheril and Joseph (2010) whilst the right image is of an 
ARDS patient and was obtained from Mackay and Al Haddad (2009).  
 
1.5. The role of bicarbonate in human physiology 
The anion bicarbonate (HCO3
-
) plays an important role in mammalian physiology, 
particularly in the regulation of intracellular and extracellular pH. Its ability to be reversibly 
converted into CO2, via an reaction with H
+
, not only provides a way for HCO3
-
 to diffuse 
across cell membranes in a gaseous form but it also forms the CO2-HCO3
-
 buffer system to 
maintain the pH of body fluids (Marques et al., 2003). The effect of CO2 and HCO3
-
 on pH is 
summarized by the Henderson-Hasselbalch equation which states that: 
pH = pKa + log10  (
[HCO3
-]
0.03 x pCO2
) 
in which pKa = 6.1 (the negative log of the carbonic acid dissociation constant). 
Another critically important role for HCO3
-
 is in mucosal protection of the GI Tract. A high 
HCO3
-
 concentration in the stomach, combined with gastric mucins, provides the stomach 
mucosa with a protective barrier against stomach acid and pepsin (Flemstrom and Isenberg, 
2001; Allen and Flemstrom, 2005). Mammalian pancreatic duct cells have been shown to 
secrete HCO3
-
 in response to cAMP agonists, primarily forskolin and secretin (Banwell et al., 
1967; Ishiguro et al., 1996) whereupon it helps solubilize digestive enzymes as well as 
neutralizing the acidic chyme entering the small intestine to provide the optimum conditions 
for pH-sensitive digestive enzymes to function (Scratcherd and Case, 1973). Further down 
the GI tract, Flemstrom et al. (1982) and (1984) showed HCO3
-
 secretion to occur in the 
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mammalian duodenum whilst Seidler et al. (1997) have also demonstrated cAMP-regulated 
HCO3
-
 secretion to occur in the duodenum, jejunum and ileum of mice. Here, HCO3
-
 
secretion again acts to neutralize gastric acid and thus protect the surface epithelium of the 
intestine. Another important role of HCO3
-
 secretion in the GI tract, which has only recently 
come to light, is that it is important in mucus release. As shown in figure 1.03, it is known 
that mucins, the large glycoproteins that constitute mucus, are stored in mucin granules due to 
the presence of the cations Ca
2+
 and H
+
 which allows negatively charged mucins to be tightly 
packed together. Chelation of these cations causes the negatively charged mucins to repel one 
another and thus expand to form the macromolecular structure of mucus. Indeed, in cervical 
tissue, mucus secretion is impaired when extracellular Ca
2+
 or extracellular H
+
 are increased 
(Espinosa et al., 2002) and there exists several studies that implicate HCO3
-
 in having a major 
role in chelation of H
+
 and Ca
2+
. Garcia et al. (2009) demonstrated that prostaglandin and 
serotonin-stimulated mucus secretion in mouse intestine was impaired in the absence of 
serosal HCO3
-
 or when mucosal HCO3
-
 secretion was inhibited. Similar findings have also 
been reported by Gustafsson et al. (2012) who found reducing basolateral HCO3
-
 in mouse 
ilea significantly increased the thickness of secreted mucus that was rescued by addition of 
apical HCO3
-
. Furthermore, HCO3
-
 mimicked the effect of EGTA on mucus diffusivity in 
airway epithelia supporting the hypothesis that HCO3
-
 acts to chelate Ca
2+
 and thus allow for 
efficient mucus expansion and release (Chen et al., 2010). More recently, Ridley et al. (2014) 
studied the biophysical properties of MUC5B, a mucin found in the airways. They found that 
MUC5B bound Ca
2+
 at its N-terminal D3-domain which caused the formation of cross-links 
between the MUC5B polymers allowing them to be tightly condensed into vesicles. The 
conformational state of the polymers to allow for Ca
2+
-mediated cross-links was dependent 
on a low pH in the vesicle. Therefore, this study proposed HCO3
-
 secretion would induce a 
conformational change within the MUC5B polymers, abolish the Ca
2+
-mediated cross-links, 
and allow for efficient mucus expansion and secretion. Together, these studies indicate that 
impaired epithelial HCO3
-
 secretion, as observed in Cystic Fibrosis, a hereditary disease in 
which mutations in the gene for the Cl
-
 channel, Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR) leads to loss of functional expression at the apical membrane 
of secretory epithelia (see section 1.6.1), contributes to the thick, sticky mucus observed in 
mucus secreting organs that characterizes this disease. HCO3
-
 transport can also act as a 
stimulus for important physiological processes to occur. For instance, fertilisation relies 
heavily on the presence of HCO3
-
. Both spermatogenesis in Leydig cells and capacitation of 
sperm inside the female reproductive tract require the transportation of HCO3
-
 into sperm 
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cells to trigger cell signalling cascades that initiate these processes key to reproduction (Zeng 
et al., 1995; Hess et al., 2005). Thus it is clear that HCO3
-
 has important roles in a variety of 
tissue in the body. However, currently it is its role in the lungs which is gaining major interest 
within the field of airway physiology and pathophysiology. 
 
 
Figure 1.03. Hypothesis for the role of HCO3
-
 secretion in mucus release and expansion from 
mucin granules.  Chelation of the cations Ca
2+ 
and H
+
 by secreted HCO3
-
 causes negatively charged 
mucins to repel one another and therefore rapidly expand when released from goblet or mucus cells. 
Figure taken from Garcia et al. (2009). 
 
1.6. HCO3
-
 Secretion in Human Airways 
The human airways can be separated into two components: the conducting airways, which 
include the larynx, trachea, bronchi and bronchioles and are responsible for the transportation 
of gas inside the lungs; and the respiratory airways, which include the alveoli and which is 
the site of gas exchange (Fowler, 1948). Lining the conducting airways is a thin layer of fluid 
(6-10µm) known as the airway surface liquid (ASL) which is shown in figure 1.04.  
12 
 
 
Figure 1.04: The conducting airways are covered with a thin layer of airway surface liquid 
(ASL). (A) is a cartoon representation of where the ASL is located in the airways. Figure adapted 
from Verkman (2002). (B) shows an in vitro image of human tracheobronchial epithelial cells stained 
green using 10µM calcein/AM and the overlaying fluid stained using dextrans conjugated to Texas 
Red. Figure taken from Matsui et al. (1998) .  
 
The ASL consists of two layers: the underlying periciliary layer and the overlying mucus 
layer. The mucus layer predominantly consists of water and mucins and is responsible for 
trapping inhaled pathogens, which are removed by subsequent mucociliary clearance (Matsui 
et al., 1998; Knowles and Boucher, 2002). Airway mucins have been shown to bind a variety 
of pathogens, notably Pseudomonas aeruginosa (Vishwanath and Ramphal, 1984) and 
Haemophilus influenzae (Kubiet and Ramphal, 1995), and this forms part of the innate 
defence of the lung to inhaled pathogens. The periciliary layer consists of salts and water and 
both the volume and pH of the periciliary layer are important for efficient mucociliary 
clearance and maintenance of mucus properties (Bhaskar et al., 1991; Tarran et al., 2006). 
The importance of tight regulation of the ASL pH was demonstrated by Pezzulo et al. (2012) 
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who showed that killing of Staphylococcus aureus was impaired when porcine ASL pH was 
reduced from ~7.9 to ~7.4. Furthermore, airway antimicrobial peptide activity was also 
impaired at the lower pH. These findings demonstrate the importance of HCO3
-
 in ASL, not 
only in accommodating efficient mucus expansion (as discussed in 1.5.) but also in regulation 
of pH-sensitive innate defence mechanisms of the airways. The traditional model of the ASL 
is that it exists as a “gel on liquid” form. However, this was recently challenged by Button et 
al. (2012) who suggested that the periciliary layer is a mesh due to the presence of mucins 
tethered to the cilia of epithelial cells that effectively form a periciliary brush (fig. 1.05) to 
prevent the overlying mucus from clogging the periciliary layer and impairing ciliary beat 
frequency.  
 
Figure 1.05: Schematic diagram of how the pericilarly layer may exist as a mesh due to the 
presence of mucins tethered to the cilia of surface epithelia.  Figure taken from Button et al. 
(2012). 
 
In the upper airways, the periciliary layer composition and volume is primarily controlled by 
the submucosal glands which contain a subset of cells known as serous cells (fig. 1.06). 
These cells are able to secrete Cl
-
, to provide a driving force for water transport, and HCO3
-
, 
to control both the volume and the pH of the secreted fluid.  Ballard et al. (1999) provided 
clear evidence that the site for the majority of ASL secretion is from glands lying below the 
mucosal layer rather than surface epithelia itself by demonstrating that in porcine airways, 
acetylcholine-stimulated fluid secretion was unaffected when the surface epithelia was 
removed. Further ex vivo studies on intact submucosal glands from porcine, murine and 
human airways, show fluid secretion is increased in response to a variety of stimuli including 
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carbachol, VIP and forskolin (Joo et al., 2002; Ianowski et al., 2007). Whilst many studies 
have clearly shown SMGs to mediate fluid secretion, less attention has been paid to the 
composition of this fluid, specifically the role for HCO3
-
 in the fluid. In 1992, Smith and 
Welsh were the first to suggest HCO3
-
 is secreted across airway epithelia by demonstrating a 
reduction in forskolin-induced short-circuit current (Isc) across human nasal epithelia in the 
absence of HCO3
-
 (Smith and Welsh, 1992). In vitro studies on a model human serous cell 
line (Calu-3) have also revealed HCO3
-
 to be a key component of the fluid secreted from 
these cells. Devor et al. (1999) used Isc measurements to show that forskolin stimulated an Isc 
across the Calu-3 cell that was reduced upon the removal of HCO3
-
 from the bath solution 
suggesting HCO3
-
 is secreted from the Calu-3 cell (Devor et al., 1999). This supported 
previous work by Lee et al. (1998) who discovered that forskolin-stimulated Isc in Calu-3 cell 
was not due to Cl
-
 or Na
+
 flux and was reduced when HCO3
-
 was removed suggesting that the 
majority of the forskolin-stimulated Isc was due to HCO3
-
 flux. Similarly, Garnett et al. 
(2011), Shan et al. (2012) and Huang et al. (2012) have all demonstrated that HCO3
-
 
secretion occurs in Calu-3 cells. This work indicates that serous cells possess the necessary 
machinery for both Cl
-
 and HCO3
-
 secretion. 
 
Figure 1.06: The submucosal gland is responsible for the majority of the airway surface liquid  
and mucus secretion.  Serous cells of the submucosal gland are heavily involved in regulating the 
volume and the composition of the ASL due to their coordinated activity of surface ion transporters. 
Figure adapted from Salinas et al. (2005).  
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1.6.1. Role of CFTR and Anion Exchangers in HCO3
-
 Secretion 
Serous cells of the SMG express high levels of CFTR on the apical surface (Engelhardt et al., 
1994). CFTR is a Cl
-
 channel that belongs to the ATP-binding cassette (ABC) family of 
transporters and is expressed on the apical membrane of surface epithelia. CFTR consists of 
two transmembrane spanning domains, each containing 6 transmembrane spanning segments 
and 2 nucleotide binding domains (NBD1 and NBD2). The two transmembrane spanning 
domains are joined by a regulatory (R) domain which possesses 9 consensus sites for 
phosphorylation by PKA as well as sites for PKC phosphorylation (Riordan et al., 1989; 
Picciotto et al., 1992; Sheppard and Welsh, 1999). The 3D structure of CFTR is shown in 
figure 1.07A. Upon CFTR phosphorylation of the R domain, a conformational change occurs 
in the R domain which allows the two NBDs to interact and bind ATP causing the channel to 
open. Subsequent ATP hydrolysis at NBD2 results in channel closure (fig. 1.07B) . The 
requirement for both CFTR phosphorylation as well as ATP in channel gating was shown by 
Anderson et al. (1991) who demonstrated that CFTR activity was dependent on PKA 
phosphorylation and the presence of MgATP.  
 
Figure 1.07: Structure and gating of CFTR.  (A) shows a 3D homology model in which the two 
membrane spanning domains (MSDs) are shown in green and the two nucleotide binding domains 
(NBDs) are shown in pink. The regulatory (R) domain is shown in grey. Figure taken from Serohijos 
et al. (2008). (B) displays how PKA-dependent phosphorylation of the R domain facilitates a 
conformational change in CFTR to allow ATP to bind to the NBDs and induce channel opening and 
Cl
-
 secretion. ATP hydrolysis at NBD2 closes the channel. Figure taken from Chen et al. (2006). 
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The major signalling pathway that regulates CFTR activity is the cAMP/PKA pathway and 
activation of CFTR stimulates transepithelial Cl
-
 and fluid secretion in CFTR-expressing 
tissues (Cheng et al., 1991; Haws et al., 1994; Cobb et al., 2002; Cobb et al., 2003; Derand et 
al., 2004; Hentchel-Franks et al., 2004). The role of CFTR-dependent anion secretion and 
subsequent fluid secretion has been studied extensively in the airways. Joo et al. (2002) 
demonstrated that cAMP-elevating agonists, Vasoactive Intestinal Peptide (VIP) and 
forskolin, increased fluid secretion from submucosal glands which was absent in glands 
isolated from non CFTR-expressing tissue. Studies performed on Calu-3 cells revealed that 
treatment with a variety of phosphodiesterase inhibitors that increase cAMP levels activates 
electrogenic Cl
-
 secretion which is inhibitable by the non-specific CFTR inhibitor 
glybenclamide (Cobb et al., 2002) whilst stimulation of Calu-3 cells with VIP induced efflux 
of I
-
 which was sensitive to H-89 and glybenclamide but not DIDS suggesting VIP activated 
PKA-regulated, CFTR-dependent I
-
 transport (Derand et al., 2004). Similarly, Rollins et al. 
(2008) demonstrated that activation of the adenosine receptor subtype A2B, a Gs coupled 
receptor that stimulates adenylyl cyclase and cAMP production, caused CFTR-dependent 
fluid secretion in primary human bronchial epithelia.  Not only does CFTR stimulate Cl
-
 
secretion but it also inhibits the epithelial Na
+
 channel, ENaC, to prevent Na
+
 reabsorption 
from the lumen of the airways and thereby further increasing the osmotic gradient for water 
transport (Mall et al., 1999). Lee and Foskett (2010) have suggested an alternative 
mechanism of cAMP-dependent CFTR activation. Studies on primary porcine serous cells 
revealed that stimulation of cells with the cAMP agonists VIP and forskolin also induced an 
elevation in [Ca
2+
]i., a process that was PKA-dependent. The researchers suggested that this 
cAMP-induced increase in [Ca
2+
]i caused Ca
2+
 activated K
+
 channels to increase the 
electrochemical driving force for Cl
-
 secretion via CFTR. Furthermore, they showed mouse 
serous cells were unable to secrete fluid in response to cAMP agonists because there was no 
accompanying increase in [Ca
2+
]i (Lee and Foskett, 2012). Only when Ca
2+
-activated K
+
 
channels were activated with 1-EBIO did forskolin stimulate fluid secretion from mouse 
serous cells and highlights the importance of cAMP and Ca
2+
 crosstalk in order to regulate 
CFTR-dependent ion and fluid secretion. The role of CFTR in mediating fluid secretion has 
been well described but what is less well known is how it also regulates HCO3
-
 secretion in 
the airways.  
Although research has shown airway HCO3
-
 secretion to be cAMP-activated and CFTR-
dependent, how this HCO3
-
 secretion is achieved is still controversial.  Illek et al. (1997) 
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recorded Isc in Calu-3 cells and demonstrated a cAMP-induced Isc which possessed a HCO3
-
 
dependent component. The HCO3
-
 induced Isc was activated by the CFTR modulator 
genistein and inhibited by the CFTR blocker glybenclamide leading the researchers to 
conclude that CFTR directly mediates HCO3
-
 efflux. This was supported by studies 
performed on pancreatic duct cells that showed CFTR to possess HCO3
-
 transporting 
capabilities (Ishiguro et al., 1996). Shan et al. (2012) also proposed that HCO3
-
 is secreted 
through CFTR in the airways as they found HCO3
-
 secretion to be blocked by the CFTR 
inhibitor GlyH-101, as well as by genetic knockdown of CFTR in Calu-3 cells. The 
importance of CFTR in regulating HCO3
-
 secretion is highlighted when studying HCO3
-
 
transport in CF tissue. Impaired HCO3
-
 secretion has been shown in a number of different CF 
tissue including CF canine airways (Smith and Welsh, 1992), CF murine intestinal epithelia 
(Xiao et al., 2012), CF human nasal epithelia (Paradiso et al., 2003) as well as in cell lines 
transfected with mutant CFTR (Choi et al., 2001). Furthermore, Coakley et al. (2003) 
demonstrated that cultured primary human bronchial epithelia (HBEs) were able to secrete 
HCO3
-
 in response to an acidic ASL, a process enhanced by intracellular cAMP elevations. 
However, HBEs isolated from CF patients were unable to alkalinize an acidic ASL in basal or 
cAMP elevated conditions, consistent with impaired CFTR-dependent HCO3
-
 secretion in 
these cells. Similar findings were reported by Paradiso et al. (2003) who found that the rate of 
HCO3
-
 secretion in primary nasal epithelia isolated from CF patients was significantly lower 
than that of non-CF nasal epithelia. In addition, forskolin was only able to increase the rate of 
HCO3
-
 secretion in non-CF cells. Therefore, whilst it is clear CFTR plays a major role in 
HCO3
-
 secretion, more recently it has been speculated, that in some tissue at least, CFTR may 
indirectly regulate HCO3
-
 secretion due to the activation of associated Cl
-
/HCO3
-
 exchangers. 
Studies performed in kidney cells, intestinal cells and pancreatic duct cells have revealed that 
members of the SLC26 family of Cl
-
/HCO3
-
 exchangers, SLC26A3, SLC26A4 and 
SLC26A6, function to secrete HCO3
-
 in these tissue (Soleimani et al., 2001; Stewart et al., 
2011). Studies into SLC26 family members interactions with CFTR have shown that 
SLC26A9, a SLC26 family member transporter expressed in airway epithelia (Lohi et al., 
2002), acted as a cAMP-stimulated Cl
-
 channel when coexpressed with CFTR in HEK 293T 
cells and that SLC26A9 activity in HBE cells was also dependent on CFTR expression 
(Bertrand et al., 2009). A recent study by Anagnostopoulou et al. (2012) showed that 
SLC26A9 played an important role in Cl
-
 secretion in response to IL-13 to prevent airway 
mucus obstruction in mice. In 2011, our laboratory revealed that the Cl
-
/HCO3
-
 exchanger 
SLC26A4 (pendrin) directly regulated HCO3
-
 secretion in Calu-3 cells (Garnett et al., 2011). 
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However, pendrin activity was markedly reduced in the presence of the CFTR inhibitor 
GlyH-101, and the PKA inhibitor H-89, as well as being reduced in CFTR KD cells, showing 
that CFTR regulated pendrin activity. However, how this is achieved is still not fully 
understood. SLC26 transporters physically and functionally interact with the phosphorylated 
R domain of CFTR via their STAS domain as described by Ko et al. (2004) and Avella et al. 
(2011) and illustrated in figure 1.08. Furthermore, most SLC26 transporters possess a PDZ 
binding domain; a protein-protein interaction module consisting of 80-100 amino acids (Lee 
and Zheng, 2010), which enable them to bind to PDZ binding scaffold proteins, for example 
CAP70 (Rossmann et al., 2005) or NHERF1 (Lohi et al., 2003). These scaffold proteins are 
also bound to CFTR, thus tethering both transporters within the same macromolecular 
complex. However, pendrin does not possess a C-terminal PDZ domain so therefore must 
associate with CFTR in an alternative, and as of yet unidentified, mechanism. 
 
Figure 1.08: The physical and functional interaction between CFTR and SLC26 transporters. 
The phosphorylated R domain of CFTR binds to SLC26 transporters via their STAS domain to 
enables CFTR to directly regulate the activity of the SLC26 anion exchangers. Figure taken from 
Gray (2004). 
 
1.6.1.2. CFTR is contained within a macromolecular complex 
CFTR regulation by cAMP signalling is more complex than first believed. This is because 
CFTR is contained within a macromolecular complex at the apical membrane which forms a 
microdomain to localize the cAMP signalling machinery to the site of CFTR (fig 1.09). Sun 
et al., (2000) demonstrated that at the apical membrane of Calu-3 cells, CFTR binds to the 
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PDZ binding protein Na
+
/H
+
 Exchanger regulatory factor 1 (NHERF1) (Sun et al., 2000b). 
NHERF1 interacts with the anchor protein Ezrin which in turn is bound to actin to indirectly 
tether CFTR to the cytoskeleton. PKA also binds to Ezrin which enables PKA to be 
colocalized with CFTR to enable efficient CFTR activation (Sun et al., 2000a). CFTR is able 
to be activated by compartmentalized cAMP signalling, as shown by Huang et al. (2001) who 
used cAMP measurements and patch-clamp experiments to show that although apical 
adenosine caused very little increase in total cellular cAMP compared to forskolin, the extent 
of CFTR activation between the two agonists was very similar. These findings suggest 
stimulation of adenosine receptors produces a highly compartmentalized cAMP signal which 
is sufficient to activate CFTR. Compartmentalization of cAMP signalling has also been 
proposed by Barnes et al. (2005) who showed that inhibition of phosphodiesterase 4D did not 
significantly increase total [cAMP]i but was able to stimulate CFTR activity in Calu-3 cells. 
This suggests that inhibition of specific PDE activity only increases cAMP levels at a specific 
microdomain of the cell. In addition, inhibition of PKA reduced the activity of 
phosphodiesterase 4D which demonstrated the relationship that exists between cAMP 
signalling components. Furthermore, Penmatsa et al. (2010) demonstrated that, in HEK cells, 
phosphodiesterases are also located within a microdomain with CFTR by showing PDE3 
coimmunoprecipitated with CFTR, an interaction which was increased after PKA activation. 
Together, these data show that the components required for cAMP signal transduction and 
termination are all contained within a microdomain to allow for efficient cAMP-regulated 
CFTR activation without affecting other cAMP-dependent processes in other parts of the cell.  
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Figure 1.09. CFTR is contained within a macromolecular complex at the apical membrane of 
airway cells to allow compartmentalization of the cAMP signalling machinery. NHERF1 (Na
+
/H
+
 
exchange regulatory factor 1) interacts with Ezrin to provide a scaffold for PKA as well as interacting 
with actin to tether the microdomain to the cytoskeleton. Figure taken from Guggino and Stanton 
(2006) 
 
1.6.2.  Sodium Bicarbonate Cotransporters 
Whereas CFTR and Pendrin appear to mediate the apical efflux of HCO3
-
 in human airway 
Calu-3 cells, HCO3
-
 influx from the blood is believed to be controlled by NBCs. NBCs 
perform different functions depending on their expression in different tissue. For instance, an 
electrogenic Na
+
/HCO3
-
 cotransporter expressed in the kidney (kNBCe1) mediates HCO3
-
 
reabsorption whereas the same transporter expressed in the pancreas mediates HCO3
-
 
secretion (Ruiz and Arruda, 1992; Jacob et al., 2000) with the major difference between the 
two isoforms being the differences in stoichiometry of each transporter. In non HCO3
-
 
secreting tissue, NBCs act to regulate intracellular pH; for example in epididymal epithelium 
in which pHi recovery from an acid load is both Na
+
 and HCO3
-
-dependent and is prevented 
by non-specific pharmacological inhibition of NBC (Zuo et al., 2011). However, in HCO3
-
 
secreting tissue, NBCs have another role; to transport HCO3
-
 from the blood and accumulate 
it into the cell. Studies performed on rabbit colonic crypts have shown that Na
+
-dependent 
HCO3
-
 uptake across the basolateral membrane was activated by forskolin and inhibited by 
the NBCe1 inhibitor S089 demonstrating the role of NBCe1 in cAMP-stimulated HCO3
-
 
transport (Bachmann et al., 2003). Genetic knockdown of an electroneutral Na
+
/HCO3
-
 
cotransporter (NBCn1) in mice show a significant reduction in forskolin-stimulated HCO3
-
 
secretion in the duodenum and highlights the importance of these cAMP-regulated 
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transporters in HCO3
-
 secreting epithelia (Chen et al., 2012). In Calu-3 cells, Devor et al. 
(1999) demonstrated that forskolin-stimulated HCO3
-
 secretion is markedly reduced when a) 
Na
+
 is absent from the serosal solution and b) DNDS or ouabain are present at the basolateral 
membrane thus implicating a role for NBC in accumulation of intracellular HCO3
-
 for 
secretion at the apical membrane. These findings are supported by Shan et al. (2012) who 
have also shown HCO3
-
 secretion to be Na
+
-dependent in Calu-3 cells. Furthermore, Calu-3 
cells also express both NBCe1 and NBCe2 on their basolateral membranes (Kreindler et al., 
2006). Studies on porcine bronchi show that removal of Na
+
 from the serosal solution 
markedly inhibits forskolin-stimulated fluid secretion although, surprisingly, this has no 
effect on HCO3
-
 concentration of the secreted fluid suggesting that basolateral NBC is 
responsible for mediating fluid secretion yet cells may possess other mechanisms to ensure 
that the pH of secreted fluid is maintained e.g. Na
+
/H
+
 exchangers (Ballard et al., 1999). 
These findings demonstrate the importance of coordinating the activity of both apical and 
basolateral HCO3
-
 transporters to achieve efficient HCO3
-
 secretion in the airways and other 
HCO3
-
 secretory tissue. 
 
1.6.3.  Model of anion secretion in Calu-3 cells 
A current model for anion secretion in Calu-3 cells is shown in figure 1.10. The model 
includes the key pHi regulatory transporters that have been shown to be expressed in Calu-3 
cells. At the basolateral membrane, HCO3
-
 enters the cell from the serosa due to the activity 
of the cAMP-regulated NBCs with a Na
+
 gradient maintained by the basolateral Na
+
/K
+
 
ATPase (not included in fig 1.10). At the apical membrane, activation of CFTR promotes Cl
-
 
efflux as well as stimulation of the Cl
-
/HCO3
-
 exchanger pendrin. This enables HCO3
-
 
secretion to occur across the apical membrane via pendrin, whilst Cl
-
 is recycled due to the 
coordinated activity of both CFTR and pendrin. Importantly, our laboratory has shown that 
increases in intracellular cAMP inhibit the basolateral Cl
-
/HCO3
-
 exchanger (AE2) (Garnett et 
al., 2011; Garnett et al., 2013) to prevent loss of intracellular HCO3
-
 across the basolateral 
membrane.  
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Figure 1.10: A model of anion secretion in the Calu-3.  This model demonstrates how Calu-3 cells 
achieve HCO3
-
 secretion upon stimulation by a cAMP agonist. CFTR = Cystic fibrosis 
transmembrane conductance regulator; NHE = Na
+
/H
+
 Exchanger; NBC = Na
+
/HCO3
-
 Cotransporter; 
tmAC = transmembrane adenylyl cyclase; AE2 = anion exchanger 2. 
 
 
1.7.  Hypothesis and Aims 
Given that hypercapnia has been shown to affect cAMP signalling in mammalian cells 
(Townsend et al., 2009; Cook et al., 2012) and knowing that cAMP plays a major role in the 
efficient secretion of HCO3
-
 in airway epithelia, I hypothesise that hypercapnia will cause a 
dysregulation of cAMP-dependent HCO3
-
 secretion in Calu-3 cells. 
The major aim of the current study was to investigate the effect of acute and chronic 
hypercapnia on cAMP-regulated ion and fluid transport in a model human airway epithelial 
cell line.  
The specific aims of this work were to: 
 assess whether hypercapnia can affect intracellular cAMP levels in a model of human 
airway epithelial cells. 
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 study transepithelial ion and fluid transport in a polarised monolayer of human airway 
epithelia and deduce whether hypercapnia can alter the activity of known HCO3
-
 
transporters in these cells. 
 understand the key signalling components involved in any CO2-induced alterations in 
ion and fluid transport. 
 investigate the effects of chronic hypercapnia in a clinically-relevant setting by 
observing whether hypercapnia can alter the wound healing ability of Calu-3 cells.
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Chapter 2:  Methods 
2.1. Cell Culture 
All cell culture techniques were carried out in a class II vertical laminar flow hood (Jouan 
Ltd, UK). All equipment was sterilized prior to use and all consumables were pre-warmed to 
37˚C in a water bath prior to use. Calu-3 cells (ATCC HTB-55) (Shen et al., 1994) were 
grown in 75cm
2
 flasks (Corning) in 30mls of culture medium consisting of Eagle’s Minimum 
Essential Medium (EMEM) supplemented with 10% fetal calf serum, 1% non-essential 
amino acids, 2mM L-Glutamine, 100Uml
-1
 penicillin and 100gml-1 streptomycin. Cells were 
initially seeded at 3 x 10
6
 cells/flask and became confluent after 7 days. Cells were incubated 
at 37°C in humidified air containing 5% (v/v) CO2 and were only used between passage 20 
and passage 50. To subculture cells, the media was removed and cells were washed 3 times 
with sterile phosphate buffered saline (PBS). Cells were then incubated in 5ml of trypsin 
solution (0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) in Earle’s 
balanced salt solution) for 20 minutes in a humidified incubator at 37ºC. When approximately 
50% of cells had detached, these cells were added to 10mls pre-warmed culture medium and 
a further 5ml of trypsin solution was added to the flask and incubated for another 20 minutes. 
This ensured the remaining cells detached and these cells were added to the culture medium. 
The resulting cell suspension was centrifuged at 1500g for 3 minutes. The supernatant was 
discarded and the cell pellet was re-suspended in 10 ml of media before cells were seeded as 
required.  
 
2.2. Transepithelial Resistance Measurements 
The transepithelial electrical resistance (TEER) was routinely measured using an epithelial 
voltohmmeter (World Precision Instruments, UK) to determine when cells had formed a 
polarized monolayer which generally occurred after 6 days as indicated by a transepithelial 
electrical resistance of above 600Ω cm-2 (fig. 2.01). All resistance measurements presented in 
this work are corrected for the resistance of an empty transwell which was calculated as 111 
± 4 Ω cm-2 (n=6). 
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Figure 2.01: Change in the transepithelial electrical resistance (TEER) of Calu-3 cells grown as 
a polarised monolayer on permeable transwell supports.  Each data point represents mean ± 
S.E.M., n = 6 for each. 
 
2.3. Short circuit current measurements using an Ussing Chamber 
The Ussing Chamber, named after its founder Hans Ussing (Ussing and Zerahn, 1951), is a 
device that allows for the measurement of transepithelial ion transport across epithelial cells 
by recording the short-circuit current (Isc) across a monolayer of epithelia. The Isc is the 
current required to clamp the transepithelial voltage (Vte) to 0mV and thus changes in Isc 
reflect changes in ion transport across the epithelial monolayer. Calu-3 cells were cultured on 
to 12 mm permeable Snapwell supports with 0.4μm pore polyester membrane insert 
(Corning, UK) at a seeding density of 2.5 x 10
5
 cells/well and were studied 8-10 days post-
seeding. Snapwells were mounted into the Ussing chamber in which each chamber was 
connected to a calomel voltage sensing electrode and a AgCl2 current sensing electrode (both 
stored in 3M KCl) by 3M KCl salt bridges containing 3% Agar (fig. 2.02). The potential 
difference between the two chambers was offset prior to recording. Cells were bathed in 
7.5mls of Krebs solution that were gassed with either 5% (v/v) CO2/95% (v/v) O2 for control 
conditions or 10% (v/v) CO2/90% (v/v) O2 to induce acute hypercapnia. Pharmacological 
agents were prepared as a concentrated stock solution and the appropriate amount of drug 
was added to the chamber in order to generate the desired working concentration. To measure 
the Isc, the cells were clamped at 0mV using a DVC-1000 Voltage/Current Clamp (WPI) and 
a Powerlab 1200 feedback amplifier (AD Instruments) injected the appropriate current to 
keep Vte at 0mV. This was recorded as the Isc. To monitor transepithelial resistance (Rte), a 2 
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second 10mV pulse was applied every 30 seconds and the resulting increase in current 
enabled Rte to be calculated using Ohms Law. Vte was recorded using Scope 3 software (AD 
Instruments). 
 
Figure 2.02: Diagram to show how short-circuit current was measured using an Ussing 
chamber.  Calu-3 cells were grown as a polarised monolayer on permeable Snapwell supports, 
inserted into an Ussing chamber which was bathed in 7.5mls of Krebs solution. The chamber was 
connected to voltage sensing calomel electrodes and current sensing AgCl electrodes by KCl salt 
bridges. Figure adapted from Rasgado-Flores et al. (2013). 
 
2.4. Intracellular pH Measurements 
In order to investigate HCO3
-
 transport in Calu-3 cells, real-time intracellular pH 
measurements were performed. Cells were cultured on 12mm permeable Transwell supports 
with 0.4 μm pore polyester membrane insert (Corning, UK) at an initial seeding density of 
2.5 x 10
5
 cells/well and were studied 8-12 days post-seeding. Cells were washed in 
NaHEPES solution and incubated for one hour in NaHEPES containing 10µM 2'-7'-
bis(carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) added to the 
apical compartment. Cells were then mounted on to the stage of a Nikon flour inverted 
microscope (magnification of x60 with a numerical aperture of 0.70) Krebs solutions were 
gassed with 5% (v/v) CO2/95% (v/v) O2 for control conditions and this gas composition was 
altered to 10% (v/v) CO2/90% (v/v) O2 to induce hypercapnia. Solutions were perfused across 
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the apical and basolateral compartments of the cell at 37°C at a speed of 3ml/min (apical) and 
6ml/min (basolateral). pHi was measured using a Life Sciences Microfluorimeter System. 
Cells were alternatively excited at 490 nm  (H
+
 -sensitive) and 440 nm (H
+ 
-insensitive) 
wavelengths every 1.024s by a 75W xenon short arc lamp (Osram, Germany) using a rainbow 
filter wheel (Life Sciences Resources, UK) and a dichroic mirror allowed omitted light to be 
collected at 510 nm. The ratio of 490 nm emission to 440 nm emission was recorded using 
PhoCal 1.6b software and was converted into a pHi value using the standard curve obtained 
from the intracellular pHi calibration (see section 2.4.1.). For analysis of pHi measurements, 
ΔpHi was determined by calculating the mean basal pHi over a time period of 60 seconds 
before and after a solution change. This was then subtracted from the mean pHi that results as 
a consequence of the solution change. Rate of pHi change (ΔpHi/Δt) was determined by 
performing a linear regression over a period of no less than 30 seconds of data (see figure 
2.03). The ΔpHi/Δt was converted to transmembrane HCO3
-
 efflux (-J(B)) by multiplying 
ΔpHi/Δt by total buffering capacity of the cell (βtot). βtot = βi + βHCO3- where βi represents the 
intrinsic buffering capacity and βHCO3- is the CO2-HCO3
-
 buffer system-dependent buffering 
capacity (see section 2.4.2.). 
 
Figure 2.03. Analysis of pHi experiments.  Change in pHi was measured by calculating the mean 
pHi before and after treatment (navy blue areas) and subtracting the steady state pHi resulting from 
treatment (pink area). To measure rate of pH change (ΔpHi/Δt), a linear regression was performed on 
at least 30seconds of data during pH change as shown in orange. 
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2.4.1. Intracellular pH Calibration 
Cells were treated the same way as in Intracellular pH Measurements but this time were 
perfused with high K
+
 solutions (120mM K
+
) containing 10µM nigericin and each set to a 
known pH. Nigericin is a K
+
/H
+
 exchanger ionophore to activate K
+
/H
+
 exchange which 
allowed intracellular [H
+
] to equilibrate with extracellular [H
+
] (Hegyi et al., 2003). 490/440 
ratios were converted into a pHi using the standard curve as shown in figure 2.04B. Several 
calibrations were performed throughout the duration of this work in order to routinely 
calibrate intracellular pH in different batches of Calu-3 cells. 
 
Figure 2.04: Intracellular pHi calibration of Calu-3 cells.  (A) shows a representative experiment 
in which Calu-3 cells were loaded for one hour with 10µM BCECF-AM and perfused with high K
+
 
solutions of known pH containing 10µM nigericin. (B) shows the resulting standard curve that was 
used to calculate pHi from 490/440 ratios. Data represents mean ± S.E.M.; n = 4, r
2
 = 0.954. 
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2.4.2. Determining Intracellular Buffering Capacity 
In order to determine the buffering capacity of cells (βtot), the intrinsic buffering capacity (βi) 
was added to the buffering capacity of the CO2-HCO3
-
 buffer system (βHCO3-).  βi was 
calculated using the NH4
+
 pulse technique (Roos and Boron, 1981). Here, cells were exposed 
to solutions containing differing amounts of NH4Cl, ranging from 0mM NH4Cl to 30mM 
NH4Cl. NH3 enters the cell and subsequently binds to free protons to form NH4
+
 and cause an 
alkalisation of pHi. βi is then calculated via the following equation:  
βi = Δ[NH4
+
]i 
       ΔpHi 
βHCO3- is calculated using the formula: 
βHCO3- = 2.3 x [HCO3
-
]i 
in which the Henderson Hasselbalch equation states: 
 [HCO3
-
]i = pCO2 x 10
(pH – pK)
 
The buffering capacity for Calu-3 cells at varying CO2 concentrations is displayed in figure 
2.05. 
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Figure 2.05: Buffering capacity of Calu-3 cells when exposed to different concentrations of CO2.  
Total buffering capacity (βtot) was calculated by adding the intrinsic buffering capacity of Calu-3 cells 
(βi) to the buffering capacity of the CO2/HCO3
-
 buffer system (βHCO3-) βtot was calculated for cells 
exposed to 2.5% CO2, 5% CO2 and 10% CO2. n = 6 for each. 
 
2.5. Intracellular Ca
2+
 Measurements 
Calu-3 cells were cultured on 25mm diameter glass coverslips (VWR) at an initial seeding 
density of 1 x 10
6
 cells/coverslip and studied 3-4 days post seeding when cells were 
approximately 80% confluent. Cells were washed in NaHEPES and incubated with 5µM 
Fura-2 AM (Grynkiewicz et al., 1985) for one hour before the dye was removed and cells 
were incubated for 15 minutes in NaHEPES to allow for de-esterification of the dye. 
Incomplete de-esterification of Fura-2 AM will lead to artefacts within the experiment as 
Fura-2 AM is fluorescent but Ca
2+
-insensitive.  Cells were mounted onto a Nikon fluor oil 
immersion microscope (magnification of x40 with a numerical aperture of 1.3) and heated to 
37˚C. Krebs solutions were gassed with 5% (v/v) CO2/95% (v/v) O2 for control conditions 
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and this gas composition was altered to 10% (v/v) CO2/90% (v/v) O2 to induce hypercapnia. 
Solutions were perfused across cells at a speed of 3ml/min. To measure [Ca
2+
]i, cells were 
alternatively excited at 340nm and 380nm wavelengths every 0.250s and emitted light 
collected at 510nm. Fluorescence at 340nm is sensitive to high [Ca
2+
]i and fluorescence at 
380nm is sensitive to low [Ca
2+
]i. The ratio of 340 nm emission to 380 nm emission was 
recorded using InCyt PM-2 software. 
 
2.6. Fluid Secretion Assays 
The effects of chronic hypercapnia on Calu-3 cell physiology were assessed by fluid 
secretion assays in which the volume and composition of fluid secreted by cells over a 24 
hour period was measured. Cells were first washed three times with PBS in order to remove 
any mucus that may have accumulated over time. Extra care was taken when removing the 
PBS to ensure no residual fluid remained in the transwell at the end of the washes. Solutions 
containing desired pharmacological agents were then added to the transwells (1ml 
basolaterally, 200µl apically) and cells were incubated at 37˚C in humidified air containing 
5% (v/v) CO2 (control) or 10% (v/v) CO2 (hypercapnia) for 24 hours. The apical fluid was 
then removed and its volume measured. 180µl was removed first and then the rest of the fluid 
was removed 1µl at a time to ensure high accuracy. Samples were collected in an Eppendorf 
tube and, after a brief incubation in the appropriate incubator, had the pH assessed using a 
micro pH probe. Samples were then stored at -20˚C to allow for further analysis using the 
PAS Assay (see section 2.9.). 
 
2.7. Radiolabelled cAMP Assay 
Calu-3 cells were cultured in 12 well plates (Corning, UK) at an initial seeding density of 3 x 
10
5
 cells/well and used 7 days post-seeding at approximately 80% confluency. Cells were 
treated with 100µl [
3
H]-adenine at a concentration of 2µCurie/ml and incubated for 2 hours at 
37°C in humidified air containing 5% (v/v) CO2. This ensured that at least some adenine-
containing molecules synthesised after treatment would be labelled with the 
3
H isotope. Cells 
were then washed twice with PBS and incubated for a further 30 minutes at 37°C in 
humidified air containing 5% (v/v) CO2/95% (v/v) O2 (normocapnic controls) or 10% (v/v) 
CO2/90% (v/v) O2 (hypercapnia). Incubation was performed in normal growth medium that 
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had been pregassed with the appropriate CO2 concentration and titrated to pH 7.4 using 1M 
NaOH. Incubation also took place in the presence of 1mM IBMX to prevent breakdown of 
any cAMP. Forskolin (5µM) was then added to the cells for 10 minutes before the assay was 
ended by removal of media and lysis of cells by adding 5% (w/v) trichloroacetic acid 
containing 1mM ATP and 1mM cAMP for one hour at 4°C. 
cAMP levels in lysates were measured by the double column chromatography procedure 
described by Johnson et al. (1994). The lysate was added to columns containing 1ml anion 
exchange resin DOWEX 50 which had been prewashed with 1M HCl. This acidified 
DOWEX 50 traps any neutrally charged cAMP but does not trap the negatively charged 
adenine, adenosine, AMP, ADP or ATP, which flowed through the column and was collected 
in scintillation vials. The DOWEX 50 columns were then placed above columns containing 
Al2O3 and were washed through with ddH2O. This caused cAMP to be washed off the 
DOWEX and trapped on the Al2O3 which becomes acidic in the presence of H2O. Finally, the 
Al2O3 columns were washed with Tris-HCl (pH 7.5) to neutralize the Al2O3 and thus wash 
off the cAMP to collect in scintillation vials. 2.5mls of scintillation fluid was added to each 
vial and the radioactivity of each sample was measured using a scintillation liquid analyzer 
Tricab 2900 TR (PerkinElmer) in which radioactive particles emitting from the 
3
H isotope 
transferred energy to the scintillation fluid causing the emission of photons allowing for 
luminescence measurements. The radioactive counts were processed using QuantaSmart 
software and the ratio of the DOWEX 50 flow-through counts to the Al2O3 flow-through 
counts were used to normalize the amount of [
3
H]-cAMP to total cellular [
3
H]-adenine.  
 
2.8. Measurements of extracellular ATP 
Calu-3 cells, cultured on 12mm permeable Transwell supports and studied 10 days post 
seeding, were washed three times with PBS. For normocapnic controls, cells were incubated 
for 20 minutes in pregassed 25mM NaHCO3 solution containing 10mM HEPES, 0.6mM 
NaOH and 15mM Mannitol (pH 7.4 when gassed with 5% (v/v) CO2/95% (v/v) O2) at 37°C 
in humidified air containing 5% (v/v) CO2. For cells exposed to hypercapnia, they were 
incubated for 20 minutes in pregassed 25mM NaHCO3 solution containing 10mM HEPES, 
10mM NaOH (pH 7.4 when gassed with 10% (v/v) CO2/90% (v/v) O2) at 37°C in humidified 
air containing 10% (v/v) CO2. The assay is highly sensitive to salts hence the reason to omit 
NaCl, KCl, MgCl2 and CaCl2. 50µl of solution was added to the apical compartment and 
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200µl of solution was added to the basolateral compartment. After incubation, both apical 
and basolateral solutions were very carefully removed to minimize mechanically-induced 
ATP release. Assays were performed by adding 15 µL of luciferin to 15 µL of sample in a 
black 96-well plate. A blank of 15 µL assay buffer with 15 µL luciferin was subtracted from 
the readings of samples. Luciferin and samples containing luciferin were kept out of contact 
with light due to the photosensitivity of the reagent 
All luciferase assays were performed using the Roche Applied Science ATP bioluminescence 
assay kit HS II and read using a BioTek Flx800 multidetection microplate reader. The 
luminometer was set to record luminescence with a sensitivity of 125 and an integration time 
of 6s with no filter. All readings were taken 25s after the addition of luciferin to the samples. 
 
2.9. PAS Assay 
To measure the mucin content of secreted apical fluid, the periodic acid-Schiff’s (PAS) assay 
was used. The PAS assay is used to detect glycoproteins which relies on a periodic 
acid/acetic acid mixture oxidizing hydroxyl groups in sugars to form aldehydes. These 
formed aldehydes then react with Schiff’s reagent to form a purple colour which can then be 
analysed by spectrophotometry. To generate a standard curve, pig mucin (a gift from Prof. 
Jeff Pearson, Newcastle University) was diluted to (in µg/ml) 100, 50, 20, 10, 5, 2 and 1 and 
100µl of standards were added to a 96 well plate in duplicate. 100µl of sample was made to 
1ml by addition of deionised water and 100µl was added to wells in duplicate. 100µl of a 
periodic acid/acetic acid mix (made from 10µl periodic acid added to 7% acetic acid) was 
added to all standards and samples and the plate was incubated for 60 minutes at 37°C. In 
addition, 0.1g of sodium metabisulphate was added to 6mls of Schiff’s reagent and this was 
also incubated for 30 minutes at 37°C before 100µl was added to all standards and samples. 
The plate was then incubated at room temperature for 30 minutes before absorbance was read 
at 550nm using a BioTek ELx808 Absorbance Microplate Reader. Absorbance was then 
converted to mucin concentration using the standard curve shown in figure 2.06. 
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Figure 2.06: Standard curve generated for the Periodic acid Schiffs assay. Pig mucin samples of 
known concentration were added to a periodic acid/acetic acid mix before addition of Schiffs reagent 
and absorbance measured at 550nm using a BioTek ELx808 Absorbance Microplate Reader. Data 
represents mean of samples run in duplicate; r
2
 = 0.994. 
 
2.10. Wound Healing Assay 
Calu-3 cells, cultured on 12mm permeable Transwell supports and studied 8-12 days post 
seeding, were exposed to a single scratch using a P200 pipette tip, washed three times in PBS 
and incubated for one hour at 37°C in humidified air containing 5% (v/v) CO2 in air to bring 
the cells and plate up to temperature. Cells were placed in the Nikon BioStation CT at 37°C 
in humidified air containing 5% (v/v) CO2 for normocapnia or 10% (v/v) CO2 for 
hypercapnia and imaged under phase contrast at x4 magnification every four hours for 36 
hours. Three different fields of view within one transwell were imaged and the area of the 
wound was calculated using ImageJ software as shown in figure 2.07. 
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Figure 2.07: Example analysis of wound healing assay.  The wound was drawn around using the 
polygon tool in ImageJ and the resulting area of wound size was calculated. 
 
2.11. Confocal Microscopy 
The actin cytoskeleton network was visualised using confocal microscopy. Calu-3 cells were 
cultured on 12mm permeable Transwell supports and studied 8-12 days post seeding. Media 
was removed and cells were incubated in pregassed high Cl
-
 Krebs solution for 20 minutes at 
37˚C in humidified air containing 5% (v/v) CO2 (control) or 10% (v/v) CO2 (hypercapnia) for 
20 minutes before 5µM forskolin was added for 10 minutes. After treatment, cells were 
washed three times with PBS and then fixed by treating with 4% paraformaldehyde (PFA) for 
10 minutes. Cells were then washed three times for 5 minutes with PBS before washing with 
50mM NH4Cl to quench any remaining PFA. Cells were permeabilized with 1% Triton X-
100 in PBS for 5 minutes and then subsequently washed three times for 5 minutes with PBS. 
PBS containing 3% FCS and 0.1% azide was then added to block non-specific binding. At 
this point, the transwell membrane was cut out and placed in a 12 well plate with the apical 
side facing upwards. 200µl of PBS containing 3% FCS, 0.1% azide and 0.25% Phalloidin–
Tetramethylrhodamine B isothiocyanate (Phalloidin-TRITC) (Sigma) was then added to cells 
for 30 minutes at room temperature before cells were washed twice with PBS. Cells were 
rinsed with PBS before 0.2µg/ml 4',6-diamidino-2-phenylindole (DAPI) was then added for 
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two minutes. After rinsing, cells were then mounted on slides using 1-2 drops of Vectashield 
mounting medium (Vector Laboratories, UK). 
Cells were visualized using a Nikon A1R Confocal microscope at x60 magnification using a 
0.1 DIC lens with a numerical aperture of 1.4. To visualize DAPI stained specimens, cells 
were excited with the DAPI excitation wavelength of 405nm and imaged at the emission 
wavelength of 450nm. To visualize TRITC stained specimens, cells were excited with the 
TRITC excitation wavelength of 595nm and imaged at the emission wavelength of 561nm. Z-
stacks were taken at a rate of 15µm 2.5 seconds
-1
. Data was analysed using ImageJ software. 
 
2.12. End Point PCR 
To assess the expression of proteins at the mRNA level, RNA was extracted from polarised 
Calu-3 cells using the QIAGEN RNeasy Mini Kit. Briefly, RNA was extracted using 1% β-
mercaptoethanol and purified using spin technology as per manufacturer’s instructions. RNA 
yield and purity was assessed using a Nanodrop 2000 (Thermo Scientific, UK).  To remove 
any DNA that may contaminate the RNA, 4.5µg RNA was added to 4.5µl DNase (BioLine) 
and 2µl DNase Buffer (BioLine) made up to 20µl with Mill-Q H2O. This was incubated at 
37°C for 30 minutes before 4µl DNase stop buffer (BioLine) was added for 10 minutes at 
65°C.  
The purified RNA was reverse transcribed into cDNA using the following reaction mix:  
10µl pure RNA 
3.2µL 25mM Magnesium Chloride  
10x Reaction Buffer, (BioLine) 
16µl dNTPs (BioLine) 
2µl of random Hexamers (10µM),  
1µl Reverse Transcriptase (BioLine) 
3.8µl Milli-Q H2O 
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The reverse transcription reaction was then carried out as shown in table 2.01. 
Step Temperature (˚C) Duration (mins) Number of Cycles 
1 42 60 1 
2 95 5 1 
3 5 5 1 
Table 2.01: Conditions for reverse transcription of mRNA into cDNA 
 
To perform End Point PCR, the following reaction mix was used 
 0.8µl 50mM MgCl2 
4µl 10x Reaction Buffer (BioLine) 
0.5µl Taq DNA Polymerase (BioLine) 
20.7µl Milli-Q H2O 
2µl forward primer made to 10pmol/µl (Eurofins Genomics) 
2µl reverse primer made to 10pmol/µl (Eurofins Genomics) 
10µl cDNA 
 
The End Point PCR reaction was then carried out according to table 2.02. 
Step Temperature (˚C) Duration (mins) Number of Cycles 
1 95 5 1 
2 
95 0.5 
35 Annealing Temp 0.5 
72 0.5 
3 72 12 1 
Table 2.02: Conditions for End Point PCR 
 
8µl of PCR product was then combined with 2µl loading dye (BioLine) and run on a 1.5% 
Agarose TBE (54g Tris, 27.5g boric acid, 20ml 0.5M EDTA per 1L de-ionised water, pH 8.0) 
gel containing 0.006% Ethidium Bromide at 70V for one hour. 5µl of Hyperladder IV 
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(BioLine) was used as a molecular weight marker. The gel was viewed using the Bio Rad Gel 
Doc EZ Imager and Image Lab 4.0 software. 
Primer sequences for PCR reactions are displayed in table 2.03 
Gene Sequence 
Annealing 
Temp (˚C) 
Expected 
Product Size 
CFTR Fwd: 5'-AATGTAACAGCCTTCTGGGAG-3' 57.9 391 
Rev: 5'-GTTGGCATGCTTTGATGACGCTTC-3' 62.7   
NBCe1 (SLC4A4) Fwd: 5'-GGTGTGCAGTTCATGGATCGTC-3' 62.1 336 
Rev: 5'-GTCACTGTCCAGACTTCCCTTC-3' 62.1   
NBCe2 (SLC4A5) Fwd: 5'-ATCTTCATGGACCAGCAGCTCAC-3' 60.6 468 
Rev: 5'-TGCTTGGCTGGCATCAGGAAG-3' 61.8   
NBCn1 (SLC4A7) Fwd: 5'-CAGATGCAAGCAGCCTTGTGTG-3' 62.1 328 
Rev: 5'-GGTCCATGATGACCACAAGCTG-3' 62.1   
NDCBE1 (SLC4A8) Fwd: 5'-GCTCAAGAAAGGCTGTGGCTAC-3' 62.1 243 
Rev: 5'-CATGAAGACTGAGCAGCCCATG-3' 62.1   
NCBE (SLC4A10) Fwd: 5'-GCAGGTCAGGTTGTTTCTCCTC-3' 62.1 498 
Rev: 5'-TCTTCCTCTTCTCCTGGGAAGG-3' 62.1   
Pannexin 1 Fwd: 5'-AGAGCGAGTCTGGAAACC-3' 56.0 133 
Rev: 5'-CAAGTCTGAGCAAATATGAGG-3' 55.9   
Pannexin 2 Fwd: 5'-AAGCAGATCCAGTCCAAG-3' 53.7 82 
Rev: 5'-GGGCTCTTCTCCTTCTCC-3' 58.2   
Table 2.03: Primer sequences, annealing temperatures and expected product size for End Point 
PCR experiments.  Primer sequences for NBC family members were obtained from Damkier et al. 
(2007) and primer sequences for pannexin family members were obtained from Ransford et al. (2009) 
 
2.13. Western Blot 
Western Blots were performed to investigate whether hypercapnia had any effects on protein 
expression, specifically on CFTR expression. Calu-3 cells were cultured on 12mm permeable 
Transwell supports and studied 8-12 days post seeding. For studies into acute hypercapnia, 
Calu-3 cells were incubated in pre-gassed high Cl
-
 Krebs solution at 37°C in humidified air 
containing 5% (v/v) CO2 (normocapnic controls) or 10% (v/v) CO2 (hypercapnic) for 20 
minutes before addition of either agonist or vehicle for a further 10 minutes. For studies into 
chronic hypercapnia, Calu-3 cells were instead incubated for 24 hours prior to cell lysis. Cells 
were lysed with RIPA buffer consisting of (in mM) 150 NaCl, 1 Tris-HCl, 1% Deoxycholic 
Acid, 1% Triton X-100 and 0.1% SDS with a protease inhibitor tablet (Roche) added to 
10mls of RIPA buffer. Cells were shaken at 4°C for 30 minutes before they were scraped 
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using a pipette tip to aid lysis. The lysate was collected in an Eppendorf tube which was then 
centrifuged for 20 minutes at 12,000 RPM at 4°C to remove the cell debris. 
To quantify protein, the Pierce Assay was performed in which 10µl protein samples were 
added to 150µl 660 Pierce Reagent (Sigma Aldrich) in duplicate and absorbance was 
measured at 660nm using a using a BioTek ELx808 Absorbance Microplate Reader. Protein 
concentration was calculated from a standard curve generated from known concentrations of 
Bovine Serum Albumin (0, 0.0625, 0.125, 0.25, 0.5, 1 and 2mgs/ml) as shown in figure 2.08. 
 
Figure 2.08. Standard curve for protein quantification generated using the Peirce Assay. BSA 
samples of known concentration were added to 660 Peirce Reagent (Sigma Aldrich) and absorbance 
measured at 660nm using a using a BioTek ELx808 Absorbance Microplate Reader. Data represents 
mean of samples ran in duplicate; r
2
 = 0.998. 
 
Gel electrophoresis was performed on NuPAGE precast 4-12% gels. 15µg protein was 
combined with 4µl NuPAGE Loading Buffer and 2µl NuPAGE reducing agent and heated to 
70°C for 10 minutes prior to loading into the gel.  2µl of reference ladder (Novex) was also 
loaded into the gel. Electrophoresis was performed at 200V for 1 hour. The gel was then 
transferred to a nitrocellulose membrane at 400mA for 1 hour 30 minutes at 4°C. The 
membrane was blocked for one hour in blocking buffer consisting of PBS + 0.1% Tween 20 
(PBST) containing 5% dried skimmed milk powder (Marvel) before primary 596 anti-CFTR 
monoclonal antibody was added overnight at 4°C at 1:3000 dilution in blocking buffer. The 
membrane was then washed using PBST before the anti-mouse Horse Radish Peroxidase 
(HRP) secondary antibody was added at 1:3000 dilution in blocking buffer for one hour. Any 
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unbound secondary antibody was then washed off with PBST. To detect any HRP activity, 
equal volumes of the enhanced chemiluminescent substrates Enhanced Luminol Reagent and 
the Oxidizing Reagent (Thermo Scientific) were added to the blot for 10 minutes before the 
blot was exposed to Kodak Scientific Imaging film for 1 minute. The film was developed and 
the band intensity was analysed using ImageJ software. To reprobe the blot, Restore Western 
Blot Stripping Buffer (Thermo Scientific) was added for 15 minutes at room temperature, the 
blot was then washed in PBST and blocked in blocking buffer for one hour before another 
immunoblot was performed. To detect β-actin expression, a monoclonal goat anti-actin 
antibody was added at a 1:2000 dilution in blocking buffer for 2 and a half hours. The 
membrane was then washed using PBST before an anti-goat HRP secondary antibody was 
added at 1:3000 dilution in blocking buffer for one hour and HRP activity was assessed as 
previously stated. 
 
2.14. Solutions and Reagents 
All reagents were purchased from Sigma Aldrich apart from forskolin, U73122, HC067047, 
H-1152, ouabain, dorsomorphin (R & D Systems); BCECF-AM, Fura-2 AM, H2-DIDS, 
DIDS (Invitrogen) and SQ22536, GlyH-101, CFTRinh 172 (Calbiochem). All gas cylinders 
were purchased from BOC and consisted of the following mixtures: 5% CO2/95% O2, 10% 
CO2/90% O2 and 2.5% CO2/97.5% O2. 
NaHEPES solution consisted of (in mM) 130 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 NaHEPES 
and 10 D-Glucose.  1M HCl was used to calibrate the solution to pH 7.6 at room temperature. 
High Cl
-
 Krebs solution consisted of (in mM) 25 NaHCO3, 115 NaCl, 5 KCl, 1 CaCl2 1 
MgCl2 and 10 D-Glucose. For high Cl
-
, Na
+
 free solutions, NaHCO3 was replaced with 
choline bicarbonate and NaCl was replaced with NMDG-Cl which was made by adding HCl 
to 1M NMDG solution until pH reached 7.2. Zero Cl
-
 Krebs solution consisted of (in mM) 25 
NaHCO3, 115 NaGluconate, 2.5 K2SO4, 1 CaGluconate, 1 MgGluconate and 10 D-Glucose. 
For zero Cl
-
, Na
+
 free solutions,  NaHCO3 was replaced with choline bicarbonate and Na 
Gluconate was replaced with NMDG-Gluconate which was made by adding gluconic acid to 
1M NMDG until pH reached 7.2. 
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Intracellular pHi calibration solutions consisted of (in mM) 5 NaCl, 130 KCl, 1 CaCl2, 1 
MgCl2, 10 D-Glucose, 10 HEPES (for solutions set at pH 7.6 or below) or 10 TRIS (for 
solutions set at pH 7.8 or above) as well as 10µM nigericin. Solutions were set to desired pH 
by using 1M HCl or 1M NaOH. 
Solutions used to determine intracellular buffering capacity consisted of (in mM) 4.5 KCl, 1 
MgCl2, 2 CaCl2, 5 BaCl, 10 HEPES, 10 D-Glucose as well as varying concentrations of 
NH4Cl/NMDG-Cl, ranging from 0 NH4Cl/145 NMDG-Cl to 30 NH4Cl/115 NMDG-Cl. All 
solutions were titrated to pH 7.4 at 37˚C using 1M CsOH. 
 
2.15.  Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 4 software. Student’s t-test, one 
way ANOVA (with Tukey’s multiple comparison post-test) or two way ANOVA (with 
Bonferroni post-test) were carried out where applicable to determine statistical significance 
between measurements. A p value of <0.05 was considered statistically significant. 
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Chapter 3:  Effect of acute hypercapnia on cAMP-dependent HCO3
- 
transport in Calu-3 cells 
3.1.  Introduction 
As already discussed in chapter 1, there exists a great body of evidence that demonstrates the 
role of the second messenger, cAMP, in the regulation of HCO3
-
 secretion in a variety of 
human tissue, including airway epithelia. cAMP has been shown to stimulate HCO3
-
 secretion 
via PKA-dependent phosphorylation of CFTR (Devor et al., 1999; Hug et al., 2003; Garnett 
et al., 2011) and increase the activity of NBCs to accumulate HCO3
-
 into the cell from the 
blood (Bachmann et al., 2003; Bachmann et al., 2008; Chen et al., 2012). Our laboratory, and 
others, have used intracellular pH measurements to demonstrate that in Calu-3 cells, 
elevations in [cAMP]i activated CFTR-dependent Cl
-
/HCO3
-
 exchange and inhibited 
basolateral AE2 to favour a vectorial HCO3
-
 transport from the blood to luminal membrane 
(Garnett et al., 2011; Garnett et al., 2013; Kim et al., 2014). Furthermore, our laboratory has 
also described that acute hypercapnia significantly reduced both forskolin-stimulated and 
parathyroid hormone-stimulated cAMP levels in two renal cell lines: HEK-PR1 and OK cells 
which affected the cAMP-dependent activity of NHE3 (Cook et al., 2012). Thus, should this 
effect of hypercapnia also be present in airway epithelia, it would be predicted that cAMP-
dependent regulation of HCO3
-
 transport would be impaired. This chapter details the 
investigations into the effects of acute hypercapnia on cAMP-regulated HCO3
-
 transport in 
Calu-3 cells. 
 
3.2.  Acute hypercapnia attenuates forskolin-stimulated cAMP levels in Calu-3 cells 
To investigate whether hypercapnia was able to modulate [cAMP]i in Calu-3 cells, cells were 
stimulated with either vehicle (DMSO) or forskolin and [cAMP]i was measured by a 
radiolabelled cAMP assay. Incubation solutions were buffered to pH 7.5 to eliminate any 
effects of extracellular pH (pHe) on [cAMP]i. Intracellular pH measurements revealed that 
exposure of Calu-3 cells to 10% CO2 induced an intracellular acidosis of 0.18 ± 0.01 pH units 
(n=60) which recovered after ~20 minutes (fig 3.01A). Further investigations into the 
mechanisms underlying this recovery process are detailed in section 3.11. It is important to 
note that exposure of polarized Calu-3 cells to hypercapnia does not affect the integrity of the 
epithelial monolayer as measured by transepithelial electrical resistances (TEER). In 
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normocapnia, TEER was 671 ± 42 Ω cm-2 (n=3) whilst in cells exposed to acute hypercapnia, 
TEER was 600 ± 42 Ω cm-2 (p>0.05; n=3) and highlights that acute hypercapnia has no major 
effect on the ability of Calu-3 cells to form a highly resistive monolayer. Thus, cells were 
exposed to 10% CO2 for 20 minutes prior to forskolin stimulation to ensure any effects of 
hypercapnia on [cAMP]i were due to CO2 per se and not CO2-induced acidosis. In 
normocapnia (5% CO2), forskolin stimulated a 3.3 ± 0.5 fold increase in intracellular cAMP 
levels (p<0.001; n=6; fig 3.01B). Although cells exposed to 10% CO2 for 20 minutes also 
demonstrated a significant 2.3 ± 0.4 fold increase in intracellular cAMP levels (p<0.05 n=6; 
fig 3.01B), this increase in intracellular cAMP was 36 ± 9% lower than that observed in 
normocapnia (p<0.05) demonstrating that acute hypercapnia attenuates cAMP production in 
Calu-3 cells. 
 
Figure 3.01: Acute hypercapnia attenuates forskolin-stimulated cAMP levels in Calu-3 cells.  
(A) shows the effect of hypercapnia (10% CO2) on pHi of Calu-3 cells and demonstrated cells recover 
pHi from CO2-induced acidosis after ~20 minutes. (B) shows the effect of acute hypercapnia on 
intracellular cAMP in which cells were incubated for 20 minutes in either 5% CO2 (v/v) in air or 10% 
CO2 (v/v) in air before being stimulated with either vehicle (DMSO) or 5µM forskolin for a further 10 
minutes. Intracellular cAMP levels were measured by measuring the amount of [
3
H]-cAMP molecules 
in each sample. *** = significant effect of forskolin (p<0.001; * = p<0.05); † = significant effect of 
hypercapnia (p<0.05). Data represents mean ± S.E.M.; n = 6 for each. 
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3.3.  Acute hypercapnia reduces forskolin-stimulated increases in short-circuit 
current 
To assess whether the effects of acute hypercapnia on forskolin-stimulated elevations in 
[cAMP]i would lead to alterations in cAMP-regulated ion transport, the short circuit current 
(Isc) of Calu-3 cells was measured in cells exposed to either 5% (v/v) CO2/95% (v/v) O2 
(control) or 10% (v/v) CO2/90% (v/v) O2 for 20 minutes prior to recording. To measure 
electrogenic Cl
-
 secretion, cells were stimulated with 5µM forskolin in the presence of a 
basolateral to apical Cl
-
 gradient, achieved by reducing apical Cl
-
 to 40mM whilst 
maintaining basolateral Cl
-
 at 124mM. Figure 3.02A shows a representative Isc recording 
under normocapnic conditions and figure 3.02B shows a representative Isc recording under 
hypercapnic conditions. In normocapnia, prior to reducing the apical Cl
-
 concentration, Calu-
3 cells displayed a basal Isc of 5.2 ± 0.4µA and further investigations showed that this basal 
Isc was relatively insensitive to both basolateral bumetanide (25µM) and EIPA (3µM), 
whereas CFTRinh 172 (20µM) was able to reduce basal Isc by 48.5 ± 4.2% (p<0.01; n=3) 
indicating low level CFTR activity mediated this Isc. Interestingly, in cells exposed to 20 
minutes hypercapnia, the basal Isc was reduced to 1.3 ± 1.3µA (p<0.01 vs. normocapnia; n=8; 
fig. 3.02C) implying that acute hypercapnia inhibited CFTR in basal conditions. Forskolin 
induced an increase in Isc which peaked after approximately 90s to a maximal level and then 
decreased slightly until a new steady state was reached. The forskolin-induced increase in Isc 
was blocked by a combination of apical CFTRinh-172 (20µM) and basolateral bumetanide 
(25µM) implying that CFTR mediated the increase in Isc. The fact that CFTRinh 172 did not 
completely block the response to forskolin alone suggests a CFTR-independent component to 
the response. However, other groups have reported that 50µM CFTRinh 172 was required to 
inhibit CFTR in the Ussing chamber setup, and as such there maybe concentration-dependent 
issues evident here (Schwarzer et al., 2010). The maximal forskolin-stimulated increase in Isc 
(ΔIsc) was 19.3 ± 2.0µA cm
-2
 (n=10) in normocapnia compared to 14.1 ± 1.1µAcm
-2
 in acute 
hypercapnia (p=0.053 vs. normocapnia; n=8; fig. 3.02D). The rate of forskolin-stimulated Isc 
increase in normocapnia was 10.4 ± 1.3µA cm
-2 
min
-1
 (n=10) which was reduced to 5.7 ± 0.6 
µA cm
-2 
min
-1 
(p<0.01 vs. normocapnia; n=8; fig. 3.02E) in cells exposed to acute 
hypercapnia. These findings suggest that the attenuation of forskolin-stimulated cAMP levels 
by acute hypercapnia were sufficient to reduce cAMP-regulated anion secretion in Calu-3 
cells. 
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Figure 3.02: Acute hypercapnia reduces forskolin-stimulated Isc in Calu-3 cells.  Cells were 
grown on permeable Snapwell supports and forskolin-stimulated electrogenic Cl
-
 secretion was 
measured using an Ussing chamber. (A) shows a representative recording of a control experiment in 
which cells were exposed to 5% (v/v) CO2/95% (v/v) O2 and (B) shows a representative recording of 
an in which cells were exposed to 10% (v/v) CO2/90% (v/v) O2  for 20 minutes prior to being studied. 
Apical Cl
-
 was reduced to 40mM and cells were stimulated with forskolin (5µM) before addition of 
apical CFTRinh-172 (20µM) and basolateral bumetanide (25µM) as indicated. The inset shows that a 2 
second 10mV pulse was applied across the cells every 30 seconds to monitor transepithelial electrical 
resistance (TEER). These pulses were removed from the trace in order to display the effects of 
treatment more clearly. The basal Isc (C), the maximal forskolin-stimulated increase in Isc (D) and the 
rate of increase in forskolin-stimulated Isc (E) are displayed. ** = significant effect of hypercapnia 
(p<0.01). Data represents mean ± S.E.M.; n = 10 for normocapnia and n = 8 for hypercapnia.  
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The response of Calu-3 cells to other cAMP agonists was also assessed. Adenosine (10µM) 
stimulated a maximal increase in Isc of 25.2 ± 3.6µA cm
-2
 at a rate of 23.9 ± 10.9µA cm
-2
 
min
-1
 (n=3) whilst dibutrylyl cAMP (800µM) stimulated a maximal increase in Isc of 16.4 ±  
3.7µA cm
-2
 at a rate of 11.3 ± 2.0µA cm
-2
 min
-1
 (n=4). Figure 3.03 shows these values are 
comparable to forskolin-stimulated cells and suggest that forskolin-induced changes in Isc are 
cAMP-dependent. Furthermore, preincubation of cells for one hour with the PKA inhibitor 
H-89 reduced the forskolin-stimulated maximal increase in Isc by 62 ± 7% (n=4; p<0.05; fig. 
3.03A) and the rate of Isc increase by 78 ± 7% (n=4; p<0.05; fig. 3.03B) and implicates 
forskolin-stimulated changes in Isc were due to cAMP activation of PKA and subsequent 
phosphorylation of CFTR to mediate electrogenic Cl
-
 secretion.  
 
 
Figure 3.03: Forskolin-stimulated increases in Isc are cAMP and PKA-dependent.  The effect of 
the cAMP agonists adenosine (10µM) and dibutrylyl cAMP (800µM) as well as the PKA inhibitor H-
89 (50µM) on Isc in Calu-3 cells were measured. The maximal increase in Isc (A) and the rate of Isc 
increase (B) induced by each agonist are displayed. * = significant effect of H-89 (p<0.05). Data 
represents mean ± S.E.M.; n=6 for forskolin, n=3 for adenosine and n=4 for dibutrylyl cAMP and 
forskolin + H-89. 
 
Although the reduced forskolin-stimulated CFTR-dependent Isc measurements observed in 
acute hypercapnia were likely to be due to a result of CO2-induced reductions in [cAMP]i, a 
reduced expression of CFTR at the apical membrane would also be predicted to cause this 
effect. Therefore, two independent western blots were carried out on cells that had been 
incubated for 20 minutes in pregassed high Cl
-
 Krebs solution exposed to either 5% CO2, 5% 
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CO2 + 5 minute forskolin stimulation, 10% CO2 or 10% CO2 + 5 minute forskolin 
stimulation. Each time, the protein samples were generated in Newcastle but one Western 
Blot was performed by myself in Newcastle (figs. 3.04A and B) and another blot was 
performed in the laboratory of Professor Ursula Seidler in Hannover, Germany (figs. 3.04C 
and D). In each case, there appeared to be a trend for CFTR expression to be higher in cells 
that had been exposed to acute hypercapnia compared to the normocapnic controls. These 
data suggest, therefore, that the effect of hypercapnia on CFTR-dependent Isc measurements 
is actually an underestimation of the degree by which hypercapnia can reduce CFTR activity 
although whether the effects of hypercapnia on CFTR expression translates to an increased 
membrane expression is unresolved at the present time. 
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Figure 3.04: Acute hypercapnia increases total CFTR expression in Calu-3 cells.  (A) shows the 
results from a Western Blot performed by myself in Newcastle, in which the effect of forskolin and 
acute hypercapnia on CFTR protein expression was assessed and normalized to actin expression. The 
data is summarized in (B). For each experimental condition, 3 lysates were generated from 3 separate 
transwell. These lysates were combined to produce one lysate for each experimental condition; thus 
data represents mean of n=1. (C) shows the results from a Western Blot in which the samples were 
generated in Newcastle but the Western Blot was performed in the laboratory of Prof. Ursula Seidler 
(Hannover, Germany). Here, for each experimental condition, 3 lysates were generated from 3 
separate samples and each lysate was ran on the gel so that each sample was performed in triplicate. 
The data is summarized in (D). Data represents mean of triplicate sample; n=1 for each condition.  
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3.4. cAMP agonists produce an intracellular acidification in Calu-3 cells 
Agonists that raise intracellular cAMP levels have previously been shown to induce HCO3
-
 
secretion in Calu-3 cells using short circuit current measurements or by measuring changes in 
secreted HCO3
-
 via the pH stat technique (Devor et al., 1999; Krouse et al., 2004; Shan et al., 
2012). Here, real-time intracellular pH measurements were used to assess changes in HCO3
-
 
transport. As shown in figure 3.05A, in normocapnic conditions, addition of 5µM forskolin 
induced an intracellular acidification in Calu-3 cells indicative of net HCO3
-
 efflux from the 
cells until a new steady state pHi was reached. This acidification was reversible after 
forskolin wash off. The magnitude of the acidification was 0.18 ± 0.01 pH units (n=155) and 
equated to a HCO3
-
 flux of 9.4 ± 0.5mM HCO3
-
 min
-1
 (n=155) when corrected for buffering 
capacity of the cells. 10µM adenosine produced a similar intracellular acidification to 
forskolin. Adenosine caused pHi to decrease by 0.16 ± 0.01 units (n=14) and induced a 
HCO3
-
 flux at a rate of 7.9 ± 1.1mM HCO3
-
 min
-1
 (n=14). 
 
 
 
Figure 3.05: cAMP agonists induced a reversible intracellular acidification in Calu-3 cells.  5µM 
apical forskolin (A) or 10 µM bilateral adenosine (B) were added to Calu-3 cells and the pHi changes 
resulting from agonist stimulation were assessed. 
 
3.5.  Profile of cAMP-induced intracellular acidification 
3.5.1.  HCO3
-
 Dependence 
To verify that the intracellular acidification following stimulation of cells with a cAMP 
agonist was HCO3
-
 dependent, 25mM NaHCO3 was replaced with equimolar NaHEPES and 
cells were stimulated with forskolin (fig. 3.06A). In HCO3
-
 containing conditions, forskolin 
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induced an intracellular acidification of 0.19 ± 0.02 pH units (n=4) with a HCO3
-
 flux of 12.2 
± 1.5mM min
-1
 (n=4). However, there was no observed intracellular acidification in the 
presence of NaHEPES. Here, forskolin induced a decrease in pHi of 0.02 ± 0.003 (p<0.01 vs. 
HCO3
-
 containing conditions; n=4; fig. 3.06B) which produced no measureable HCO3
-
 flux 
(0.0 ± 0.0mM min
-1
; p<0.01 vs. HCO3
-
 containing conditions; n=4; fig. 3.06C). These data 
imply that the cAMP-stimulated intracellular acidification is a result of HCO3
-
 secretion from 
the cells. 
 
Figure 3.06: Forskolin-stimulated intracellular acidification is HCO3
-
 dependent.  (A) shows a 
representative experiment in which cells were stimulated with forskolin in either HEPES buffered 
solutions or HCO3
-
 containing solutions buffered with 5% (v/v) CO2/95% (v/v) O2. The delta pH and 
the rate of HCO3
-
 flux resulting from forskolin stimulation are shown in (B) and (C) respectively. ** = 
significant difference between HEPES and HCO3
-
 containing conditions (p<0.01). Data represents 
mean ± S.E.M; n=4. 
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3.5.2. Effect of membrane potential 
To further characterize the cAMP-induced intracellular acidification, cells were depolarized 
by perfusion with a modified high K
+
 Krebs solution in which KCl was increased to 115mM 
and NaCl was reduced to 5mM to eliminate the electrical driving force for anion secretion. 
As figure 3.07 shows, in control conditions, addition of forskolin caused a decrease in pHi of 
0.14 ± 0.01 (n=4; fig. 3.07B) and a HCO3
-
 flux of 4.6 ± 0.4mM min
-1
 (n=4; fig. 3.07C). 
However, in the presence of high extracellular K
+
, forskolin addition caused a decrease in pHi 
of 0.04 ± 0.01 (p<0.001 vs. control; n=4; fig. 3.07B) which produced no measureable HCO3
-
 
flux (HCO3
-
 flux = 0.0 ± 0.0mM min
-1
; p<0.001 vs. control; n=4; fig. 3.07C). This 
abolishment of forskolin-stimulated intracellular acidification in depolarized cells indicated 
that anion secretion (i.e. HCO3
-
) underlies the response to cAMP agonists. 
 
Figure 3.07: Depolarization of Calu-3 cells prevents forskolin-stimulated intracellular 
acidification.  (A) shows a representative experiment in which the effect of high extracellular [K
+
] on 
the forskolin-stimulated intracellular acidification was assessed. The delta pH (B) and HCO3
-
 flux (C) 
were compared between the control response and the response in the presence of 115mM extracellular 
K
+
.  *** = significant effect of high extracellular [K
+
] (p<0.001). Data represents mean ± S.E.M; n = 
4 for each. 
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3.5.3. SQ 22,536 Sensitivity 
Both forskolin and adenosine stimulate cAMP production via an activation of transmembrane 
adenylyl cyclase (tmAC) either directly, by forskolin, or due to activation of G-protein 
coupled receptors by adenosine. Therefore, it would be predicted that forskolin or adenosine-
induced intracellular acidification would be blocked by inhibition of tmAC. Cells were 
preincubated for one hour with the tmAC inhibitor SQ 22,536 (500µM) and the response to 
5µM forskolin was assessed immediately, and then after 20 minutes of inhibitor wash out 
(fig. 3.08A). As shown in figure 3.08B, SQ 22,536 had no effect on the delta pH resulting 
from forskolin stimulation (initial response = 0.21 ± 0.03; response after inhibitor wash out = 
0.22 ±0.02; p>0.05; n=3) but SQ 22,536 did appear to have an inhibitory effect on the rate of 
forskolin-stimulated HCO3
-
 flux (initial response = 6.6 ± 1.3mM min
-1
; response after 
inhibitor wash out = 14.3 ± 1.7mM min
-1
; p<0.05; n=3; fig 3.08C). These findings suggested 
that inhibition of tmAC is able to impair cAMP-stimulated HCO3
-
 transport and that the 
forskolin-stimulated increases in cAMP is dependent on the activity of tmAC. 
 
Figure 3.08: Preincubation of Calu-3 cells with SQ 22,536 causes a reversible decrease in the 
rate of the forskolin-stimulated intracellular acidification.  (A) shows a representative experiment 
in which cells were preincubated with 500µM SQ22,536 for one hour and the response to 5µM 
forskolin was assessed immediately and then 20 minutes later. The delta pH (B) and HCO3
-
 flux (C) 
were compared between the initial response to forskolin and the response after washing. * = 
significant difference after washing (p<0.05). Data represents mean ± S.E.M; n=3. 
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3.5.4.  H-89 Sensitivity 
One of the major actions of cAMP is to activate PKA, which phosphorylates downstream 
targets (e.g. CFTR). Our laboratory has shown that inhibition of PKA, using H-89, blocked 
forskolin-stimulated CFTR-dependent anion exchange activity in Calu-3 cells, thus 
highlighting the importance of PKA in cAMP-regulated HCO3
-
 transport (Garnett et al., 
2011). To assess whether the cAMP-induced intracellular acidification was PKA-dependent, 
cells were preincubated with 50µM H-89 for one hour and the response to 10µM adenosine 
was assessed immediately and then after 20 minutes of inhibitor wash out (fig. 3.09A). This 
was also compared to control experiments performed on the same day in which cells had not 
been treated with H-89. For control experiments, adenosine produced an HCO3
-
 flux of 7.6 ± 
1.1mM min
-1
. In H-89 treated cells, the HCO3
-
 efflux induced by immediate stimulation with 
adenosine was significantly reduced to 2.5 ± 0.5mM min
-1
 (p<0.05 vs. control cells; n=4; fig. 
3.09C) implying that PKA was involved in producing the intracellular acidification in 
response to a cAMP agonist. However, it appeared that H-89 was reversible as in H-89 
preincubated cells, after 20 minutes of inhibitor wash out, there was some recovery in the 
response to adenosine with adenosine-stimulated HCO3
-
 flux increasing to 5.6 ± 0.9mM min
-1
 
which was not statistically significantly different to control conditions (p>0.05 vs. control 
cells; n=4; fig 3.09C).  
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Figure 3.09: Preincubation of Calu-3 cells with H-89 causes a reversible decrease in the rate of 
the adenosine-stimulated intracellular acidification.  (A) shows a representative experiment in 
which cells were preincubated with 50µM H-89 for one hour and the response to 10µM bilateral 
adenosine was assessed immediately and then 20 minutes later. The delta pH (B) and HCO3
-
 flux (C) 
were compared between the initial response to adenosine and the response after washing as well as 
untreated controls.  * = significant effect of H-89 vs. untreated controls (p<0.05). Data represents 
mean ± S.E.M; n = 8 for untreated cells and n = 4 for H-89 treated cells. 
 
3.5.5.  GlyH-101 Sensitivity 
Having shown that the cAMP-induced intracellular acidification was tmAC and PKA-
dependent, it was important to assess whether the HCO3
-
 efflux was mediated via CFTR. 
Cells were stimulated with forskolin in the presence or absence of the CFTR inhibitor GlyH-
101 (Muanprasat et al., 2004) as shown in figure 3.10A. In control conditions, forskolin 
induced a decrease in pHi of 0.16 ± 0.03 units (n=4) and a HCO3
-
 flux of 10.2 ± 3.3mMmin
-1
 
(n=4). However, in the presence of GlyH-101, forskolin elicited a decrease in pHi of 0.03 ± 
0.02 units (n=4; p<0.05 vs. control; fig. 3.10B) and a HCO3
-
 flux of 2.2 ± 0.5mM min
-1
 (n=4; 
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p<0.05 vs. control; fig. 3.10C). Therefore, these data show that the forskolin-stimulated 
intracellular acidification resulting from HCO3
-
 flux is almost completely CFTR-dependent. 
 
 
Figure 3.10: GlyH-101 inhibits forskolin-stimulated intracellular acidification.  (A) shows an 
example pHi trace in which the effect of GlyH-101 (10µM) on the forskolin-stimulated intracellular 
acidification was assessed. The delta pH (B) and HCO3
-
 flux (C) were compared between the control 
response and the response in the presence of GlyH-101.  * = significant effect of GlyH-101 (p<0.05). 
Data represents mean ± S.E.M; n = 4 each. 
 
3.6. Hypercapnia increases the magnitude and rate of cAMP-induced intracellular 
acidification 
My results have shown that addition of agonists that elevate intracellular cAMP produced an 
intracellular acidification as a result of CFTR-dependent HCO3
-
 secretion. Therefore, to 
investigate how acute hypercapnia affected cAMP-regulated HCO3
-
 transport, cAMP agonists 
were added when cells were exposed to 10% CO2. As already shown in figure 3.01A, 
exposure of Calu-3 cells to 10% CO2 caused an intracellular acidification which took 
approximately 20 minutes for cells to recover from. Therefore, cells were stimulated with 
cAMP agonist after pHi recovery to eliminate any differences in pHi affecting the response to 
agonist stimulation. This assay, illustrated in figures 3.11A and D, was used to investigate the 
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effect of acute hypercapnia on cAMP-stimulated HCO3
-
 transport and is therefore used for a 
large part of this work. As shown in figure 3.11, both forskolin and adenosine-stimulated 
intracellular acidifications were significantly enhanced in hypercapnic conditions. In 
normocapnia, forskolin caused pHi to decrease by 0.19 ± 0.01 and induced a HCO3
-
 flux of 
9.7 ± 0.5mM HCO3
-
 min
-1
 (n=130). However, in hypercapnia forskolin caused pHi to 
decrease by 0.35 ± 0.01 (p<0.001 vs. normocapnia; n=130; fig. 3.11B) and induced a HCO3
-
 
flux of 37.6 ± 1.5mM HCO3
-
min
-1
  (p<0.001 vs. normocapnia; n=130; fig. 3.11C) which 
corresponded to a 2.0 ± 0.04 fold increase in the magnitude of the acidification (p<0.001; 
n=130) and a 4.5 ± 0.2 fold increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.001; 
n=130). Similarly, in normocapnia, adenosine caused pHi to decrease by 0.16 ± 0.01 (n=14) 
and induced a HCO3
-
 flux of 7.9 ± 1.1mM HCO3
-
 min
-1
 (n=14). However, in hypercapnia 
adenosine caused pHi to decrease by 0.27 ± 0.02 (p<0.001 vs. normocapnia; fig. 3.11E) and 
induced a HCO3
-
 flux of 23.0 ± 2.7mM HCO3
- 
min
-1
 (p<0.001 vs. normocapnia; fig. 3.11F) 
which corresponded to a 1.7 ± 0.1 fold increase of in the magnitude of the acidification 
(p<0.001; n=14) and a 3.2 ± 0.3 fold increase in the rate of adenosine-stimulated HCO3
-
 flux 
(p<0.001; n=14). Therefore, these data showed that acute hypercapnia modulated cAMP-
regulated HCO3
-
 transport in Calu-3 cells. 
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Figure 3.11: Acute hypercapnia increases the magnitude and rate of forskolin and adenosine-
stimulated intracellular acidification.  (A) shows a representative experiment in which Calu-3 cells 
were stimulated with 5µM forskolin in normocapnia and hypercapnia. The delta pH (B) and the 
HCO3
-
 flux (C) resulting from forskolin stimulation are displayed. *** = significant effect of 
hypercapnia (p<0.001). Data represents mean ± S.E.M., n = 130 for each. (D) shows a representative 
experiment in which Calu-3 cells were stimulated with 10µM bilateral adenosine in normocapnia and 
hypercapnia.. The delta pH (E) and the HCO3
-
 flux (F) resulting from adenosine stimulation are 
displayed. *** = significant effect of hypercapnia (p<0.001). Data represents mean ± S.E.M., n = 14 
for each. 
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A dose response curve of the forskolin-stimulated decrease in pHi and the rate of forskolin-
stimulated HCO3
-
 flux are shown in figs 3.12A and 3.12B and respectively. In hypercapnic 
conditions, the forskolin-stimulated intracellular acidification was significantly enhanced at 
3, 5, 10 and 30µM forskolin (p<0.05).  
 
Figure 3.12: The effect of hypercapnia on the dose response of forskolin-stimulated acidification 
in Calu-3 cells . Cells were stimulated with increasing concentrations of forskolin and the delta pH 
(A) and rate of HCO3
-
 efflux (B) were assessed in normocapnia and hypercapnia. * = significant effect 
of hypercapnia (p<0.05; ** = p<0.01; *** = p<0.001). Data represents mean ± S.E.M., n = 3 for each 
except for concentration of 3µM and 5µM in which n = 6.  
 
3.7. CO2 per se mediates the effects of hypercapnia 
3.7.1. The effect of CO2-induced intracellular acidosis 
As already discussed, Calu-3 cells were able to recover their pHi within 20 in response to 
CO2-induced acidosis and therefore, differences in pHi could be eliminated as the cause of the 
observed effect of hypercapnia. However, it could be argued that the CO2-induced 
intracellular acidification itself may induce changes in cAMP-regulated HCO3
-
 transport. To 
test this, Calu-3 cells in normocapnia were exposed to an acid load by addition of 40mM 
sodium acetate (fig. 3.13A). This induced an intracellular acidification of 0.19 ± 0.04 pH 
units (n=3) which was comparable to the acidosis produced by 10% CO2 in experiments 
performed on the same day (0.26 ± 0.05 pH units; p>0.05 vs. sodium acetate; n=3; fig. 
3.13B). Furthermore, Calu-3 cells were able to recover from sodium acetate-induced acidosis 
over 20 minutes to again mimic the effect of 10% CO2. In experiments where cells were 
exposed to hypercapnia, the forskolin-stimulated delta pH and HCO3
-
 flux were significantly 
increased 1.8 ± 0.1 and 2.4 ± 0.2 fold respectively (p<0.05 vs. normocapnia; n=3 for each; 
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figs 3.13C and D). However, this was not observed in cells exposed to 40mM sodium acetate; 
delta pH increased 1.4 ± 0.1 fold (p>0.05 vs. control; fig. 3.13C) and HCO3
-
 flux increased 
1.4 ± 0.5 fold (p>0.05 vs. control; fig. 3.13D).  These data suggest the CO2-induced 
acidification of pHi did not contribute to the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. 
 
 
Figure 3.13: CO2-induced intracellular acidosis does not contribute to the effect of hypercapnia 
on cAMP-regulated HCO3
-
 transport. (A) shows an example experiment in which cells were 
stimulated with 5µM forskolin in normocapnia with an acid load induced into the cells by the addition 
of 40mM Na Acetate. The magnitude of the acidification induced by 10% CO2 and Na Acetate is 
shown in (B). The delta pH (C) and HCO3
-
 flux (D) resulting from forskolin-stimulation were 
compared between cells exposed to 10% CO2 and cells exposed to Na Acetate. * = significant effect 
of hypercapnia (p<0.05; ** = p<0.01). Data represents mean ± S.E.M.; n = 3 for each. 
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3.7.2. The effect of CO2-induced extracellular acidosis 
The data from figure 3.13 revealed that CO2-induced intracellular acidosis did not contribute 
to the effect of hypercapnia on cAMP-regulated HCO3
-
 transport.  However, the effects of 
extracellular pH (pHe) still needed to be assessed. When Krebs solution containing 25mM 
HCO3
-
 was gassed with 5% CO2/95% O2, the pH of the solution was 7.44 ± 0.02 (n=4). 
However, gassing with 10% CO2/90% O2 caused the pH of the solution to decrease to 7.13 ± 
0.04 (n=3). Therefore differences in pHe could be contributing to the observed effect of 
hypercapnia. In order to control for differences in pHe, solutions needed to be at the same pH 
when gassed with either 5% or 10% CO2 but without altering the HCO3
-
 concentration. 
Therefore, Krebs solutions were modified and the compositions of the solutions used in the 
following experiments are given in table 3.01. To set pH to 7.44 in solutions gassed with 10% 
CO2, 10mM HEPES and 10mM NaOH were added (solution C) whilst for solutions gassed 
with 5% CO2, 10mM HEPES and 0.6mM NaOH was added to the solution along with 20mM 
mannitol to overcome the differences in osmolarity (solution B). When pHe was maintained 
at 7.44, hypercapnia still significantly augmented both the adenosine-induced delta pH and 
HCO3
-
 flux by 1.7 ± 0.1 and 4.3 ± 0.7 fold respectively (p<0.05 vs. normocapnia; n=3 for 
each) as shown in figure 3.14. This suggests that differences in pHe do not contribute to the 
effect of hypercapnia on intracellular acidification. 
Table 3.01: Modifications to high Cl
-
 Krebs solution in order to assess the effects of hypercapnia 
when extracellular pH is equal in both normocapnic and hypercapnic conditions. 
 
 
  CO2 HEPES NaOH Mannitol pH Osmolarity 
Solution A 5% - - - 7.4 280 
Solution B 5% 10mM 0.6mM 20mM 7.4 310 
Solution C 10% 10mM 10mM - 7.4 310 
Solution D 5% 10mM 0.6mM 
 
7.4 290 
Solution E 5% - - 10mM 7.4 290 
Solution F 5% - - 20mM 7.4 310 
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Figure 3.14: The effects of hypercapnia on the forskolin-stimulated intracellular acidification 
are not due to differences in extracellular pH.  Modifications to high Cl
-
 Krebs solution allowed the 
pH of the solution to be set to pH 7.44 when gassed with either 5% CO2/95% O2 (v/v) or 10% 
CO2/90% O2 (v/v). The forskolin-stimulated decrease in pHi (A) and HCO3
-
 flux (B) are displayed. * 
= significant effect of hypercapnia (p<0.05). Data represents mean ± S.E.M., n=3 for each. 
 
As the above experiments had been carried out using solutions containing NaOH and HEPES, 
it was necessary to ensure that the presence of HEPES and NaOH did not affect the responses 
to adenosine. Therefore, HEPES/NaOH-containing (solution D) and HEPES/NaOH-free 
solution containing mannitol (solution E) were compared to determine the effect, if any, of 
HEPES and NaOH. In control experiments, adenosine induced a decrease in pHi of 0.26 ± 
0.01 (n=3) and a HCO3
-
 flux of 8.6 ± 0.8mM HCO3
-
 min
-1
 (n=3). These responses were not 
significantly different to those observed in HEPES/NaOH-containing solutions; delta pH = 
0.25 ± 0.02 (p>0.05 vs. controls) and HCO3
-
 flux = 10.0 ± 1.0mM HCO3
- 
min
-1
 (p>0.05 vs. 
control; n=3 for each) and shows that inclusion of HEPES and NaOH into the solutions did 
not alter the cells response to cAMP stimulation. Addition of HEPES and NaOH also 
inevitably increased osmolarity of the solutions and, as such, this parameter was also 
controlled for by comparing a standard solution of 280mOsm (solution A) to a high 
osmolarity solution of 310mOsm (solution F). In control experiments, adenosine induced a 
decrease in pHi of 0.20 ± 0.03 (n=3) and a HCO3
-
 flux of 6.0 ± 0.9mM HCO3
- 
min
-1
 (n=3). 
These responses were not significantly different to those observed in hyperosmotic solutions; 
delta pH = 0.17 ± 0.03 (p>0.05 vs. controls; n=3) and HCO3
-
 flux = 7.3 ± 2.5mM HCO3
- 
min
-1
 
(p>0.05 vs. control; n=3) and shows that the 30mOsm difference did not alter the cells 
response to cAMP stimulation. Finally, all previous experiments had been carried out by 
performing the 5% response first and the 10% response second. When attempting to do this 
the other way round, a change from 10% CO2 to 5% CO2 produced an alkalinisation of pHi 
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which did not subsequently recover. Therefore, in order to ensure there were no time-
dependent effects on Calu-3 cells responses to cAMP stimulation, two responses to adenosine 
were measured with the second one measured 20 minutes after the first one to mimic the time 
points of the normal assay. In the first response, adenosine induced a decrease in pHi of 0.18 
± 0.01 (n=3) and a HCO3
-
 flux of 4.6 ± 0.5mM HCO3
- 
min
-1
 (n=3). These responses were not 
significantly different to those observed in the second response 20 minutes later; delta pH = 
0.20 ± 0.02 (p>0.05 vs. first response; n=3) and HCO3
-
 flux = 7.3 ± 1.9 mM HCO3
- 
min
-1
 
(p>0.05 vs. first response; n=3) and shows that the effect of hypercapnia was not simply 
observed because it was always measured after stimulation of the cells in normocapnia. 
 
3.7.3. The effect of carbonic anhydrase-dependent hydration of CO2 
Hypercapnia may produce a significant increase in cAMP-stimulated intracellular 
acidification due to the fact that increased intracellular CO2 would favour an increased 
production of HCO3
-
 due to the action of carbonic anhydrase catalysing the formation of 
carbonic acid. A higher intracellular [HCO3
-
] would increase the driving force for HCO3
-
 
efflux and therefore may produce the increase in cAMP-induced acidification observed in 
hypercapnic conditions. Therefore, to test this possibility, cells were treated with the non-
specific carbonic anhydrase inhibitor acetazolamide to assess whether increased intracellular 
HCO3
-
 underlies the effect of hypercapnia. In control experiments, hypercapnia elicited a 2.0 
± 0.04 fold increase in the magnitude of the forskolin-stimulated intracellular acidification 
(p<0.05; n=4; fig. 3.15A) and a 3.1 ± 0.7 fold increase in the rate of forskolin-stimulated 
HCO3
-
 flux (p<0.05; n=4; fig. 3.15B). In acetazolamide treated cells, hypercapnia induced a 
1.5 ± 0.2 fold increase in the magnitude of the forskolin-stimulated intracellular acidification 
(p<0.05 vs. normocapnia; p>0.05 vs. control experiments; n=4; fig. 3.15A) and a 2.3 ± 0.3 
fold increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.05 vs. normocapnia; p>0.05 
vs. control experiments; n=4; fig. 3.15B). These data suggest that a CO2-induced increase in 
HCO3
-
 production via carbonic anhydrase activity does not underlie the effects of 
hypercapnia in Calu-3 cells. 
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Figure 3.15: Acetazolamide does not block the effect of hypercapnia on the forskolin-stimulated 
acidification. Calu-3 cells were stimulated with 5µM forskolin in normocapnic (5% CO2) and 
hypercapnic (10% CO2) in the presence or absence of 100µM acetazolamide. The delta pH (A) and 
the HCO3
-
 flux (B) resulting from forskolin stimulation are displayed. * = significant effect of 
hypercapnia (p<0.05; ** = p<0.01); † = significant effect of acetazolamide (p<0.05). Data represents 
mean ± S.E.M.; n = 4 for each. 
 
3.7.4. CO2 does not mediate its effects on cAMP-regulated HCO3
-
 transport via sAC 
The findings displayed in figure 3.7 suggest that activation of tmAC is important for 
forskolin-stimulated HCO3
-
 transport in Calu-3 cells. Although our laboratory has shown CO2 
can modulate tmAC activity (Townsend et al., 2009; Cook et al., 2012), CO2 has also been 
shown to regulate sAC activity (Schmid et al., 2010; Rahman et al., 2013) and that sAC can 
regulate CFTR in Calu-3 cells (Wang et al., 2008). Therefore, changes in sAC activity may 
underlie the effect of elevated CO2 on cAMP-regulated HCO3
-
 transport. To test this, the sAC 
inhibitor KH7 was used to see whether it could block the effect of hypercapnia. KH7 had a 
small but significant effect on the magnitude of the forskolin-stimulated intracellular 
acidification; in control conditions, hypercapnia increased the magnitude of the acidification 
1.5 ± 0.1 fold (p<0.05 vs. normocapnia; n=4; fig 3.16A) but this was reduced to a 1.3 ± 0.03 
fold increase of in KH7 treated cells (p>0.05 vs. normocapnia; p>0.05 vs. control 
experiments; n=4; fig. 3.16A) and suggests there may be a small role of sAC in responses to 
hypercapnia. However, when looking at the rate of forskolin-stimulated HCO3
-
 flux resulting 
from forskolin stimulation, hypercapnia caused this to increase 2.9 ± 0.03 fold in control 
experiments (p<0.05; n=4; fig. 3.16B) and 2.6 ± 0.3 fold in KH7 treated cells (p<0.05 vs. 
normocapnia; p>0.05 vs. control experiments; n=4; fig 3.16B). Together, these data suggest 
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that sAC has a minimal role in mediating the effects of hypercapnia on cAMP-regulated 
HCO3
-
 transport.  
 
Figure 3.16: KH7 does not block the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification.  The effect of the sAC inhibitor KH7 (10µM) on the forskolin-stimulated 
acidification was assessed in hypercapnic conditions. The delta pH (A) and the HCO3
-
 flux (B) 
resulting from forskolin stimulation are displayed. * = significant effect of hypercapnia (p<0.05). Data 
represents mean ± S.E.M.; n=4 for each. 
 
3.7.5. CO2 does not mediate its effects on adenosine-stimulated HCO3
-
 transport via 
regulation of PLA2 
Given that both adenosine and forskolin evoke very similar responses in Calu-3 cells that are 
both similarly modulated by hypercapnia, it strongly suggests that both are signalling via the 
same pathway i.e. by elevating intracellular cAMP levels. However, Cobb et al. (2002) have 
shown that adenosine can also activate phospholipase A2 in Calu-3 cells when signalling via 
A2B receptors. Inhibition of PLA2 activity reduced CFTR activity when expressed in cos-7 
cells. Furthermore, activation of PLA2 caused production of arachidonic acid which, when 
added exogenously, increased intracellular cAMP levels in Calu-3 cells. It was therefore 
important to know whether the CO2-mediated changes in adenosine-stimulated intracellular 
acidification were PLA2 dependent. The PLA2 inhibitor AACOCF3 was unable to block the 
effect of hypercapnia on adenosine-stimulated cells; hypercapnia increased the magnitude of 
the adenosine-stimulated intracellular acidification 1.9 ± 0.2 fold in control conditions 
(p<0.01; n=4) and 1.8 ± 0.2 fold in the presence of AACOCF3 (p<0.01; n=4; fig. 3.17A). 
Similarly, hypercapnia enhanced the rate of forskolin-stimulated HCO3
-
 flux 4.0 ± 0.7 fold in 
control conditions (p<0.01; n=4) and 4.2 ± 0.8 fold in the presence of AACOCF3 (p<0.01; 
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n=4; fig. 3.17B).  These data suggest that (i) the adenosine-stimulated intracellular 
acidification is not dependent on PLA2 and (ii) hypercapnia does not modulate the PLA2 
pathway to mediate its effects in adenosine-stimulated cells. 
 
Figure 3.17: AACOCF3 does not block the effect of hypercapnia on adenosine-stimulated 
intracellular acidification. The effect of PLA2 inhibitor AACOCF3 (20µM) on the adenosine-
stimulated acidification was assessed in hypercapnic conditions. The delta pH (A) and the HCO3
-
 flux 
(B) resulting from adenosine stimulation are displayed. *** = significant effect of hypercapnia 
(p<0.001). Data represents mean ± S.E.M.; n=4 for each. 
 
3.8. Hypocapnia does not modulate cAMP-regulated HCO3
-
 transport 
To investigate the dose-response of cAMP-regulated HCO3
-
 transport to CO2, the effect of 
hypocapnia (2.5% CO2) was assessed on the forskolin-stimulated intracellular acidification. 
As shown in figure 3.18A, exposure of cells to 2.5% CO2 induced an intracellular 
alkalinisation of 0.25 ± 0.05 units (n=3) that did not recover after twenty minutes. This 
highlights that Calu-3 cells have adaptive mechanisms to recover from intracellular acidosis 
but not intracellular alkalinisation, perhaps suggesting Calu-3 cells are much more tolerant to 
increases in pHi as opposed to decreases.  When assessing the forskolin-stimulated 
intracellular acidification, hypocapnia actually caused a 4.9 ± 1.9 fold reduction in the 
magnitude of the acidification (p<0.05; n=3; fig. 3.18B). However, there was no effect of 
hypocapnia on the rate of forskolin-stimulated HCO3
-
 flux compared to normocapnia. Here, 
hypocapnia induced a 0.7 ± 0.1 fold change in the rate of forskolin-stimulated HCO3
-
 flux 
(p>0.05; n=3; fig. 3.18C) Together, these data suggest hypocapnia may have a small effect on 
regulation of cAMP-stimulated HCO3
-
 transport, although whether this is due to the increased 
in pHi or an effect of the lower CO2 is still yet to be determined. 
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Figure 3.18: Hypocapnia does not modulate forskolin-stimulated HCO3
-
 transport in Calu-3 
cells. (A) shows a representative experiment in which cells were stimulated with 5µM forskolin in 
normocapnia (5% CO2) and after 20 minutes exposure to hypocapnia (2.5% CO2). The delta pH (B) 
and HCO3
-
 flux (C) are summarized. * = significant effect of hypocapnia (p<0.05). Data represents 
mean ± S.E.M.; n=3 for each.  
 
3.9. Permeability of Calu-3 Cells to CO2 
It was initially believed that gases crossed cell membranes passively and there was no 
requirement for carrier proteins. However, several studies have suggested that aquaporins 
mediate CO2 transport into and out of cells. Expression of AQP1 in Xenopus oocytes 
significantly enhances their CO2 permeability (Nakhoul et al., 1998) whilst AQP1 mediates 
60% of CO2 transport across red blood cells (Endeward et al., 2006). Musa-Aziz et al. (2009) 
showed that AQP4 and AQP5 were also CO2 permeable when expressed in Xenopus oocytes 
and imply that CO2 transport across the lipid bilayer is mediated by aquaporin-dependent 
facilitated diffusion. An alternative explanation of CO2 permeability was suggested by Itel et 
al. (2012) who argued that the cholesterol content of the lipid bilayer was a major 
determinant of CO2 permeability. In MDCK cells, increasing membrane cholesterol reduced 
CO2 diffusion into the cell whereas the opposite was true when membrane cholesterol was 
decreased. This paper also reported that AQP1 expression enhanced CO2 diffusion supporting 
findings from previously mentioned studies. A summary of the role of aquaporins in gas 
transport across cells is reviewed by Herrera and Garvin (2011). 
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To investigate the permeability of Calu-3 cells to CO2, intracellular pH measurements were 
performed with the premise that when CO2 enters the cells, an intracellular acidification 
would occur due to the formation of carbonic acid and subsequent dissociation into H
+
 and 
HCO3
-
. Figure 3.19A shows that applying 10% CO2 to both the apical and basolateral 
membrane elicited an intracellular acidification of 0.24 ± 0.02 units (n=6) which is reversible 
after 10% CO2 is removed. Applying 10% CO2 to the apical membrane caused an 
acidification of 0.22 ± 0.02 (n=6) units whilst applying 10% CO2 to the basolateral membrane 
causes an acidification of 0.01 ± 0.01 units (p<0.001 vs. bilateral or apical 10% CO2; n=6; 
fig. 3.19B). Therefore, these findings show that only the apical membrane of Calu-3 cells are 
CO2-permeable and may indicate differences in cholesterol levels and/or aquaporin 
expression at each membrane. Physiologically, these findings are interesting given that serous 
cells may in fact be insensitive to changes in PaCO2 if CO2 from the blood is unable to cross 
the basolateral membrane. To determine whether the asymmetry in CO2 membrane 
permeability is specific for this gas, NH3 transport was also assessed. AQP1 has also been 
reported to be permeable to NH3 permeable and therefore any similarities between CO2 and 
NH3 permeability in Calu-3 cells would suggest AQP1 is responsible for transportation of 
CO2 (Musa-Aziz et al., 2009). 20mM NH4Cl was added to either the apical membrane or 
basolateral membrane and the resulting pHi changes that resulted were assessed. If 
membranes are permeable to NH3, an alkalinisation will result from NH3 entry into cells and 
association with H
+
 to form NH4
+
. Addition of apical NH4Cl caused a pH increase of 0.62 ± 
0.10 units (n=4) whilst addition of basolateral NH4Cl actually caused a pH decrease of 0.14 ± 
0.04 units (n=4; p<0.001 vs apical NH4Cl). Therefore, like with CO2, there exists differences 
in membrane permeability to NH3 and suggests differential expression of aquaporins may be 
responsible for this asymmetry. 
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Figure 3.19: Only the apical membrane of Calu-3 cells is permeable to CO2.  (A) shows a 
representative experiment in which cells were exposed to 10% CO2 either bilaterally (bi), 
basolaterally only (bl) or apically only (ap). The acidification that results from 10% CO2 treatment is 
displayed in (B). *** = significant effect of administering 10% CO2 to the basolateral membrane only 
(p<0.001). Data represents mean ± S.E.M.; n = 6 for each. 
 
3.10. CO2 elicits membrane specific effects 
Given the asymmetry in membrane permeability to CO2 in Calu-3 cells, it was interesting to 
see whether the effects of hypercapnia on cAMP-regulated HCO3
-
 transport were also 
dependent on the site of CO2 exposure. The response to forskolin was measured in 
normocapnia and then again in cells that had been exposed to either apical, basolateral or 
bilateral 10% CO2. Bilateral 10% CO2 increased the magnitude of the forskolin-stimulated 
intracellular acidification 1.7 ± 0.1 fold (p<0.05 vs. normocapnia; n=3) which was similar to 
the 2.2 ± 0.3 fold increase observed when 10% CO2 was applied apically only (p<0.05 vs. 
normocapnia; n=3; figure 3.20A). However, in the presence of basolateral 10% CO2, only a 
1.3 ± 0.1 fold increase in the magnitude of the forskolin-stimulated intracellular acidification  
was observed which was not statistically significantly different from normocapnia (p>0.05 vs. 
normocapnia; n=3; fig 3.20A). Furthermore, when assessing the rate of forskolin-stimulated 
HCO3
-
 flux, the fold increases in bilateral hypercapnia, apical hypercapnia and basolateral 
hypercapnia were 3.5 ± 0.6 (p<0.05 vs. normocapnia; n=3), 2.5 ± 0.3 (p<0.05 vs. 
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normocapnia; n=3) and 1.6 ± 0.3 (p>0.05 vs. normocapnia; n=3) respectively (fig. 3.20B). 
These data show that the effect of hypercapnia on cAMP-regulated HCO3
-
 transport is 
dependent on CO2 being applied to the apical membrane.  
 
 
Figure 3.20: Only apical CO2 induced modulations to forskolin-stimulated intracellular 
acidification. Calu-3 cells were stimulated with 5µM forskolin in normocapnia (5% CO2) and 
hypercapnia (10% CO2) with 10% CO2 applied either to both membranes (bilateral) or only either the 
apical membrane or basolateral membrane. The delta pH (B) and the rate of HCO3
-
 flux (C) resulting 
from forskolin stimulation are displayed. * = significant effect of hypercapnia (p<0.05; ** = p<0.01). 
Data represents mean ± S.E.M.; n = 3 for each. 
 
3.11. Recovery of pHi from CO2-induced acidosis 
It was interesting to understand more about the pHi recovery that occurs after Calu-3 cells are 
exposed to 10% CO2 and attempt to identify the CO2-sensitive mechanisms/transporters that 
facilitated pHi recovery. The following equation was used to calculate % recovery from CO2-
induced acidosis with the values obtained as indicated in figure 3.21A. 
% Recovery = 
pHi 10% end - pHi 10% start
pHi 5% - pHi 10% start
 x 100 
In control experiments, cells exhibited a 96.3 ± 3.0% (n=70) recovery in pHi from CO2-
induced acidosis. However, when basolateral Na
+
 was removed, recovery was significantly 
reduced to -10.5 ± 21.4% (n=5; p<0.001 vs. control; fig. 3.21B). This abolishment of pHi 
recovery suggested this process was completely Na
+
-dependent. Removal of basolateral Cl
-
 
or addition of basolateral DIDS (100µM) reduced recovery to 49.6 ± 2.9% (p<0.05 vs. 
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control; n=3; fig. 3.4B) and 44.3 ± 3.8% (p<0.05 vs. control; n=3; fig. 3.21B) respectively. 
Interestingly, inhibition of NHEs using 3µM EIPA had no effect on recovery (% recovery = 
85.0 ± 8.4% (p>0.05 vs. control; n=4; fig. 3.21B)) suggesting that H
+
 efflux via NHEs did not 
underlie the increase in pHi. Finally, increasing intracellular cAMP levels using forskolin 
reduced recovery to 0.4 ± 7.9% (p<0.001 vs. control; n=3; fig. 3.21B) and suggested that the 
transporters involved in mediating recovery were negatively regulated by cAMP.  
 
Figure 3.21: pHi recovery after CO2-induced acidosis is Na
+
-dependent and inhibited by 
forskolin. (A) shows an example experiment in which the recovery of pHi after CO2-induced acidosis 
can be quantified. (B) summarizes the effects of removal of basolateral Na
+
 or Cl
-
, addition of 
basolateral DIDS (100µM) or EIPA (3µM) or addition of 5µM forskolin on pHi recovery. * = 
significant effect of treatment (p<0.05; *** = p<0.001). Data represents mean ± S.E.M., n numbers 
displayed in parenthesis. 
 
 
3.12. Effects of hypercapnia on other cAMP signalling agents 
I have currently shown that the cAMP elevating agonists forskolin and adenosine both induce 
an intracellular acidification in Calu-3 cells that is due to cAMP-regulated, CFTR-dependent 
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HCO3
-
 secretion. This acidification is modulated by hypercapnia and suggests a CO2-induced 
change in intracellular cAMP levels may underlie this phenomenon. As both forskolin and 
adenosine increase intracellular cAMP via an activation of tmAC, it was worth investigating 
whether hypercapnia could modulate HCO3
-
 transport when intracellular cAMP levels were 
raised independently of tmAC activity. 
 
3.12.1. IBMX 
Phosphodiesterases (PDEs) are the enzymes responsible for cAMP breakdown and it has 
been shown that inhibition of these enzymes increase intracellular cAMP sufficiently enough 
to activate CFTR-dependent Isc in Calu-3 cells (Cobb et al., 2003). For a detailed review of 
the biochemistry of PDEs, see Conti and Beavo (2007). Thus, hypercapnia may modulate 
cAMP-dependent processes due to effects on PDE activity in Calu-3 cells. To investigate this 
possibility, cells were stimulated with either forskolin (control) or IBMX, a non-specific PDE 
inhibitor, in normocapnia and hypercapnia. A representative experiment in which cells were 
stimulated with 1mM IBMX alone is shown in figure 3.22A. In control experiments 
performed on the same day in which cells were stimulated with forskolin, hypercapnia 
induced a 1.8 ± 0.2 fold increase in the magnitude of the forskolin-stimulated intracellular 
acidification (p<0.05; n=3; fig. 3.22B) and a 2.4 ± 0.4 fold increase in the rate of forskolin-
stimulated HCO3
-
 flux (p<0.05; n=3; fig 3.22C). Stimulation of cells with IBMX did induce 
an intracellular acidification consistent with increases in [cAMP]i underlying this process. 
However, hypercapnia only elicited a 1.3 ± 0.1 fold increase in the magnitude of IBMX-
stimulated intracellular acidification (p>0.05; n=3; fig. 3.22B) and a 1.5 ± 0.1 fold increase in 
the rate of IBMX-stimulated HCO3
-
 flux (p>0.05; n=3; fig. 3.22C). These data suggest that 
hypercapnia is unable to modulate intracellular cAMP levels when they are raised by 
phosphodiesterase inhibition as opposed to activation of tmAC. 
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Figure 3.22: Hypercapnia does not alter the IBMX-stimulated intracellular acidification. (A) 
shows a representative experiment in which Calu-3 cells were stimulated with 1mM IBMX in 
normocapnia and after 20 minutes exposure to hypercapnia. Control experiments in which 5µM 
forskolin was used to stimulate intracellular acidification were performed on the same day. The delta 
pH (B) and the rate of HCO3
-
 flux (C) resulting from forskolin stimulation or IBMX stimulation are 
displayed. ** = significant effect of hypercapnia (p<0.01); Data represents mean ± S.E.M.; n=3 for 
each. 
 
3.12.2. Dibutrylyl-cAMP 
An alternative way to increase intracellular cAMP levels independently of tmAC activity is 
by using a membrane permeant cAMP analogue. Dibutrylyl-cAMP (db-cAMP) is one such 
analogue that, due to the presence of a dibutrylyl group, is cell permeable. To investigate 
whether hypercapnia could modulate exogenous cAMP signalling, the effect of db-cAMP 
signalling in normocapnia and hypercapnia was investigated. Ideally, these experiments 
would have been performed on the same transwell of cells. However, it was found that 
although db-cAMP did induce an intracellular acidification, consistent with this response 
being cAMP-regulated, the acidification was irreversible, implying that db-cAMP is unable 
to be broken down by endogenous phosphodiesterases. Therefore, repeated exposures to db-
cAMP in the same experiment were impossible, so separate experiments for normocapnia and 
hypercapnia were performed. Figures 3.23A and 3.23B show example experiments carried 
out in normocapnia and hypercapnia respectively. Unpaired analysis of the forskolin-
stimulated intracellular acidification showed that hypercapnia did not significantly enhance 
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the magnitude of the response, only increasing it 1.3 ± 0.2 fold (p>0.05; n=3; fig. 3.23C). 
This was also the case in db-cAMP-stimulated cells in which hypercapnia induced a 2.1 ± 0.8 
fold increase in the magnitude of the acidification (p>0.05; n=3; fig. 3.23C). However, 
hypercapnia did significantly enhance the rate of HCO3
-
 flux 2.4 ± 0.8 and 4.1 ± 1.9 fold in 
forskolin and db-cAMP-stimulated cells respectively (p<0.05; n=3; fig. 3.23D). Therefore, 
these data suggest that hypercapnia can modulate exogenous cAMP levels and therefore 
indicate that CO2 is not only modulating tmAC activity in these cells as initially thought. 
However, given the unpaired nature of these experiments, the data is not as robust as it could 
be and alternative cAMP analogues should be explored before this data is deemed conclusive. 
 
Figure 3.23: Hypercapnia is able to modulate dibutrylyl-cAMP-stimulated intracellular 
acidification in Calu-3 cells. (A) shows an example experiment in which cells were stimulated with 
5µM forskolin and then 800µM db-cAMP in normocapnia and (B) shows the same protocol repeated 
in cells exposed to 20 minutes hypercapnia. The delta pH (C) and the rate of HCO3
-
 flux (D) resulting 
from forskolin or db-cAMP stimulation are displayed. * = significant effect of hypercapnia (p<0.05); 
Data represents mean ± S.E.M.; n=3 for each. 
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3.12.3. Multidrug Resistance Proteins 
The multidrug resistance proteins (MRPs) are a family of ABC transporters that have been 
shown to transport cyclic nucleotides in mammalian cells (Jedlitschky et al., 2000; Chen et 
al., 2001; van Aubel et al., 2002). Inhibition of MRPs in T84 cells dose-dependently reduced 
forskolin-stimulated elevations in extracellular cAMP ([cAMP]e) implicating the role of these 
transporters in regulating cAMP efflux from the cell (Xie et al., 2011). Hamilton et al. (2001) 
have shown that MRP-1 is expressed on the basolateral membranes in Calu-3 cells and given 
their role in cAMP transport, it was important to test whether these transporters play a role in 
CO2-induced changes in cAMP-regulated HCO3
-
 transport. As shown in figure 3.24A, cells 
were treated with the MRP inhibitor MK-571 and the response to forskolin stimulation was 
assessed in normocapnia and hypercapnia and the data was compared to control experiments 
performed on the same day. In control experiments, hypercapnia induced a 2.4 ± 0.3 fold 
increase in the magnitude of the forskolin-stimulated intracellular acidification (p<0.05; n=3; 
fig. 3.24B) and a 5.7 ± 0.6 fold increase in the rate of forskolin-stimulated HCO3
-
 flux 
(p<0.05; n=3; fig. 3.24C). However, in the presence of MK-571, the effect of hypercapnia 
was abolished. Here, hypercapnia induced a 1.0 ± 0.1 fold increase in the magnitude of the 
forskolin-stimulated intracellular acidification (p>0.05; n=3; fig. 3.24B) and a 1.1 ± 0.2 fold 
increase in the rate of forskolin-stimulated HCO3
-
 flux (p>0.05; n=3; fig. 3.24C). What was 
also interesting was the fact that MK-571 abolished the recovery of pHi from CO2-induced 
acidosis (fig. 3.24D). These findings show that inhibition of MRPs prevent the effect of 
hypercapnia on cAMP-regulated HCO3
-
 transport and suggest that hypercapnia may reduce 
[cAMP]i due to increased efflux via MRPs. Furthermore, the results also support the idea that 
elevations in intracellular cAMP prevents pHi recovery from CO2-induced acidosis, likely 
due to a downregulatory effect of cAMP on the transporter(s) responsible for this recovery, 
and implies that the MRPs are active during exposure to 10% CO2.  
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Figure 3.24: MK-571 blocks the effect of hypercapnia on the forskolin-stimulated intracellular 
acidification. (A) shows a representative experiment in which the effect of bilateral MK-571 (10µM) 
on forskolin-stimulated intracellular acidification in normocapnia and hypercapnia was assessed. The 
delta pH (B) and the HCO3
-
 flux (C) resulting from forskolin stimulation in control cells or MK-571-
treated cells are displayed. ** = significant effect of hypercapnia (p<0.01; *** = p<0.001). (D) shows 
the effect of MK-571 on the recovery in pHi from CO2-induced acidosis. *** = significant effect of 
MK-571 (p<0.001). Data represents mean ± S.E.M.; n=3 for each. 
 
In attempt to identify which membrane the apparent CO2-sensitive MRPs were expressed, 
MK-571 was added to one membrane only and the response to forskolin in normocapnia and 
hypercapnia was measured. Figure 3.25A shows the effect of apical MK-571 and figure 
3.25B shows the effect of basolateral MK-571. As can be seen, distinct differences exist 
depending on which membrane MK-571 is applied. Firstly, apical MK-571 blocked recovery 
of pHi from CO2-induced acidosis; a phenomenon which was not observed when MK-571 
was applied basolaterally (fig 3.25E). Furthermore, only apical MK-571 was able to block the 
effect of hypercapnia on the forskolin-stimulated intracellular acidification. In control 
experiments performed on the same day and in basolateral MK-571 experiments, hypercapnia 
increased the magnitude of the forskolin-stimulated intracellular acidification 2.0 ± 0.2 fold 
and 2.0 ± 0.1 fold respectively (p<0.01; n=3 for each; fig. 3.25C). Similarly, hypercapnia also 
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increased the rate of forskolin-stimulated HCO3
-
 flux 4.9 ± 0.8 fold and 3.4 ± 0.6 fold 
respectively (p<0.05; n=3 for each; fig. 3.25D). However, in the presence of apical MK-571, 
the magnitude of forskolin-stimulated intracellular acidification and the rate of forskolin-
stimulated HCO3
-
 flux were only enhanced 0.9 ± 0.1 fold and 1.2 ± 0.3 fold respectively 
(p>0.05; n=3; figs 3.25C and D). This effect of apical MK-571 mimics the response to 
bilateral MK-571 and implies that the potential CO2-sensitive MRP transporters are located at 
the apical membrane. 
 
Figure 3.25: Apical but not basolateral MK-571 blocks the effect of hypercapnia on the 
forskolin-stimulated intracellular acidification. (A) shows a representative experiment in which 
MK-571 (10µM) was applied apically and (B) shows a representative experiment in which MK-571 
(10µM) was applied basolaterally. The delta pH (C) and the HCO3
-
 flux (D) resulting from forskolin 
stimulation in control cells or MK-571-treated cells are displayed. ** = significant effect of 
hypercapnia (p<0.01; *** = p<0.001). (E) shows the effect of MK-571 on the recovery in pHi from 
CO2-induced acidosis. *** = significant effect of MK-571 (p<0.001). Data represents mean ± S.E.M.; 
n=3 for each. 
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In attempt to quantify MRP activity in Calu-3 cells in normocapnia and hypercapnia, the rate 
of efflux of a MRP specific substrate was measured. Loading cells with the dye 5-
chloromethyl-fluorescein diacetate (CMFDA) causes CMFDA to enter the cell where it is 
metabolized by intracellular esterases into glutathione-methylfluorescein (GSMF) which is a 
substrate for MRPs (Bogman et al., 2003; Suda et al., 2011). As GSMF is fluorescent, 
measuring the rate at which fluorescence decreased gave a measure of GSMF efflux from the 
cells. Cells were initially perfused with Krebs solution gassed with either 5% CO2 or 10% 
CO2 for 20 minutes before a 5 minute wash-in of probenecid to inhibit MRPs and thus 
prevent immediate efflux once the dye had loaded. Perfusion was then switched off and cells 
were loaded with 1µM CMFDA and fluorescence increased as GSMF accumulated inside the 
cell. After 20 minutes, perfusion was switched on to wash away the probenecid and 
fluorescence decreased as GSMF was transported out of the cell and washed away. The rate 
at which fluorescence decreased by 50% was measured by performing a linear regression 
between the maximal fluorescence and 50% of the maximal fluorescence as shown in figure 
3.26A. In normocapnic conditions, fluorescence at 490nm decreased at a rate of 124 ± 32 
counts sec
-1
 (n=4) which was not statistically different than the fluorescent decrease of 192 ± 
39 counts sec
-1
 in hypercapnia (p>0.05; n=3) although there does appear to be a small trend 
for hypercapnia to increase GSMF efflux consistent with the idea that hypercapnia may 
activate MRPs and thus activate MRP-mediated cAMP efflux. 
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Figure 3.26: Acute hypercapnia has no effect on the rate of MRP-mediated GSMF efflux from 
Calu-3 cells. (A) shows a representative experiment in normocapnia in which the effect of CMFDA 
(1µM) on the fluorescence measured at 490nm was measured to assess the rate of MRP-mediated 
GSMF efflux. The red line demonstrates the linear regression calculated between the maximal 490nm 
counts and the time at which 490nm counts had decreased by 50%. (B) summarizes the effect of 
hypercapnia on the rate of decrease in 50% of the 490nm counts. Data represents mean ± S.E.M., n=4 
for normocapnia and n=3 for hypercapnia.  
 
3.13. Disruption of compartmentalization of cAMP signalling does not prevent the 
effect of hypercapnia 
As discussed in chapter 1, section 1.6.1.2, CFTR is contained within a macromolecular 
complex in epithelial cells that localizes the cAMP signalling machinery into a microdomain 
allowing for efficient signal transduction. The macromolecular complex is tethered to the 
actin cytoskeleton via scaffold proteins, including Ezrin, and the importance of the actin 
cytoskeleton integrity in CFTR regulation and cAMP compartmentalization was shown by 
Monterisi et al. (2012). Here, researchers demonstrated that pharmacological disruption of 
the actin cytoskeleton in human bronchial epithelial cells reduced membrane cAMP levels 
but increased cytosolic cAMP levels, suggesting a loss of cAMP compartmentalization. This 
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was accompanied by a reduction in CFTR-dependent Cl
-
 secretion, highlighting the 
importance of cAMP compartmentalization in efficient CFTR activation. Pharmacologically, 
the actin cytoskeleton can be disrupted by either latrunculin or cytochalasin D, each with a 
slight different mechanism of action. Latrunculin is able to bind to actin monomers and thus 
prevent depolymerisation into new F-actin filaments (Coue et al., 1987; Morton et al., 2000) 
whilst cytochalasin D binds to actin monomers and stimulates actin ATPase activity which 
initially increases the rate of actin polymerization. However, the accumulation of actin bound 
to ADP drastically impairs the polymerization of actin monomers into actin filaments 
(Sampath and Pollard, 1991). To assess whether hypercapnia mediated its effects on cAMP-
dependent HCO3
-
 transport by disrupting cAMP compartmentalization, Calu-3 cells were 
preincubated for one hour with either 10µM latrunculin B or 10µM cytochalasin D. To fully 
establish the effect of these compounds, confocal images of the actin cytoskeleton were taken 
as shown in figure 3.27A as well as transepithelial electrical resistance measurements to 
determine whether disruption of the actin cytoskeleton affected the monolayer integrity (fig. 
3.27B). Figure 3.27A (far left panel) shows the cytoskeleton of untreated cells at the x-y focal 
plane. Cytochalasin D treatment (fig. 3.27A, left middle panel) caused a marked disruption of 
the cytoskeleton with the phalloidin staining appearing more punctate and much less 
organised. This is accompanied by a significant decrease in TEER that occurs within the first 
30 minutes of treatment and persists over a 2 hour period (fig 3.27B). Interestingly, 
latrunculin B treatment (fig. 3.27A, middle  right panel) did not appear to affect the overall 
global structure of the actin cytoskeleton, yet it induced a significant reduction in TEER, even 
more so than cytochalasin D (fig. 3.27B), indicating that the effects of latrunculin on actin 
cytoskeleton organization are much more subtle than the effects of cytochalasin D. Finally, it 
was worth noting that acute hypercapnia did not affect the gross organization of the actin 
cytoskeleton as highlighted in figure 3.27A (far right panel). 
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Figure 3.27: The effect of cytochalasin D and latrunculin B on actin cytoskeleton integrity and 
transepithelial electrical resistance in Calu-3 cells. (A) shows Calu-3 cells that were either 
untreated (far left panel) or either incubated for one hour with 10µM cytochalasin D (middle left 
panel) or 10µM latrunculin B (middle right panel) or incubated for 20 minutes in 10% CO2 (far right 
panel) and stained with 0.25% Texas-Red Phalloidin to visualize F-actin using confocal microscopy. 
(B) displays the effects of 10µM cytochalasin D or 10µM latrunculin B on TEER measurements made 
every 30 minutes over a 2 hour period. *** = significant effect of treatment vs. control (p<0.001); † = 
significant effect of Lat B vs. Cyt D (p<0.001). Data represents mean ± S.E.M.; n=3 for each. 
 
To assess whether disruption of the actin cytoskeleton affected the response to hypercapnia, 
Calu-3 cells were preincubated for one hour with either 10µM latrunculin B or 10µM 
cytochalasin D and compared to control experiments performed on the same day. Figure 
3.28A shows the effect of cytochalasin D on the response to forskolin. In control 
experiments, hypercapnia caused a 1.7 ± 0.1 fold increase in the magnitude of the forskolin-
stimulated intracellular acidification (p<0.05; n=4; fig. 3.28B) and increased the rate of 
forskolin-stimulated HCO3
-
 flux 3.4 ± 0.1 fold (p<0.01; n=4; fig. 3.28C). In cytochalasin D 
treated cells, hypercapnia caused a 1.5 ± 0.1 fold increase in the magnitude of the forskolin-
stimulated intracellular acidification (p<0.05; n=4) and increased the rate of forskolin-
stimulated HCO3
-
 flux 3.8 ± 0.6 fold (p<0.01 n=4). Thus, even though cytochalasin D caused 
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a clear disruption of the actin cytoskeleton, this had no effect on the CO2 modulation of the 
forskolin-stimulated intracellular acidification suggesting that compartmentalized cAMP is 
not essential for mediating the response to hypercapnia. Similarly, latrunculin B treatment did 
not prevent the effect of hypercapnia. In these experiments, the magnitude of the forskolin-
stimulated intracellular acidification and the rate of forskolin-stimulated HCO3
-
 flux were 
increased 1.9 ± 0.1 fold (p<0.05; n=3; fig. 3.29B) and 2.7 ± 0.4 fold (p<0.05; n=3; fig. 3.29C) 
respectively in control experiments and increased 1.6 ± 0.2 fold (p<0.05; n=3; fig. 3.29B) and 
3.0 ± 0.7 fold (p<0.05; n=3; fig. 3.29C) respectively in latrunculin B treated cells. 
Latrunculin B treatment did appear to increase the rate of forskolin-stimulated HCO3
-
 flux in 
both normocapnia and hypercapnia, with these difference significant in hypercapnic 
conditions (p<0.05). This likely reflects the fact that latrunculin B treated monolayers were 
very leaky such was the pronounced effect of latrunculin B on TEER. 
 
Figure 3.28: Cytochalasin D does not block the effects of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were preincubated for one hour with cytochalasin D (10µM) and stimulated with 5µM forskolin in 
normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin 
stimulation are summarized. ** = significant effect of hypercapnia (p<0.01; *** = p<0.001); Data 
represents mean ± S.E.M.; n=4 for each. 
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Figure 3.29: Latrunculin B does not block the effects of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
preincubated for one hour with latrunculin B (10µM) and stimulated with 5µM forskolin in 
normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin 
stimulation are summarized. * = significant effect of hypercapnia (p<0.05); † = significant effect of 
latrunculin B treatment (p<0.05). Data represents mean ± S.E.M.; n=3 for each. 
 
3.14. Effects of acute hypercapnia on specific H
+
/HCO3
-
 transporters 
3.14.1. Apical HCO3
-
 efflux  
The forskolin-stimulated intracellular acidification, used as an assay to measure cAMP-
regulated HCO3
-
 transport, is the result of at least two components of HCO3
-
 transport: apical 
HCO3
-
 efflux and basolateral HCO3
-
 influx. The fact that elevations in intracellular cAMP 
induced an intracellular acidification suggests that, during that period, HCO3
-
 efflux is greater 
than HCO3
-
 influx until a new steady state in pHi is reached. The modulation of the response 
by hypercapnia suggests CO2 is either increasing HCO3
-
 efflux or, conversely, inhibiting 
HCO3
-
 influx, or indeed both. Therefore, it was important to measure the activity of HCO3
-
 
transporters at each membrane in an attempt to understand how CO2 was able to modulate 
cAMP-regulated HCO3
-
 transport. One approach to study HCO3
-
 transport at each membrane 
was by using the inhibitor stop technique (Hegyi et al., 2003). Here, inhibition of basolateral 
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pHi regulatory transporters (i.e. NBC, NHE and AE2) allowed for the study of apical HCO3
-
 
efflux only. As shown in figure 3.30A, cells were stimulated with 5µM forskolin and an 
acidification occurred until a new steady state pHi was reached. At this point, 500µM DIDS 
and 3µM EIPA was added to the basolateral membrane to inhibit NBC, AE2 and NHE. 
Addition of these inhibitors induced a secondary intracellular acidification as together they 
prevented HCO3
-
 influx across the basolateral membrane but HCO3
-
 efflux across the apical 
membrane could continue and as such, this acidification represents a measure of apical 
CFTR-dependent HCO3
-
 efflux only. Basolateral inhibitors and forskolin were washed off 
and the process was repeated in hypercapnia. The forskolin-stimulated intracellular 
acidification was significantly enhanced 1.7 ± 0.3 fold and 3.1 ± 0.1 fold in both magnitude 
of intracellular acidification and in rate of HCO3
-
 flux respectively (p<0.05; n=3 for each; figs 
3.30B and C). However, there was no effect of hypercapnia on the acidification produced 
when DIDS and EIPA were added to the basolateral membrane. Hypercapnia induced a 0.7 ± 
0.1 fold increase in the magnitude of this acidification (p>0.05; n=3; fig. 3.30B) and a 1.3 ± 
0.3 fold increase of in the rate of HCO3
-
 efflux across the apical membrane (p>0.05; n=3; fig. 
3.30C). These data suggest that apical HCO3
-
 transport is unaffected by hypercapnia and 
implies that the increased acidification seen in hypercapnic conditions is more likely the 
result of a reduction in basolateral HCO3
-
 influx. The same findings were also observed when 
adenosine was used to stimulate cAMP-regulated HCO3
-
 transport. 
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Figure 3.30: Apical HCO3
-
 efflux is unaffected by acute hypercapnia. (A) shows a representative 
experiment in which the effect of hypercapnia on 5µM forskolin-stimulation and subsequent addition 
of H2-DIDS (500µM) and EIPA (3µM) to inhibit basolateral pHi regulatory transporters was assessed. 
The delta pH (B) and the HCO3
-
 flux (C) resulting from forskolin stimulation and subsequent addition 
of basolateral inhibitors are displayed. * = significant effect of hypercapnia (p<0.05). Data represents 
mean ± S.E.M.; n=3 for each. 
 
To further investigate the effects of acute hypercapnia on CFTR-dependent HCO3
-
 efflux 
across the apical membrane, CFTR-dependent anion exchange was assessed in normocapnia 
and hypercapnia. Garnett et al. (2011) showed that Calu-3 cells express the Cl
-
/HCO3
-
 
exchanger pendrin on the apical membrane and that it is regulated by CFTR. Removal of Cl
-
 
from the apical membrane reverses the exchanger such that HCO3
-
 accumulates within the 
cell and an alkalinisation occurs. Reintroduction of apical Cl
-
 allows the exchanger to 
function in its normal direction and HCO3
-
 leaves the cell. The resulting reacidification can 
be used to measure CFTR-dependent HCO3
-
 secretion at the apical membrane and, thus, this 
was measured in normocapnia and hypercapnia, as shown in figure 3.31A. In normocapnia, 
removal of apical Cl
-
 caused pHi to increase by 0.79 ± 0.01 (n=3) units whilst in hypercapnia 
this increase in pHi was 0.85 ± 0.07 (p>0.05; n=3 fig. 3.31B). Furthermore, reintroduction of 
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apical Cl
-
 caused pHi to reacidify at a rate of 0.49 ± 0.04 pH units min
-1
 in normocapnia and 
0.48 ± 0.04 pH units min
-1
  in hypercapnia (p>0.05; n=3; fig. 3.31C) which was calculated as 
a HCO3
-
 efflux of 138 ± 8mM HCO3
- 
min
-1
  and 204 ± 33mM HCO3
- 
min
-1
 respectively 
(p>0.05; n=3; fig. 3.31D). These data show that CFTR-dependent anion exchange activity 
was unaffected by acute hypercapnia and support the findings from the inhibitor stop 
experiments that HCO3
-
 transport across the apical membrane is insensitive to changes in 
CO2. 
 
Figure 3.31: CFTR-dependent anion exchange activity is unaffected by acute hypercapnia. (A) 
shows a representative experiment in which the effect of acute hypercapnia on forskolin-stimulated, 
CFTR-regulated apical HCO3
-
 transport was assessed by removal and subsequent readdition of apical 
Cl
-
. The delta pH in response to removal of Cl
-
 is shown in (B). The reacidification and the HCO3
-
 
flux resulting from readdition of apical Cl
-
 are shown in (C) and (D) respectively. Data represents 
mean ± S.E.M.; n=3 for each. 
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3.14.2. Basolateral HCO3
-
 Influx 
Members of the Na
+
/HCO3
-
 Cotransporter (NBC) family serve as the major HCO3
-
 importers 
in HCO3
-
 secreting tissue (Bachmann et al., 2003) and therefore changes in NBC activity will 
impact on HCO3
-
 secretion across HCO3
-
 secretory epithelia. End-point PCR revealed that 
both SLC4A4 (electrogenic Na
+
/HCO3
-
 Cotransporter 1) and SLC4A7 (electroneutral 
Na
+
/HCO3
-
 Cotransporter 1) were expressed in Calu-3 cells (fig. 3.32). SLC4A4 favours a 
stoichiometry of 2 HCO3
-
 : 1 Na
+
 (Romero et al., 1997) whilst SLC4A7, being electroneutral, 
has a stoichiometry of 1 HCO3
-
 : 1 Na
+
 (Pushkin et al., 1999).  
 
Figure 3.32: Members of the NBC family, SLC4A4 and SLC4A7, are expressed in Calu-3 cells. 
End-Point PCR on RNA samples extracted from Calu-3 cells grown as a polarized monolayer were 
analysed for the expression of members of the NBC family of HCO3
-
 transporters. CFTR expression 
was also analysed as a positive control. 
 
To determine whether CO2 alters cAMP-regulated HCO3
-
 transport by altering the activity of 
NBC, NBC activity was assessed using the technique employed by Yang et al., (2009). Here, 
removal of basolateral Na
+
 causes pHi to decrease due to inhibition of NBC-dependent HCO3
-
 
influx whilst subsequent reintroduction of basolateral Na
+
 reactivates NBC and the 
subsequent alkalinisation is a result of NBC-dependent HCO3
-
 influx and can therefore be 
used as a measure of NBC activity. Experiments were carried out in the presence of EIPA to 
inhibit the Na
+
/H
+
 exchanger. Firstly, it was necessary to determine whether NBC activity in 
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Calu-3 cells was cAMP-dependent. Figure 3.33A shows an example trace in which the effect 
of forskolin on NBC activity was assessed. 5µM forskolin stimulated a 2.3 ± 0.4 fold increase 
in NBC activity (n=3; p<0.05), whilst other cAMP agonists, adenosine (10µM) and IBMX 
(1mM), stimulated a 2.5 ± 0.5 (n=3; p<0.05) and 2.3 ± 0.5 (n=3; p<0.05) fold increase in 
NBC activity respectively (fig. 3.33B). These findings indicate that NBC activity in Calu-3 
cells is cAMP-regulated and therefore could be affected by acute hypercapnia. 
 
 
Figure 3.33: cAMP agonists stimulate Na
+
-dependent HCO3
-
 import in Calu-3 cells. (A) shows a 
representative experiment in which NBC activity was assessed under basal and forskolin-stimulated 
conditions by removal and subsequent reintroduction of basolateral Na
+
 to inhibit and reactivate 
NBC-mediated HCO3
-
 transport. EIPA (3µM) was present to inhibit the Na
+
/H
+
 exchanger. (B) shows 
the effect of the cAMP agonists forskolin (5µM), adenosine (10µM) and IBMX (1mM) on NBC-
dependent HCO3
-
 influx. * = significant effect of agonist stimulation; (p<0.05). Data represents mean 
± S.E.M.; n=3 for each. 
 
The effect of acute hypercapnia on cAMP-regulated NBC activity was next assessed. Here, 
NBC activity was measured in normocapnic conditions or after cells had been exposed to 20 
minutes hypercapnia as shown in figures 3.34A and B respectively. In normocapnia, 
forskolin stimulated a NBC-dependent HCO3
-
 influx of 12.5 ± 1.8mM min
-1
 (n=7) whilst in 
hypercapnia, forskolin-stimulated NBC-dependent HCO3
-
 influx was 11.3mM min
-1
 ± 1.7 
(n=7; p>0.05 vs. normocapnia; fig. 3.34C). These findings suggest that acute hypercapnia 
does not affect cAMP-stimulated NBC activity. 
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Figure 3.34: Acute hypercapnia does not affect forskolin-stimulated NBC activity. Example 
experiments to assess forskolin-stimulated NBC activity in normocapnia (A) and hypercapnia (B) are 
shown. Measurements were carried out in the presence of 3µM EIPA. The effect of acute hypercapnia 
on forskolin-stimulated NBC-dependent HCO3
-
 influx is summarized in (B). Data represents mean ± 
S.E.M.; n=7. 
 
Similar findings were observed when the cAMP agonist was changed to adenosine. These 
sets of experiments were performed in a paired manner, with responses in both normocapnia 
and hypercapnia measured on the same transwell (fig. 3.35A). In normocapnia, adenosine 
(10µM) stimulated a NBC-dependent HCO3
-
 influx of 12.5 ± 1.8mM min
-1
 (n=4) whilst in 
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hypercapnia, adenosine-stimulated NBC-dependent HCO3
-
 influx was 14.6 ± 1.6mM min
-1
 
(n=4; p>0.05; fig. 3.35B). These findings support the notion that although hypercapnia can 
modulate intracellular cAMP levels and cAMP-dependent HCO3
-
 transport, this is not related 
to a change in NBC activity. 
 
Figure 3.35: Acute hypercapnia does not affect adenosine-stimulated NBC activity. (A) shows a 
representative experiment in which adenosine-stimulated NBC activity was assessed in normocapnia 
(5% CO2) and hypercapnia (10% CO2) in the presence of 3µM EIPA. The effect of acute hypercapnia 
on adenosine-stimulated NBC-dependent HCO3
-
 influx is summarized in (B). Data represents mean ± 
S.E.M.; n=4. 
 
The current assay used to measure basolateral Na
+
-dependent HCO3
-
 import could be 
influenced by CFTR-dependent HCO3
-
 export occurring across the apical membrane 
simultaneously and, as such, it was important to measure NBC-mediated HCO3
-
 import in a 
more isolated manner. To do this, NBC activity was measured in the presence of 10µM 
GlyH-101 to inhibit cAMP-stimulated, CFTR-dependent apical HCO3
-
 efflux (fig. 3.36A). As 
shown in figure 3.36B, in the presence of GlyH-101, Na
+
-dependent HCO3
-
 influx increased 
1.7 ± 0.3 fold in normocapnia (n=4; p<0.05) and 2.0 ± 0.3 fold in hypercapnia (n=4; p<0.05). 
These findings are to be expected given there is no longer an apical efflux pathway for HCO3
-
 
 90 
 
and thus realkalinisation of pHi would occur much faster as HCO3
-
 accumulated within the 
cell. However, even in the presence of GlyH-101, the rate of Na
+
-dependent HCO3
-
 influx 
was unchanged in acute hypercapnia compared to normocapnia (22.4 ± 1.7mM min
-1
 vs. 21.8 
± 3.0mM min
-1
 respectively; n=4; p>0.05; fig. 3.36B). These findings again provide strong 
evidence that cAMP-stimulated NBC activity is unaffected by changes in CO2. 
 
Figure 3.36: Acute hypercapnia does not affect the activity of Na
+
/HCO3
-
 Cotransporters when 
measured in the presence of GlyH-101. (A) displays a representative experiment in which 5µM 
forskolin was used to stimulate basolateral Na
+
-dependent HCO3
-
 influx whilst GlyH-101 (10µM) was 
added to the apical membrane to prevent CFTR-dependent apical HCO3
-
 efflux. (B) summarizes the 
effect of hypercapnia on NBC-dependent HCO3
-
 influx with and without GlyH-101. * = significant 
effect of GlyH-101 (p<0.05). Data represents mean ± S.E.M.; n = 7 for non GlyH-101 treated cells 
and n=4 for GlyH-101 treated cells. 
 
Although end point PCR revealed that SLC4A10 (a Na
+
-dependent Cl
-
/HCO3
-
 exchanger) 
was not expressed in Calu-3 cells, it was interesting to assess the Cl
-
 dependence of Na
+
-
dependent HCO3
-
 transport. Figures 3.37A and B show example experiments used to measure 
Na
+
-dependent, Cl
-
 independent HCO3
-
 influx in normocapnia and hypercapnia respectively, 
in which forskolin-stimulated Na
+
-dependent HCO3
-
 transport was compared to Na
+
-
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dependent HCO3
-
 transport in the absence of basolateral Cl
-
. Interestingly, in both 
normocapnia and hypercapnia, the rate of Na
+
-dependent HCO3
-
 influx was significantly 
increased when basolateral Cl
-
 was removed. In normocapnia, removal of basolateral Cl
-
 
increased Na
+
 dependent HCO3
-
 influx 1.8 ± 0.2 fold (n=5; p<0.05) whilst in hypercapnia, 
this increase was 2.0 ± 0.1 fold (n=5; p<0.01; fig. 3.37C). These findings suggested that there 
may exist a Na
+
-dependent Cl
-
/HCO3
-
 exchanger in Calu-3 cells that acts to recycle HCO3
-
 
across the basolateral membrane in normal conditions, which, in the absence of basolateral 
Cl
-
, favours HCO3
-
 influx to contribute to the greater realkalinisation rate observed. 
Nevertheless, the rate of Na
+
-dependent HCO3
-
 influx in Cl
-
 free conditions was unchanged in 
hypercapnia relative to normocapnia (23.4 ± 3.8mM min
-1
 vs. 19.8 ± 2.19mM min
-1
 
respectively; p>0.05; n=5; fig. 3.37C) implying that a putative Na
+
-dependent Cl
-
/HCO3
-
 
exchanger was also insensitive to changes in CO2 and therefore does not underlie the CO2-
induced changes in cAMP-regulated HCO3
-
 transport. 
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Figure 3.37: Acute hypercapnia does not alter the activity of a putative Na
+
-dependent Cl
-
/HCO3
-
 exchanger.  (A) shows a representative experiment in which Na
+
-dependent HCO3
-
 influx 
was assessed in basolateral Cl
-
 containing and basolateral Cl
-
 free conditions after 5µM forskolin-
stimulation in 5% CO2. 3µM EIPA was present to inhibit Na
+
/H
+
 exchange. The same approach was 
used in cells exposed to acute hypercapnia (B). (C) displays the effect of basolateral Cl
-
 removal on 
the Na
+
-dependent HCO3
-
 influx as well as the effect of hypercapnia; * = significant effect of 
basolateral Cl
-
 removal (p<0.05; ** = p<0.01) Data represents mean ± S.E.M. n = 5 for each.  
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To further verify that cAMP-stimulated NBC activity was unaffected by hypercapnia, cells 
were stimulated with forskolin in the absence of basolateral Na
+
 (fig. 3.38A). If NBC activity 
was altered by hypercapnia then inhibition of its activity by removal of basolateral Na
+
 
should prevent the CO2 effect. However, even in the absence of basolateral Na
+
, there was 
still a significant 1.9 ± 0.2 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification (p<0.05; n=3; fig. 3.38B) and a significant 2.6 ± 0.5 fold increase in 
the rate of forskolin-stimulated HCO3
-
 flux (p<0.05; n=3; fig. 3.38C). Thus, this supports 
previous data that shows hypercapnia did not alter cAMP-stimulated NBC activity in order to 
produce its alterations in forskolin-stimulated HCO3
-
 transport. 
 
Figure 3.38: Hypercapnia augments forskolin-stimulated intracellular acidification even in 
absence of basolateral Na
+
. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 5µM forskolin in normocapnic (5% CO2) and hypercapnic (10% CO2) in the absence 
of basolateral Na
+
. The delta pH (B) and the HCO3
-
 flux (C) resulting from forskolin stimulation are 
displayed. * = significant effect of hypercapnia (p<0.05). Data represents mean ± S.E.M.; n = 3 for 
each. 
 
One interesting observation from the previous experiments was the effect of hypercapnia on 
the magnitude of the acidification when basolateral Na
+
 was removed under basal conditions. 
This difference can be seen clearly in figure 3.38A. Further analysis revealed that, in 
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normocapnia, the magnitude of this acidification was 0.09 ± 0.02 whilst in hypercapnia it was 
0.26 ± 0.05 (p<0.05 vs. normocapnia; n=3). These findings imply that basal NBC activity (i.e. 
in the absence of cAMP stimulation) was enhanced by hypercapnia, and this was further 
explored in the next set of experiments. Both basal and stimulated NBC activity was assessed 
in either normocapnia (fig. 3.39A) or hypercapnia (fig. 3.39B). In normocapnia, basolateral 
Na
+
 removal in non-stimulated cells caused pHi to decrease by 0.13 ± 0.01 units (n=5) whilst 
this decrease in pHi was enhanced to 0.24 ± 0.03 in hypercapnia (p<0.01 vs. normocapnia; 
n=6; fig. 3.39C). Furthermore, the rate of basal NBC-dependent HCO3
-
 influx in 
normocapnia was 4.8 ± 0.2mM HCO3
- 
min
-1
 (n=5) which was significantly enhanced to 11.9 
± 1.6mM HCO3
- 
min
-1
 in hypercapnia (p<0.05 vs. normocapnia; n=6 fig. 3.39D). These data 
show that hypercapnia elevated basal NBC activity, likely as a mechanism to recover pHi 
from CO2-induced acidosis. As a result, forskolin-stimulation only increases NBC activity 1.4 
± 0.2 fold in hypercapnia (n=6) compared to the 2.5 ± 0.5 fold increase in normocapnia 
(p<0.05; n=5; fig. 3.39E). Therefore, under hypercapnic conditions, it appeared that cAMP 
was unable to significantly enhance NBC activity, because it was already at a maximal rate 
due to the effect of high CO2 and this may contribute to impaired HCO3
-
 transport in acute 
hypercapnic conditions. 
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Figure 3.39: Hypercapnia increases Na
+
/HCO3
-
 Cotransporter activity in basal conditions. (A) 
and (B) show representative experiments in which basal and forskolin-stimulated NBC activity was 
assessed in normocapnia and hypercapnia respectively. The delta pH resulting from basolateral Na
+
 
removal (C) and NBC-dependent HCO3
-
 influx (D) are displayed. (E) displays the fold increase in 
NBC activity by 5µM forskolin. * = significant effect of hypercapnia (p<0.05; ** = p<0.01); † = 
significant difference between basal and forskolin stimulated NBC activity. Data represents mean ± 
S.E.M.; n = 5 for normocapnia experiments and n=6 for hypercapnia experiments. 
 
Recently, investigations into NBC activity in both transfected cell lines and in primary 
murine pancreatic ductal cells have shown that the proteins belonging to the With No Lysine 
kinase (WNK) family and the Ste20p-related proline alanine-rich kinase (SPAK) family are 
able to regulate NBC activity. Yang et al. (2011a) described NBCe1-dependent HCO3
-
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transport was increased when WNK1, 3 or 4 or SPAK were knocked down in mouse 
pancreatic duct cells and decreased when WNK1 or 4 or SPAK were overexpressed. The 
effects of WNK and SPAK appeared to be a reduction in NBCe1 membrane expression given 
that overexpression of SPAK or WNK1 reduced NBCe1 surface expression in transfected 
HEK cells. The researchers showed that WNK acted as a scaffold for SPAK which 
phosphorylated NBCe1 causing a reduction in its surface expression. Given I have found 
hypercapnia upregulated NBC activity in Calu-3 cells, it was interesting to assess whether 
CO2 was able to modulate WNK/SPAK expression. Therefore, a western blot was carried out 
to measure expression of WNK4, SPAK or phosphorylated SPAK (p-SPAK) in cells that had 
been incubated for 20 minutes in pregassed high Cl
-
 Krebs solution exposed to either 5% 
CO2, 5% CO2 + 5 minute forskolin stimulation, 10% CO2 or 10% CO2 + 5 minute forskolin 
stimulation. Figure 3.40 shows the results of the Western blots. Although only representative 
of n=2 experiments, the data suggests that under basal conditions, acute hypercapnia 
decreases the expression of WNK4 but has no major effects on either SPAK or p-SPAK 
expression. Furthermore, forskolin appears to have no major effect on either WNK4, SPAK 
or p-SPAK expression.  
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Figure 3.40. Acute hypercapnia reduces WNK4 expression under basal conditions in Calu-3 
cells. (A) shows the results from a Western Blot in which the effect of forskolin (5µM) and acute 
hypercapnia on WNK4, SPAK and phosphorylated SPAK (p-SPAK) expression was assessed and 
normalized to β-actin expression. For each experimental condition, 3 lysates were generated from 3 
separate samples and each lysate was ran on the gel so that each sample was performed in triplicate. 
The data for WNK4, SPAK and p-SPAK are summarized in (B), (C) and (D) respectively. Data 
represents mean of triplicate samples performed on n=2 independent samples. The protein extraction 
was carried out by myself but the Western Blots were performed in the laboratory of Professor Ursula 
Seidler, (Hannover, Germany). 
 
3.14.3. Src kinase 
The findings that acute hypercapnia activated NBC activity in basal conditions, and therefore 
reduced the ability of cAMP to enhance its activity, may impact upon cAMP-regulated 
HCO3
-
 transport in hypercapnic conditions. Several studies have shown that the Src family 
kinases influence HCO3
-
 transport in human epithelial by regulation of NBCs, and are 
potentially sensitive to changing levels of CO2. Ruiz et al. (1999) measured NBC activity in 
rabbit proximal tubule cells by measuring pHi recovery after removal and then reapplication 
of external Na
+
. They found that CO2 enhanced NBC activity in these cells but this effect was 
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blocked by herbimycin, a Src family kinase inhibitor. Furthermore, overexpression of Csk, a 
negative regulator of Src kinase, also prevented NBC activation by CO2. Espiritu et al. (2002) 
also studied NBC activity in proximal tubule epithelium. They also demonstrated 10% CO2 
increased NBC activity in a Ca
2+
/Calmodulin-dependent manner. Furthermore, 10% CO2 also 
increased Pyk2 phosphorylation which enhanced its interaction with Src kinase. These 
findings showed that Src family kinases were involved in the CO2-dependent upregulation of 
NBC activity in kidney epithelia and suggest Src family kinases are involved in CO2 signal 
transduction. To test the role of Src kinase in mediating the response to hypercapnia in 
airway epithelia, Calu-3 cells were preincubated for one hour with Src kinase Inhibitor 1 
(SKI-1) and perfused with SKI-1 for the duration of the experiment. As shown in figure 
3.41A, the responses of cells to forskolin in normocapnia and hypercapnia were measured 
and compared to control experiments performed on the same day. In control experiments, 
hypercapnia caused a 1.9 ± 0.1 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification (p<0.05; n=3; fig. 3.41B) and increased the rate of forskolin-
stimulated HCO3
-
 flux 4.2 ± 0.2 fold (p<0.05; n=3; fig. 3.41C). Although the raw data 
displayed in figure 3.41 shows SKI-1 caused a reduction in the forskolin-stimulated 
intracellular acidification, these reductions were not sufficient enough to significantly affect 
the fold changes in the forskolin-stimulated intracellular acidification by hypercapnia. In 
SKI-1 treated cells hypercapnia caused a 1.8 ± 0.3 fold increase in the magnitude of the 
forskolin-stimulated intracellular acidification (p<0.05 vs. normocapnia; p>0.05 vs. control 
experiments; fig. 3.41B) and increased the rate of forskolin-stimulated HCO3
-
 flux 4.0 ± 1.1 
fold (p<0.05 vs. normocapnia; p>0.05 vs. control experiments; fig. 3.41C). Therefore, these 
data show that Src kinases have no role in the CO2-mediated modulation of cAMP-regulated 
HCO3
-
 transport in Calu-3 cells. 
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Figure 3.41: Src kinase inhibition does not block the effects of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were preincubated for one hour with Src kinase inhibitor 1 (SKI-1) (2µM) and perfused with SKI 
(2µM) for the duration of the experiment. Cells were stimulated with 5µM forskolin in normocapnia 
and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin stimulation are 
summarized. * = significant effect of hypercapnia (p<0.05; ** = p<0.01); † = significant effect of 
SKI-1 (p<0.05). Data represents mean ± S.E.M.; n=3 for each. 
 
3.14.4. PI3 Kinase 
Another study that investigated CO2 upregulation of NBC activity in the proximal tubule was 
performed by Bernardo et al. (2003). Here, the researchers suggested that CO2-induced 
increase in NBC proximal tubule activity was caused by increased NBC expression at the 
plasma membrane, a process dependent on PI3 Kinase – an enzyme involved in protein 
trafficking and, interestingly, able to interact with Src kinase. To test whether PI3 Kinase was 
involved in mediating the effects of hypercapnia in Calu-3 cells, cells were preincubated with 
the irreversible PI3 Kinase inhibitor wortmannin. As shown in figure 3.42, in control 
experiments, hypercapnia caused a 2.0 ± 0.1 fold increase in the magnitude of the forskolin-
stimulated intracellular acidification (p<0.001; n=3; fig. 3.42B) and increased the rate of 
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forskolin-stimulated HCO3
-
 flux 4.0 ± 0.7 fold (p<0.05; n=3; fig. 3.42C). In wortmannin 
treated cells, hypercapnia caused a 1.8 ± 0.1 fold increase in the magnitude of the forskolin-
stimulated intracellular acidification (p<0.001; n=3; fig. 3.42B) and increased the rate of 
forskolin-stimulated HCO3
-
 flux 3.6 ± 0.3 fold (p<0.05; n=3; fig. 3.42C). Therefore, these 
findings suggest PI3 Kinase is not involved in transducing the effect of hypercapnia in Calu-3 
cells. 
 
Figure 3.42: PI3 Kinase inhibition does not block the effects of hypercapnia on the forskolin-
stimulated intracellular acidification. Calu-3 cells were preincubated with the PI3 Kinase inhibitor 
wortmannin (10µM) and stimulated with 5µM forskolin in normocapnia and hypercapnia as shown in 
(A). The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin stimulation are summarized. ** = 
significant effect of hypercapnia (p<0.01; *** = p<0.001); Data represents mean ± S.E.M.; n=3 for 
each. 
 
3.14.5. Basolateral AE2 activity 
Both Garnett et al. (2011) and Kim et al. (2014) have shown that AE2 activity is reduced 
when intracellular cAMP levels increase in Calu3 cells, likely to prevent loss of HCO3
-
 across 
the basolateral membrane when cells are stimulated to secrete HCO3
-
. Thus, one would 
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predict that CO2-induced changes in intracellular cAMP may impact upon AE2 activity. AE2 
activity was measured by the method described in figure 3.31. This was done in both basal 
and forskolin-stimulated conditions in normocapnia and hypercapnia. In basal conditions, 
removal of basolateral Cl
-
 caused pH to increase by 0.26 ± 0.01 in normocapnia (n=5) but this 
was significantly reduced to 0.09 ± 0.02 in conditions of hypercapnia (p<0.001; n=6; fig. 
3.43B) Similarly, reintroduction of basolateral Cl
-
 induced a HCO3
-
 flux of 28.7 ± 9.3mM 
HCO3
- 
min
-1
  (n=5) in normocapnia but this was significantly reduced to 17.8 ± 6.2mM 
HCO3
- 
min
-1
 (p<0.05; n=5; fig. 3.43C) in hypercapnic conditions. These data suggest that 
acute hypercapnia modulates the activity of AE2 in non-stimulated conditions, implying CO2 
is able to regulate AE2 in a cAMP-independent manner. In forskolin-stimulated conditions, 
AE2 activity was abolished as already reported by our laboratory (Garnett et al., 2011; 
Garnett et al., 2013). In normocapnia, removal of basolateral Cl
-
 caused pH to increase by 
0.01 ± 0.01 (n=5) and reintroduction of basolateral Cl
-
 did not induce any measureable HCO3
-
 
efflux. In hypercapnia, identical results were observed. Removal of basolateral Cl
-
 caused pH 
to increase by 0.01 ± 0.01 (p>0.05; n=5) and reintroduction of basolateral Cl
-
 did not induce 
any measureable HCO3
-
 efflux. These findings demonstrated that although acute hypercapnia 
reduces forskolin-stimulated cAMP levels in Calu-3 cells, the reductions are not sufficient to 
relieve the cAMP-induced inhibition of AE2 activity. Thus differences in AE2 activity cannot 
explain the CO2-induced modulation of cAMP-stimulated HCO3
-
 transport in Calu-3 cells.  
 
Figure 3.43: Acute hypercapnia is unable to relieve the cAMP-induced inhibition of basolateral 
AE2 but does reduce AE2 activity in basal conditions. AE2 activity was assessed by removal and 
subsequent readdition of basolateral Cl
-
 in basal or forskolin-stimulated conditions. The delta pH 
resulting from basolateral Cl
-
 removal (A) and the rate of HCO3
-
 efflux after basolateral Cl
-
 readdition 
(B) are summarized. * = significant effect of hypercapnia (p<0.05). Data represents mean ± S.E.M.; n 
= 5 for each. 
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3.14.6. Na
+
/H
+
 Exchangers 
The NHE family of transporters may contribute to the forskolin-stimulated intracellular 
acidification and therefore could be the site of CO2 modulation. Although the forskolin-
stimulated intracellular acidification appears to be the result of CFTR-dependent HCO3
-
 
efflux across the apical membrane, changes in H
+
 transport would also contribute to changes 
in intracellular pH. To test whether NHEs were involved in mediating the response to 
hypercapnia on the forskolin-stimulated intracellular acidification, experiments were 
performed in the presence of the NHE inhibitor EIPA as shown in figure 3.44A. EIPA did not 
significantly alter the response to forskolin in normocapnia: delta pH was 0.38 ± 0.03 and 
0.40 ± 0.01 (p>0.05; n=4; fig. 3.44B) and HCO3
-
 efflux was 25.8 ± 3.4mM HCO3
- 
min
-1
 and 
34.0 ± 1.3mM HCO3
- 
min
-1
  (p>0.05; n=4; fig. 3.44C) in control and EIPA-treated conditions, 
respectively. Furthermore, in the presence of EIPA, hypercapnia caused a significant 1.5 ± 
0.1 fold increase in the magnitude of the forskolin-stimulated intracellular acidification 
(p<0.01; n=4; fig. 3.44B) and a significant 3.2 ± 0.3 fold increase in the rate of forskolin-
stimulated HCO3
-
 flux (p<0.01; n=4; fig. 3.44C). These data show that NHE transporters are 
not involved in mediating the effect of the forskolin-stimulated intracellular acidification in 
hypercapnia. 
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Figure 3.44: CO2-induced modulation of forskolin-stimulated intracellular acidification is not 
due to changes in Na
+
/H
+
 Exchanger activity. (A) shows a representative experiment in which cells 
were stimulated with 5µM forskolin in the presence of 3µM EIPA in normocapnia (5% CO2) and 
hypercapnia (10% CO2). The delta pH (B) and the HCO3
-
 flux (C) resulting from forskolin stimulation 
are displayed . ** = significant effect of hypercapnia (p<0.01; *** = p<0.001). Data represents mean 
± S.E.M.; n=4 for each. 
 
3.14.7. Na
+
-K
+
-Cl
-
 cotransporter 
The Na
+
-K
+
-Cl
-
 cotransporter 1 (NKCC1) is a transporter that facilitates the influx of Na
+
, K
+
 
and 2 Cl
-
 ions in secretory epithelia and has been found to be expressed in Calu-3 cells 
(Liedtke et al., 2001). Furthermore, data from the Ussing chamber experiments (fig. 4.2) 
show that NKCC1 has a role in forskolin-stimulated ion transport in Calu-3 cells. Changes in 
NKCC1-mediated ion transport would affect intracellular [Na
+
], [K
+
] and [Cl
-
] and therefore 
could contribute to changes in HCO3
-
 transport due to possible effects on membrane potential 
and/or CFTR-dependent Cl
-
/HCO3
-
 exchange. Therefore, the response to forskolin in 
hypercapnia was assessed in the presence of bumetanide. As shown in figure 3.45, 
bumetanide did not significantly alter the response to forskolin in normocapnia: delta pH was 
0.19 ± 0.04 in control conditions and 0.15 ± 0.01 in the presence of bumetanide (p>0.05; n=3; 
fig. 3.45B) whilst HCO3
-
 efflux was 8.9 ± 1.1mM HCO3
- 
min
-1
 in control conditions and 8.6 ± 
1.5mM HCO3
- 
min
-1
 in the presence of bumetanide (p>0.05; n=3; fig. 3.45C). Furthermore, in 
the presence of bumetanide, hypercapnia caused a significant 2.0 ± 0.1 fold increase in the 
magnitude of the forskolin-stimulated intracellular acidification (p<0.01; n=3; fig. 3.45B) and 
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a 4.5 ± 1.0 fold increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.05; n=3; fig. 
3.45C). These data show that NKCC1 is not involved in mediating the effects of hypercapnia 
on the forskolin-stimulated intracellular acidification. 
 
Figure 3.45: CO2-induced modulation of forskolin-stimulated intracellular acidification is not 
due to changes in Na
+
-K
+
-Cl
-
 Cotransporter activity. (A) shows a representative experiment in 
which cells were stimulated with 5µM forskolin in the presence of 25µM bumetanide in normocapnia 
(5% CO2) and hypercapnia (10% CO2). The delta pH (B) and the HCO3
-
 flux (C) resulting from 
forskolin stimulation are displayed. * = significant effect of hypercapnia (p<0.05; ** = p<0.01). Data 
represents mean ± S.E.M.; n=3 for each. 
 
3.14.8. Na
+
/K
+
-ATPase 
It has  previously been shown that Na
+
/K
+
-ATPase activity is reduced by hypercapnia in 
alveolar type II cells due to a CO2-induced endocytosis of the α subunit of Na
+
/K
+
-ATPase 
which led to a reduction in Na
+
 reabsorption (Briva et al., 2007). Given the Na
+
/K
+
-ATPase 
has been shown to be regulated by CO2 in other human airway epithelial cells, it was 
important to assess whether CO2 could modulate Na
+
/K
+
-ATPase activity in Calu-3 cells. 
Changes in Na
+
/K
+
-ATPase activity will alter intracellular [Na
+
] and [K
+
] and therefore could 
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affect membrane potential which could alter the driving force for HCO3
-
 transport. Thus, the 
forskolin-stimulated intracellular acidification in both normocapnia and hypercapnia was 
assessed in the presence of the Na
+
/K
+
-ATPase inhibitor ouabain (fig. 3.46A) and compared 
to control experiments performed on the same day. Ouabain has no effect on the magnitude 
of the forskolin-stimulated intracellular acidification, nor on the rate of forskolin-stimulated 
HCO3
-
 flux measured in normocapnia as shown in figures 3.46B and 3.46C respectively. 
However, in the presence of basolateral ouabain, hypercapnia only elicited a 1.3 ± 0.5 fold 
increase in the magnitude of the forskolin-stimulated intracellular acidification (p>0.05 vs. 
normocapnia; n=3; figs. 3.46B and D) and a 1.8 ± 0.4 fold increase in the rate of forskolin-
stimulated HCO3
-
 flux (p>0.05 vs. normocapnia; n=3; fig. 3.46C and E). When compared to 
control experiments performed on the same day, in which hypercapnia caused a 2.1 ± 0.1 fold 
increase in the magnitude of the forskolin-stimulated intracellular acidification (p<0.05 vs. 
normocapnia; n=3; fig. 3.46D) and a 5.7 ± 0.8 fold increase in the rate of forskolin-stimulated 
HCO3
-
 flux (p<0.05 vs. normocapnia; n=3; fig. 3.46E), it showed that ouabain was able to 
prevent the effect of hypercapnia on cAMP-regulated HCO3
-
 transport. Furthermore, cells 
treated with ouabain only exhibited a 5.1 ± 7.3% (p<0.001 vs. control; n=3; fig. 3.46F) in pHi 
recovery from CO2-induced acidosis, suggesting that the Na
+
/K
+
-ATPase plays a major role 
in this recovery process. 
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Figure 3.46: Ouabain treatment blocks the effect of acute hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which cells were 
stimulated with 5µM forskolin in the presence of 100µM ouabain in normocapnia and hypercapnia. 
The delta pH (B) and the HCO3
-
 flux (C) resulting from forskolin stimulation are displayed. The delta 
pH (D) and the HCO3
-
 flux (E) resulting from forskolin stimulation in control experiments performed 
on the same day are displayed and compared to measurements made in the presence of ouabain. * = 
significant effect of hypercapnia (p<0.05). (F) displays the effect of ouabain on recovery of pHi from 
CO2-induced acidosis. *** = significant effect of ouabain (p<0.001). Data represents mean ± S.E.M.; 
n=3 for each. 
 
3.14.9. AMP Kinase 
Given that the effect of acute hypercapnia on cAMP-regulated HCO3
-
 transport was 
prevented by treatment of cells with the Na
+
/K
+
-ATPase inhibitor ouabain, it suggested 
Na
+
/K
+
-ATPase was sensitive to CO2. This supports findings by Briva et al. (2007) who also 
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demonstrated that the Na
+
/K
+
-ATPase is sensitive to CO2 in rat alveolar type II cells and led 
to a decrease in alveolar fluid reabsorption. Further investigations into this phenomena 
revealed that the effect of hypercapnia on Na
+
/K
+
-ATPase was blocked by inhibition of AMP 
Kinase and that AMP Kinase was activated by CO2 per se (Vadasz et al., 2008). Therefore, 
the role of AMP Kinase in transducing the CO2 signal in Calu-3 cells was tested. Calu-3 cells 
were preincubated for one hour with the AMPK inhibitor dorsomorphin and perfused with 
dorsomorphin for the duration of the experiment as shown in figure 3.47A. In control 
experiments, hypercapnia caused a 1.8 ± 0.1 fold increase in the magnitude of the forskolin-
stimulated intracellular acidification (p<0.05; n=4; fig. 3.47B) and increased the rate of 
forskolin-stimulated HCO3
-
 flux 4.2 ± 0.3 fold (p<0.001; n=4; fig. 3.47C). Dorsomorphin 
treatment did not alter the effect of hypercapnia on cAMP-regulated HCO3
-
 transport. In 
dorsomorphin treated cells, hypercapnia caused a 1.7 ± 0.3 fold increase in the magnitude of 
the forskolin-stimulated intracellular acidification (p<0.05; n=4; fig. 3.47B) and increased the 
rate of forskolin-stimulated HCO3
-
 flux 3.4 ± 0.4 fold (p<0.001; n=4; fig. 3.47C). Therefore, 
these data show that AMPK has no role in the CO2-mediated modulation of cAMP-regulated 
HCO3
-
 transport in Calu-3 cells. 
 
Figure 3.47. AMP Kinase inhibition does not block the effects of hypercapnia on the forskolin-
stimulated intracellular acidification. Calu-3 cells were preincubated for one hour with the AMPK 
inhibitor dorsomorphin (1µM) and perfused dorsomorphin (1µM) for the duration of the experiment. 
Cells were stimulated with 5µM forskolin in normocapnia and hypercapnia as shown in (A). The delta 
pH (B) and HCO3
-
 flux (C) resulting from forskolin stimulation are summarized. * = significant effect 
of hypercapnia (p<0.05; ** = p<0.01); Data represents mean ± S.E.M.; n=3 for each. 
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3.15. Discussion 
3.15.1. The effects of hypercapnia on Calu-3 cells 
Administration of 10% CO2 to Calu-3 cells induced an intracellular acidosis which was found 
to recover after ~20 minutes showing that cells possess mechanisms in which they can sense 
and respond to acute hypercapnia. Characterizing the pHi recovery process showed it to be 
completely Na
+
-dependent yet unaffected by inhibition of NHEs suggesting that recovery is 
mediated via Na
+
-dependent HCO3
-
 influx as opposed to Na
+
-dependent H
+
 efflux. To 
support this, the NBC inhibitor DIDS was found to reduce recovery, implying this transporter 
does have an important role in pHi recovery. The effect of basolateral Cl
-
 removal to reduce 
recovery by ~50% was interesting. Should there be a role for AE2-dependent HCO3
-
 influx in 
pHi recovery, removal of basolateral Cl
-
 would be predicted to enhance recovery not reduce 
it. Therefore, the effect of basolateral Cl
-
 removal may be an indirect effect on NBC; for 
instance, although removal of basolateral Cl
-
 would stimulate AE2-mediated HCO3
-
 influx in 
Calu-3 cells, this would reduce the electrochemical driving force for NBC-dependent HCO3
-
 
influx and it may be such that recovery is specifically mediated by NBC-dependent HCO3
-
 
influx as opposed to AE2-dependent HCO3
-
 influx. However, it was found that forskolin, as 
well as MK-571, blocked pHi recovery, suggesting that the transporter(s) underlying pHi 
recovery are negatively regulated by cAMP and thus argue against the identity of these 
transporters being members of the NBC family, given that these transporters are cAMP-
activated (Devor et al., 1999; Bachmann et al., 2003; Bachmann et al., 2008). However, it is 
possible that elevations in [cAMP]i inhibited pHi recovery because of an activation of CFTR-
dependent HCO3
-
 efflux preventing HCO3
-
 accumulation within the cell and performing the 
same experiments in the presence of a CFTR inhibitor may yield different results.  
Calu-3 cells displayed an asymmetry in membrane permeability to CO2, with only the apical 
membrane being CO2 permeable. This asymmetry has also been reported in human retinal 
pigment epithelia (Adijanto et al., 2009) in which only the apical membrane is CO2 
permeable, and in human parietal cells, in which only the basolateral membrane is CO2 
permeable (Boron et al., 1994) and suggests a differential expression of CO2 transporters, of 
which aquaporins have been largely implicated (Nakhoul et al., 1998; Endeward et al., 2006; 
Musa-Aziz et al., 2009), may be responsible for this. Kreda et al. (2001) found that AQP5 
was expressed on the apical membrane of Calu-3 cells and AQP5 has been found to be CO2 
permeable when expressed in Xenopus oocytes (Musa-Aziz et al., 2009). Alternatively, CO2 
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permeability may be determined by the cholesterol content of the lipid bilayer as suggested 
by Itel et al. (2012). Therefore, it would be of interest to assess both the expression of 
aquaporins and the cholesterol content at each membrane to gain further insights into CO2 
permeability across human cell membranes. 
3.15.2. Acute hypercapnia modulated [cAMP]i and cAMP-regulated anion secretion  
Stimulation of Calu-3 cells with the cAMP agonists forskolin and adenosine resulted in a 
multitude of measureable responses which were all affected by acute hypercapnia. Firstly, 
forskolin-induced increases in intracellular cAMP were significantly blunted by 20 minutes 
exposure to 10% CO2. The incubation media in these experiments were buffered to pH 7.5 
and cells were allowed to recover pHi from CO2-induced acidosis prior to agonist stimulation. 
Therefore, this shows that the effect of hypercapnia was due to CO2 per se and not due to 
CO2-induced acidosis. Given that these experiments were performed in the presence of 1mM 
IBMX, it would suggest that hypercapnia was affecting cAMP synthesis due to effects on 
tmAC activity as opposed to its breakdown by phosphodiesterases and our laboratory has 
already shown tmAC per se to be sensitive to changes in CO2 (Townsend et al., 2009). 
Interestingly, hypercapnia did not affect cAMP production in non-stimulated cells. This 
implies that, in order for hypercapnia to mediate its effects on tmAC, tmAC needs to be in an 
active state. Zhang et al. (1997) have described the presence of hydrophobic forskolin 
binding pockets within tmAC and forskolin binding at these sites induces a conformational 
change allowing for dimerization of the two catalytic subunits of tmAC. Thus, it seems likely 
that CO2 can only modulate tmAC activity when it is held within this “forskolin-bound” state. 
Similar conformational changes within tmAC are induced when Gαs coupled proteins bind to 
the enzyme, implying CO2 modulates tmAC activity via the same mechanism when cells are 
stimulated with G-protein receptor agonists (Tesmer et al., 1997). It is worth noting that 
intracellular cAMP measurements were performed on non-polarized Calu-3 cells and 
therefore, it will be important to attempt these experiments on polarized monolayers in order 
to replicate conditions for pHi and Isc measurements.  
This hypercapnia-induced reduction in forskolin-stimulated cAMP levels also had major 
implications for cAMP-regulated ion transport across Calu-3 cells. In the presence of a 
basolateral to apical Cl
-
 gradient, forskolin, as well as adenosine and dibutrylyl-cAMP, 
caused an increase in Isc which reached an initial peak and then plateaued to a steady state. 
The forskolin-stimulated increase in Isc was significantly reduced by PKA inhibition and was 
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reversed by the combination of apical CFTRinh-172 and basolateral bumetanide. These data 
showed that elevations in intracellular cAMP induced CFTR-dependent electrogenic anion 
secretion in Calu-3 cells. In cells that had been exposed to 20 minutes hypercapnia, the rate of 
forskolin-stimulated increases in Isc was significantly reduced by ~45% implying that CO2-
induced reductions in intracellular cAMP were sufficient enough to reduce CFTR activity. 
Another interesting observation from the Ussing chamber studies was that acute hypercapnia 
significantly reduced basal Isc in Calu-3 cells. Given basal Isc was sensitive to CFTRinh 172, it 
suggested a large component of basal Isc was mediated by CFTR and also suggested that 
acute hypercapnia reduced the activity of non-stimulated CFTR. The Isc data is even more 
surprising given that acute hypercapnia appears to increase the total CFTR protein levels in 
Calu-3 cells. Whether this translates to an increased membrane expression remains to be seen 
but if acute hypercapnia does increase CFTR expression yet reduces cAMP-stimulated 
CFTR-dependent Cl
-
 secretion, it shows that the effect of hypercapnia on CFTR activity is 
more pronounced than first believed and that the Isc data is actually an underestimation of the 
extent of hypercapnia-induced inhibition of CFTR activity. 
 
3.15.2.  How does a CO2-induced reduction in [cAMP]i lead to an apparent increase in 
cAMP-regulated HCO3
-
 transport? 
To focus on the effects of acute hypercapnia on HCO3
-
 transport in Calu-3 cells, intracellular 
pH measurements were performed to indirectly measure HCO3
-
 transport. Addition of the 
cAMP elevating agonists forskolin, adenosine, dibutrylyl-cAMP or IBMX, all induced an 
intracellular acidification in Calu-3 cells before a new steady state pHi was reached. This 
intracellular acidification was sensitive to inhibition of tmAC, PKA and CFTR and did not 
occur in HCO3
-
 -free conditions or in depolarised cells. Together these data show that 
elevations in cAMP stimulated CFTR-dependent HCO3
-
 secretion that, temporarily, occurred 
at a greater rate than HCO3
-
 influx across the basolateral membrane; hence an acidification 
was observed. Interestingly, acute hypercapnia significantly increased both the magnitude 
and rate of forskolin and adenosine-stimulated intracellular acidification which was 
independent of differences in pHi, pHe and did not occur due to an increased formation of 
intracellular HCO3
-
 due to CO2 hydration by carbonic anhydrase. Thus CO2 per se was able 
to modulate cAMP-regulated HCO3
-
 transport, likely due to reduced intracellular cAMP 
levels. Furthermore, the effect of hypercapnia was dependent on 10% CO2 being applied to 
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the apical membrane. Basolateral 10% CO2 was unable to modulate cAMP-regulated HCO3
-
 
transport and, given I have found the basolateral membrane to be CO2 impermeable, suggests 
that in order for CO2 to mediate its effects upon cAMP signalling, it needs to be able to get 
into the cell. Consequentially, should CO2 indeed directly modulate tmAC, it would imply 
that the CO2-sensitive sites of tmAC are located on intracellular domains. Conversely, there 
may be different isoforms of tmAC expressed at each membrane, of which only the isoforms 
expressed at the apical membrane are CO2-sensitive. To get a clearer understanding of this, 
the specific isoforms of tmAC expressed in Calu-3 cells need to be identified.  
At first, one would assume that a larger forskolin-stimulated intracellular acidification in the 
presence of hypercapnia was a result of CO2 stimulating CFTR-dependent HCO3
-
 secretion 
across the apical membrane. However, this would not be expected given that hypercapnia has 
been shown to reduce intracellular cAMP levels and CFTR-dependent Cl
-
 secretion. An 
alternative explanation was that hypercapnia was reducing cAMP-regulated HCO3
-
 influx 
across the basolateral membrane which would also produce the same effect on intracellular 
acidification. This is supported by the fact that (i) CFTR-dependent Cl
-
/HCO3
-
 exchange was 
unaffected by acute hypercapnia and (ii) the CO2 effect was blocked by inhibition of pHi 
regulatory transporters at the basolateral membrane. End-point PCR revealed that two 
members of the cAMP-regulated HCO3
-
 importers belonging to the Na
+
/HCO3
-
 Cotransporter 
family, SLC4A4 and SLC4A7, were expressed in Calu-3 cells yet, crucially, cAMP-
stimulated Na
+
-dependent HCO3
-
 influx was unaffected by acute hypercapnia. Thus, although 
hypercapnia clearly modulates cAMP-regulated HCO3
-
 transport in Calu-3 cells, this does not 
appear to be mediated by altering the activity of cAMP-stimulated HCO3
-
 transporters and 
raises the question as to the identity of the CO2 target(s). One important finding from studies 
on NBC activity was the fact that hypercapnia actually stimulated NBC activity under basal 
conditions. This likely is an adaptive mechanism in Calu-3 cells to increase HCO3
-
 uptake 
into the cell in response to CO2-induced acidosis.  However, as a result of this, NBC activity 
was not able to be further enhanced in response to cAMP stimulation as it was already at near 
maximal activity. This, therefore, could underlie the effect of elevated CO2 and contribute to 
the greater forskolin-stimulated intracellular acidification observed in hypercapnic 
conditions. In normocapnia, elevations in cAMP stimulate both apical HCO3
-
 efflux and 
basolateral HCO3
-
 influx with HCO3
-
 efflux temporarily occurring at a greater rate than 
HCO3
-
 influx, hence an acidification is observed until the two processes are equal. However, 
in hypercapnia, elevations in cAMP stimulated apical HCO3
-
 efflux but due to NBC activity 
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already being near maximal, did not stimulate increased basolateral HCO3
-
 influx. This would 
therefore increase the difference between apical HCO3
-
 efflux and basolateral HCO3
-
 influx in 
response to cAMP stimulation and thus cause a greater intracellular acidification to occur. 
How hypercapnia activates NBC activity could be explained by the apparent reduction in 
WNK4 expression observed under basal, hypercapnic conditions as measured by Western 
blot. WNK4, together with SPAK, have been implicated in reducing surface expression of 
NBCe1 in pancreatic duct cells and thus a CO2-induced reduction in WNK-4 would alleviate 
this inhibitory effect of WNK-4/SPAK signalling increasing NBC activity. However, more 
repeats of the Western blot need to be performed before it can be concluded this is a real 
effect of hypercapnia in Calu-3 cells. 
An alternative hypothesis to explain the effect of acute hypercapnia on the forskolin-
stimulated intracellular acidification could be provided by the effect of ouabain. Ouabain had 
two major effects in Calu-3 cells; (i) it blocked the effect of acute hypercapnia on the 
forskolin-stimulated intracellular acidification and (ii) it prevented pHi recovery from CO2-
induced acidosis. These findings suggest that Na
+
/K
+
-ATPase may be CO2 sensitive, a 
finding which has already been reported in rat alveolar type II cells (Briva et al., 2007). How 
Na
+
/K+-ATPase may contribute to pH changes within Calu-3 cells could be explained by 
recent work by Vedovato and Gadsby (2014). Here, researchers demonstrated Na
+
/K
+
-
ATPase can act as a H
+
 importer, with H
+
 replacing a K
+
 during the pump cycle. Therefore, 
CO2 may uncouple the Na
+
/K
+
-ATPase to increase H
+
 influx across the basolateral membrane 
and therefore produce the greater intracellular acidification observed and hence explain why 
ouabain is able to block the CO2 effect. Several studies have implicated that cAMP regulates 
Na
+
/K
+
-ATPase activity with Dagenais et al. (2001), Bertorello et al. (1999) and Suzuki et al. 
(1995), demonstrating elevations in [cAMP]i activated Na
+
/K
+
-ATPase in rat ATII cells due 
to an increased insertion of the α subunit at the basolateral membrane whilst Carranza et al. 
(1996) showed forskolin and db-cAMP activated Na
+
/K
+
-ATPase in a PKA-dependent 
manner. Thus, if CO2 is able to modulate Na
+
/K
+
-ATPase activity, it would appear to be 
independent of its effects on [cAMP]i. Vadasz et al. (2008), demonstrated that CO2 inhibited 
Na
+
/K
+
-ATPase in rat ATII cells via a mechanism involving AMPK but this does not appear 
to underlie the effect of hypercapnia in Calu-3 cells given the lack of effect of AMPK 
inhibition. 
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Ouabain also prevented pHi recovery from CO2-induced acidosis, likely due to the fact that 
inhibition of Na
+
/K
+
-ATPase would abolish the inward Na
+
 gradient required to maintain 
NBC activity. It is interesting that two pharmacological agents that blocked pHi recovery, 
ouabain and MK-571, also blocked the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification suggesting that the transporters involved in pHi recovery also 
underlie the effect of hypercapnia on the forskolin-stimulated intracellular acidification. 
Thus, prevention of CO2-induced upregulation of basal NBC activity without activation of 
CFTR-dependent HCO3
-
 efflux, either by ouabain (due to an abolishment of the basolateral 
inward Na
+
 gradient) or MK-571 (due to elevated [cAMP]i activating NBC and CFTR 
simultaneously) blocks the effect of hypercapnia on the forskolin-stimulated intracellular 
acidification and suggests this process plays a major role in the effect of acute hypercapnia on 
cAMP-regulated HCO3
-
 transport in Calu-3 cells. 
The roles of other basolateral transporters in mediating the effect of hypercapnia were also 
assessed. Although AE2 activity was reduced by hypercapnia in basal conditions, the fact that 
hypercapnia was unable to relieve the cAMP-induced inhibition of AE2 suggests that 
hypercapnia was not able to reduce forskolin-stimulated cAMP levels to the extent required 
for inhibition to be reversed. As a consequence, AE2 can be eliminated from having any 
contribution to the effects of hypercapnia on cAMP-regulated HCO3
-
 transport. Similarly, 
inhibition of both NHE and NKCC1 did not affect the response to hypercapnia suggesting 
that hypercapnia was not modulating H
+
 transport via NHE or having indirect effects on other 
HCO3
-
 transporters by altering intracellular Na
+
, K
+
 or Cl
-
 concentrations.  
 
3.15.2. CO2 exhibits differential effects on cAMP-elevating agonists 
To further understand the mechanism of CO2 modulation of cAMP signalling, Calu-3 cells 
were stimulated with agents that increase cAMP independently of tmAC. Hypercapnia had no 
effect on IBMX-induced intracellular acidification yet was able to augment dibutrylyl-cAMP 
stimulated intracellular acidification. The absence of an effect of hypercapnia when cAMP 
levels are raised by inhibition of phosphodiesterases suggested that CO2 does not reduce 
[cAMP]i by increasing its breakdown and therefore appeared to target cAMP production via 
tmACs. However, the effect of CO2 on db-cAMP-stimulated intracellular acidification also 
suggested that CO2 could modulate cAMP signalling independent of tmAC yet how this 
occurs is still unclear. One possible explanation could be via effects on MRPs. The MRP 
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inhibitor, MK-571, blocked the effect of hypercapnia on cAMP-regulated HCO3
-
 transport 
and raised the intriguing possibility that hypercapnia reduced intracellular cAMP by 
activating MRP-mediated cAMP efflux as opposed to inhibition on tmAC. Thus preventing 
this reduction in [cAMP]i in hypercapnia maintained the activity of cAMP-regulated HCO3
-
 
transporters. Li et al. (2007) have described that MK-571 reduced cAMP efflux in gut 
epithelia and was able to significantly increase glybenclamide-sensitive Isc measurements 
implying prevention of cAMP efflux via MRPs is important in regulation of CFTR-dependent 
anion secretion. Only apical MK-571 was able to block the effect of hypercapnia, implying 
that any putative CO2-sensitive MRPs were located at the apical membrane and may explain 
why only apical CO2 modulates cAMP-regulated HCO3
-
 transport. In an attempt to quantify 
MRP activity in normocapnia and hypercapnia, the rate of MRP-dependent efflux of the 
fluorescent metabolite of CMFDA, GSMF was measured in Calu-3 cells. Although the rate of 
dye efflux was not statistically significant between normocapnic and hypercapnic conditions, 
there did appear to be a small trend for hypercapnia to increase MRP activity, consistent with 
a CO2-induced activation of MRP-dependent cAMP efflux. Another aspect of cAMP 
signalling which was investigated was its dependence on compartmentalization. Latrunculin 
B and cytochalasin D, two pharmacological agents that disrupt F-actin polymerization and 
therefore predicted to disrupt organization of the actin cytoskeleton, were found to 
significantly reduce TEER suggesting these agents affected actin sufficiently to modulate 
tight junction properties. Furthermore, confocal images revealed a pronounced effect of 
cytochalasin D on the organization of the actin cytoskeleton. However, neither drug was able 
to prevent the effect of acute hypercapnia on cAMP-regulated HCO3
-
 transport. Given that 
forskolin still elicited an intracellular acidification suggested that cAMP 
compartmentalization wasn’t necessary in order to produce this response. This is somewhat 
surprising if you consider that Monterisi et al. (2012) demonstrated latrunculin B 
significantly reduced cAMP-stimulated CFTR activity in HBE cells and perhaps suggests that 
(i) important differences in actin cytoskeleton organization exist between Calu-3 cells and 
HBE cells or (ii) forskolin is able to raise [cAMP]i to such an extent that even a reduction in 
cAMP in specific microdomains is not sufficient to reduce the activity of cAMP-regulated 
transporters. In a similar vein, although acute hypercapnia reduced total [cAMP]i, the fact 
that cytochalasin D or latrunculin B were unable to block the effect of acute hypercapnia on 
cAMP-regulated HCO3
-
 transport would suggest CO2 does not mediate its effects via 
disruption of the actin cytoskeleton. Further investigations into the effects of hypercapnia on 
cAMP signalling, in particular cAMP compartmentalization and whether hypercapnia only 
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modulates [cAMP]i at specific microdomains, could involve performing FRET analysis, a 
powerful microscopy technique to assess the relative levels of labelled molecules in different 
cellular regions.    
The major findings of this chapter are summarized below and in figure 3.48. 
 Acute hypercapnia induced an intracellular acidosis in Calu-3 cells which activated 
Na
+
-dependent HCO3
-
 influx to recover pHi 
 Acute hypercapnia significantly attenuated forskolin-stimulated increases in 
intracellular cAMP and reduced CFTR-dependent electrogenic anion secretion. 
 CO2-induced reductions in cAMP may be due to effects on tmAC activity per se 
and/or CO2 may activate cAMP efflux via apically located MRPs. 
 Acute apical hypercapnia modulated cAMP-stimulated, CFTR-dependent HCO3
-
 
transport in Calu-3 cells which is not due to an effect on cAMP-regulated HCO3
-
 
transporters but instead appeared to be mediated via an upregulation of basal NBC 
activity and/or activation of Na
+
/K
+
-ATPase-dependent H
+
 import. 
 CO2 upregulated NBC activity was due to an apparent reduction in WNK4 levels, thus 
reducing WNK4-mediated downregulation of NBCe1. 
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Figure 3.48. Major effects of acute hypercapnia on cAMP-dependent HCO3
-
 transport in Calu-3 
cells. Apical CO2 enters the cell and is able to modulate intracellular cAMP levels [cAMP]i due to a 
reduction in tmAC activity and/or an increased efflux of cAMP via MRPs. This reduction in [cAMP]i 
reduces CFTR-dependent anion secretion. CO2 also appears to reduce WNK4 expression to activate 
NBC under basal conditions to stimulate pHi recovery from CO2-induced acidosis as well as 
increasing Na
+
/K
+
-ATPase activity to increase H
+
 influx. 
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Chapter 4: The role of Ca
2+
/ATP signalling in underlying the effects 
of hypercapnia 
4.1. Introduction 
As shown in chapter 3, acute hypercapnia modulated forskolin-stimulated increases in 
intracellular cAMP as well as reduced CFTR-dependent anion secretion in Calu-3 cells. The 
data suggested CO2 reduced intracellular cAMP due to effects on tmAC activity per se and/or 
cAMP transport through multidrug resistance proteins (MRPs). The aim of this chapter was 
to ascertain whether hypercapnia was also modulating other cell signalling cascades to 
contribute to, or underlie, the effects of hypercapnia on cAMP signalling with particular 
focus on the role of Ca
2+
 signalling. Crosstalk between cAMP and Ca
2+
 signalling has been 
well described for the regulation of CFTR activity in airway epithelia (Lee and Foskett, 2010) 
and investigations into the molecular mechanisms behind cAMP and Ca
2+
 crosstalk have 
provided some very interesting data. Tovey et al. (2010) showed cAMP to increase the 
sensitivity of IP3 receptors to IP3 in HEK cells, allowing cAMP agonists to potentiate the 
Ca
2+
 release induced by the Ca
2+
 elevating agonist carbachol. Recently, work from Aldebaran 
Hofer’s laboratory has described a STIM-1 dependent increase in cAMP levels in response to 
depletion of Ca
2+ 
stores from the endoplasmic reticulum (ER). They describe this 
phenomenon as store operated cAMP signalling (socAMPs) and believe STIM-1 may be able 
to activate adenylyl cyclase 3 in certain cell types (Lefkimmiatis et al., 2009; Maiellaro et al., 
2012). Schwarzer et al. (2010) believe socAMPs underlies the activation of CFTR-dependent 
Cl
-
 secretion in Calu-3 cells by a molecule secreted from Pseudomonas aerginosa. 
Conversely, Jiang et al. (2011) have shown that trichosanthin-induced elevations in [Ca
2+
]i 
decrease [cAMP]i in HeLa cells due to an inhibition of adenylyl cyclases. Finally, our 
laboratory has also published data implicating a CO2-induced, IP3-dependent Ca
2+
 release 
was required for alterations to cAMP-dependent regulation of NHE3 in renal cells (Cook et 
al., 2012). Therefore it was important to assess the relationship between hypercapnia, Ca
2+
 
signalling and cAMP-dependent HCO3
-
 transport in Calu-3 cells.  
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4.2. The role of Ca
2+
 signalling in response to hypercapnia 
4.2.1. Inhibition of intracellular Ca
2+ 
signalling 
It has been reported that elevated CO2 can affect [Ca
2+
]i, with both Briva et al. (2011) and 
Bouyer et al. (2003) showing hypercapnia caused an increase in [Ca
2+
]i in epithelial cells. 
Furthermore, our laboratory has shown that acute hypercapnia reduced intracellular cAMP 
levels in renal epithelia through a mechanism involving CO2-induced IP3-dependent Ca
2+
 
release (Cook et al., 2012). Therefore, it was important to assess whether the CO2-induced 
changes to cAMP-regulated HCO3
-
 transport I have demonstrated were dependent on changes 
in [Ca
2+
]i. In order to do this, cells were preincubated for one hour with the Ca
2+
 chelator 
BAPTA-AM and the responses to forskolin in both normocapnia and hypercapnia assessed 
and compared to control experiments performed on the same day. Figure 4.01A shows a 
representative experiment of BAPTA-AM treated cells. In control experiments, hypercapnia 
increased the magnitude of the forskolin-stimulated intracellular acidification 1.5 ± 0.1 fold 
(p<0.05; n=5; fig. 4.01B) and increased the rate of forskolin-stimulated HCO3
-
 flux 3.3 ± 0.2 
fold (p<0.05; n=5; fig. 4.01C). However, in BAPTA-AM treated cells, the effect of 
hypercapnia was abolished. In these experiments, hypercapnia increased the magnitude of the 
forskolin-stimulated intracellular acidification 1.0 ± 0.1 fold (p>0.05; n=5; fig. 4.01B) and 
increased the rate of forskolin-stimulated HCO3
-
 flux 1.5 ± 0.3 fold (p>0.05; n=5; fig. 4.01C). 
In addition, BAPTA-AM was also found to prevent the effect of acute hypercapnia on 
[cAMP]i (fig. 4.01D). Together, these data implied that alterations in intracellular Ca
2+
 were 
required in order for hypercapnia to mediate its effects on cAMP-regulated HCO3
-
 transport 
in Calu-3 cells. In addition, figure 4.01A clearly shows that BAPTA-AM loaded cells were 
only able to partially recover their pHi after CO2-induced acidosis (recovery = 36.9 ± 6.8%; 
p<0.001; n=5; fig. 4.07) implying that intracellular Ca
2+
 appears to be important for the 
regulation of pHi recovery. 
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Figure 4.01. Preincubation of cells with BAPTA-AM blocks the effect of hypercapnia on the 
forskolin-stimulated intracellular acidification. (A) shows a representative experiment in which 
Calu-3 cells were preincubated with 50µM BAPTA-AM for one hour and the response to 5µM 
forskolin was assessed in normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) 
resulting from forskolin stimulation are summarized. * = significant effect of hypercapnia (p<0.05; ** 
= p<0.01). Data represents mean ± S.E.M.; n=5 for each. (D) summarizes the effect of acute 
hypercapnia on forskolin-stimulated intracellular cAMP levels +/- BAPTA-AM (50µM). * = 
significant effect of hypercapnia (p<0.05). Data represents mean ± S.E.M; n=3 for each. 
 
As our group have already shown that hypercapnia was able to modulate IP3-mediated Ca
2+
 
release (Cook et al., 2012), the effect of the phospholipase C (PLC) inhibitor U73122 
(Bleasdale et al., 1990) was assessed. Activation of PLC allows phosphatidylinositol 4,5-
bisphosphate (PIP2) to be hydrolysed into diacylglycerol (DAG) and IP3 whereupon IP3 can 
bind to IP3 receptors on the ER to trigger Ca
2+
 release. Therefore, should CO2 mediate its 
effects on cAMP-regulated HCO3
-
 transport via modulation of the PLC/IP3 signalling 
pathway, inhibition of PLC should prevent the effect of hypercapnia. Calu-3 cells were 
preincubated for one hour with U73122 and perfused with U73122 for the duration of the 
experiment (fig. 4.02A). The responses to forskolin in normocapnia and hypercapnia were 
measured and compared to control experiments performed on the same day. In control 
experiments, hypercapnia induced a 1.6 ± 0.1 fold increase in the magnitude of the forskolin-
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stimulated intracellular acidification (p<0.05; n=3; fig. 4.2B) and a 2.3 ± 0.5 fold increase in 
the rate of forskolin-stimulated HCO3
-
 flux (p<0.05; n=3; fig. 4.2C). However, in U73122-
treated cells, hypercapnia only increased the magnitude and rate of forskolin-stimulated 
HCO3
- 
flux 1.3 ± 0.3 fold (p>0.05; n=3; fig. 4.2B) and 1.5 ± 0.7 fold (p>0.05; n=3; fig. 4.2C) 
respectively. These findings implied that increases in Ca
2+
, via IP3 mediated Ca
2+
 release, 
were important for the effects of hypercapnia on cAMP signalling in Calu-3 cells. 
Interestingly, treatment with U73122 also affected pHi recovery, with cells only recovering 
pHi by 24.2 ± 9.0% after CO2-induced acidosis (p<0.001; n=3; fig. 4.7). These findings are 
similar to those observed in BAPTA-AM loaded cells and imply that the pHi recovery was 
dependent on Ca
2+
 mobilization via activation of the PLC signalling pathway. 
 
 
Figure 4.02: Inhibition of phospholipase C blocks the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. Calu-3 cells were preincubated for one hour and perfused 
with the PLC inhibitor U73122 (10µM) and the response to 5µM forskolin was assessed in 
normocapnia and hypercapnia as shown in (A). The delta pH (B) and HCO3
-
 flux (C) resulting from 
forskolin stimulation are summarized. * = significant effect of hypercapnia (p<0.05); † = significant 
effect of U73122 (p<0.01). Data represents mean ± S.E.M.; n=3 for each. 
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Given that both BAPTA-AM and U73122 prevented the effect of hypercapnia on cAMP-
regulated HCO3
-
 transport suggested that the effect of hypercapnia involved IP3-dependent 
Ca
2+
 release. To further investigate whether this was the case, the effect of the IP3R inhibitor 
2-APB (Maruyama et al., 1997) was assessed. Peppiatt et al. (2003) demonstrated that 2-APB 
inhibited histamine-induced increases in cytosolic Ca
2+
 in HeLa cells but that the effect of 2-
APB was poorly reversible. As a result, the effects of 2-APB in normocapnia and 
hypercapnia were assessed in separate experiments to negate the irreversible nature of 2-APB 
influencing the results. Figures 4.03A and B show representative experiments demonstrating 
the effects of 2-APB on the forskolin-stimulated intracellular acidification in normocapnia 
and hypercapnia respectively. In normocapnia, forskolin stimulated a HCO3
-
 flux of 9.3 ± 
1.5mM HCO3
-
 min
-1
 (n=4) but this was reduced to 5.7 ± 1.4mM HCO3
-
 min
-1
 (n=4) by 2-
APB which although was calculated as a 37.6 ± 12.1% inhibition in HCO3
-
 flux, was 
statistically not significant (p>0.05; n=4). In hypercapnia, forskolin stimulated a HCO3
-
 flux 
of 42.0 ± 10.7mM HCO3
-
 min
-1
 (n=4) but this was reduced to 16.6 ± 1.3mM HCO3
-
 min
-1
 by 
2-APB (n=4) which was calculated as a 53.7 ± 9.5% inhibition (p<0.05; n=4). Although the 
extent of the inhibition by 2-APB was not statistically significantly different between 
normocapnia and hypercapnia (p>0.05), when assessing the fold changes in the rate of 
forskolin-stimulated HCO3
-
 flux, figure 4.03E shows that, in control conditions, acute 
hypercapnia caused a 4.5 ± 0.8 fold increase in the rate of forskolin-stimulated HCO3
-
 flux 
(p<0.01; n=4), but in the presence of 2-APB, this fold increase in rate of HCO3
-
 flux was 
significantly reduced to 1.9 ± 0.3 (p<0.05; n=4). In addition, 2-APB also blocked the effect of 
acute hypercapnia on forskolin-stimulated intracellular cAMP levels (fig. 4.03F). Therefore, 
these findings show that 2-APB is able to block the effects of hypercapnia on cAMP-
regulated HCO3
-
 transport and supports previous findings from BAPTA-AM and U73122 
experiments that implicate IP3-dependent Ca
2+
 release is required to produce the effects of 
acute hypercapnia.  
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Figure 4.03: 2-APB blocks the effect of acute hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) and (B) show representative experiments in which the effect of 2-
APB (100µM) on the response to stimulation by forskolin (5µM) was assessed in normocapnia and 
hypercapnia respectively. The delta pH (C) and HCO3
-
 flux (D) resulting from forskolin stimulation 
are summarized. (E) summarizes the effect of 2-APB on the fold increase in the rate of forskolin-
stimulated HCO3
-
 flux by acute hypercapnia. * = significant effect of hypercapnia (p<0.05; ** = 
p<0.01). † = significant effect of 2-APB (p<0.05). Data represents mean ± S.E.M.; n=4 for each. (F) 
displays the effect of acute hypercapnia on forskolin-stimulated intracellular cAMP levels +/- 2-APB 
(100µM). * = significant effect of hypercapnia (p<0.05). Data represents mean ± S.E.M., n=3 for 
each. 
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One potential important player in CO2-induced changes in cAMP-stimulated HCO3
-
 transport 
could be the IP3R binding protein released with IP3 (IRBIT). As its name suggests, IRBIT, 
when phosphorylated, binds to IP3 receptors and outcompetes IP3 binding in non-stimulated 
states. Elevations in IP3 displace IRBIT, allowing for IP3-dependent release from IP3Rs of the 
ER (Ando et al., 2003; Yang et al., 2011b). The free IRBIT has then been shown to have 
major roles in regulating HCO3
-
 secretion. Yang et al. (2009) demonstrated that IRBIT 
activated both NBCe1 and CFTR in mouse pancreatic duct cells to coordinate the secretion of 
HCO3
-
. IRBIT KD cells displayed a significant reduction in NBCe1 and CFTR activity. 
Furthermore, Hong et al. (2013) have suggested that PIP2-induced activation of NBCe1 is not 
only the result of IP3-dependent Ca
2+
 release increasing Ca
2+
-dependent kinase 
phosphorylation of NBCe1, but also due to the increased concentration of cytosolic IRBIT 
able to modulate NBCe1 activity. Thus, it is apparent that IRBIT may have a major role in 
cAMP-regulated HCO3
-
 transport should CO2 mediate its effects via the elevation of IP3/Ca
2+
. 
Therefore, the effect of hypercapnia on IRBIT and phosphorylated IRBIT was assessed by a 
Western Blot. The expression of IRBIT and p-IRBIT normalized to β-actin expression is 
shown in figure 4.04. Although only representative of n=2 experiments, it appeared that 
hypercapnia had no effect on IRBIT expression but it did induce a reduction in the amount of 
phosphorylated IRBIT. Therefore, these data suggested that hypercapnia may reduce the 
amount of IRBIT bound to the IP3 receptor, possibly because hypercapnia had induced 
elevations in intracellular IP3. Thus, these findings would support the notion that raised CO2 
induced IP3-dependent Ca
2+
 release present in Calu-3 cells which acts to modulate cAMP-
regulated HCO3
-
 transport. 
 
 124 
 
 
Figure 4.04: Acute hypercapnia reduces p-IRBIT expression in Calu-3 cells. (A) shows the results 
from a Western Blot in which the effect of forskolin (5µM) and acute hypercapnia on the expression 
of IRBIT and phosphorylated IRBIT (p-IRBIT) was assessed normalized to expression of ß-actin. The 
data for IRBIT and p-IRBIT are summarized in (B) and (C) respectively. For each experimental 
condition, 3 lysates were generated from 3 separate transwells. Data represents mean of triplicate 
samples performed on n=2 independent samples. The protein extraction was carried out by myself but 
the Western Blots were performed in the laboratory of Professor Ursula Seidler, Hannover, Germany. 
 
Currently, the data suggests that hypercapnia utilized intracellular Ca
2+
 signalling to mediate 
its effects on cAMP-regulated HCO3
-
 transport. To assess whether this apparent effect of 
hypercapnia was linked to activation of downstream targets of Ca
2+
, cells were preincubated 
for one hour with the CaM Kinase Kinase (CaMKK) inhibitor STO-609. CaMKK is activated 
by binding of the Ca
2+
/calmodulin complex and is therefore activated in response to increases 
in cytosolic Ca
2+
.  An example experiment is shown in figure 4.05A. In control experiments, 
hypercapnia induced a 2.5 ± 0.3 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification (p<0.05; n=3; fig. 4.05B) and a 4.4 ± 1.7 fold increase in the rate of 
forskolin-stimulated HCO3
-
 flux (p<0.05; n=3; fig. 4.05C). This effect of hypercapnia 
remained in STO-609 treated cells. Here, hypercapnia increased the magnitude of the 
forskolin-stimulated intracellular acidification and rate of forskolin-stimulated HCO3
- 
flux 2.9 
± 0.4 fold (p<0.05; n=3; fig. 4.05B) and 9.5 ± 3.7 fold (p<0.05; n=3; fig. 4.05C) respectively. 
Therefore, CO2 does not mediate its effects by a Ca
2+
-dependent activation of CaMKK and 
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suggested that the role of Ca
2+
 is to either activate other downstream targets or directly 
influence cAMP signalling itself. 
 
Figure 4.05: Inhibition of CaM Kinase Kinase does not block the effect of hypercapnia. (A) 
shows a representative experiment in which Calu-3 cells were preincubated for one hour with the 
CaM Kinase Kinase inhibitor STO-693 (20µM) and the response to 5µM forskolin was assessed in 
normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin 
stimulation are summarized. * = significant effect of hypercapnia (p<0.05). Data represents mean ± 
S.E.M.; n=3 for each 
 
The current data suggested that hypercapnia mediated its effects on cAMP-regulated HCO3
-
 
transport via an IP3-dependent Ca
2+
 release. IP3-dependent increases in Ca
2+
 are caused by 
Ca
2+
 release from the ER and, as such, depletion of the ER Ca
2+
 stores would be predicted to 
eliminate the CO2 effect. Therefore, intracellular ER Ca
2+
 stores were depleted by exposing 
the cells to 200nM thapsigargin, a sarco/endoplasmic reticulum calcium ATP-ase (SERCA) 
inhibitor, whilst perfusing cells with a Ca
2+
-free Krebs solution in which CaCl2 was replaced 
with MgCl2 and 0.5mM EGTA added to chelate any remaining Ca
2+
. Measurements of 
intracellular Ca
2+
 in Calu-3 cells reveal that, in these conditions, exposing cells to 200nM 
thapsigargin in the absence of extracellular Ca
2+
 depletes [Ca
2+
]i causes an initial increase in 
[Ca
2+
]i due to an inhibition of Ca
2+
 reuptake into the ER. However, as [Ca
2+
]i increase, Ca
2+
 
leaves the cell along its concentration gradient and, consequentially, [Ca
2+
]i decreases (see 
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fig. 4.09A). An example pHi experiment is shown in figure 4.06A. In control experiments 
performed on the same day, hypercapnia increased the magnitude of the forskolin-stimulated 
intracellular acidification 2.0 ± 0.3 fold (p<0.05; n=4; fig. 4.06B) and increased the rate of 
forskolin-stimulated HCO3
-
 flux 2.7 ± 0.5 fold (p<0.05; n=4; fig. 4.06C). In cells pre-treated 
with thapsigargin and perfused with a Ca
2+
 free Krebs solution, hypercapnia increased the 
magnitude of the forskolin-stimulated intracellular acidification 1.7 ± 0.1 fold (p<0.05; n=4; 
fig. 4.06B) and increased the rate of forskolin-stimulated HCO3
-
 flux 2.8 ± 0.3 fold (p<0.01; 
n=4; fig. 4.06C). Therefore, these data suggest that if CO2 does modulate intracellular Ca
2+
, 
this is through a thapsigargin-insensitive store. Another interesting finding of these 
experiments was that intracellular Ca
2+
 depleted cells only exhibited a 25.2 ± 8.1% in pHi 
recovery from CO2-induced acidosis (p<0.001; n=4; fig. 4.08). These findings support the 
results from BAPTA-AM and U73122 treated cells and provide further evidence of a Ca
2+
-
dependence to the pHi recovery observed after CO2-induced acidosis. 
 
Figure 4.06: Depletion of intracellular Ca
2+
 does not alter the effect of hypercapnia. (A) shows a 
representative experiment in which Calu-3 cells were treated with 200nM thapsigargin whilst being 
perfused with Ca
2+
 free solution to deplete intracellular Ca
2+
 stores and the response to 5µM forskolin 
was assessed in normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from 
forskolin stimulation are summarized. * = significant effect of hypercapnia (p<0.05; ** = p<0.01). 
Data represents mean ± S.E.M.; n=4 for each. 
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Although in the previous set of experiments, cells had been perfused with a Ca
2+
 free 
solution, these experiments were designed to test the effect of depletion of intracellular Ca
2+
 
stores rather than study the effects of extracellular Ca
2+
 per se.  Therefore, it was of interest 
to test the effect of removal of external Ca
2+
 without thapsigargin treatment to determine 
whether CO2 was able to modulate intracellular Ca
2+
 without extracellular Ca
2+
. Cells were 
perfused with a Ca
2+
-free solution containing 0.5mM EGTA and stimulated with forskolin in 
normocapnia and hypercapnia as shown in figure 4.07A. In control experiments performed on 
the same day, hypercapnia increased the magnitude of the forskolin-stimulated intracellular 
acidification 1.5 ± 0.1 fold (p<0.05; n=3; fig. 4.07B). However, due to large variability on the 
day, the 2.2 ± 0.4 fold increase in the rate of forskolin-stimulated HCO3
-
 flux in hypercapnia 
was not statistically significant although a clear trend existed (p>0.05; n=3; fig. 4.07C). This 
was also the case when external Ca
2+
 was removed. Hypercapnia increased the magnitude of 
the forskolin-stimulated intracellular acidification fold 1.3 ± 0.1 (p<0.05; n=3; fig. 4.07B) but 
again, due to large variability, the 2.1 ± 0.6 fold increase in the rate of forskolin-stimulated 
HCO3
-
 flux in hypercapnia was not statistically significant although a clear trend did exist 
(p>0.05; n=3; fig. 4.07C). Therefore, although it cannot be conclusively deduced that external 
Ca
2+
 has no role in mediating the effects of hypercapnia, the trend for hypercapnia to still 
increase forskolin-stimulated intracellular acidification in Ca
2+
 free conditions does suggest 
this to be the case. Consistent with a role for Ca
2+
 in mediating pHi recovery from CO2-
induced acidosis, removal of extracellular Ca
2+
 caused cells to only exhibit a 36.8 ± 10.7% in 
pHi recovery (p<0.001; n=3; fig. 4.08) suggesting that both extracellular and intracellular 
Ca
2+
 are important for the pHi recovery process. 
 
 128 
 
 
Figure 4.07: Removal of extracellular Ca
2+
 does not alter the effect of hypercapnia on the 
forskolin-stimulated intracellular acidification. (A) shows a representative experiment in which 
Calu-3 cells were perfused with a Ca
2+
 free solution and the response to 5µM forskolin was assessed 
in normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin 
stimulation are summarized. * = significant effect of hypercapnia (p<0.05). Data represents mean ± 
S.E.M.; n=3 for each. 
 
 
Figure 4.08: Ca
2+
 plays a role in mediating the intracellular pH recovery in response to CO2-
induced acidosis. % recovery of pHi was measured as described in chapter 3, section 3.11. *** = 
significant effect of treatment (p<0.001). Data represents mean ± S.E.M.; n numbers displayed in 
parenthesis. 
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4.2.2.  Effect of CO2 on intracellular Ca
2+
 
The current data implied that there was a role for Ca
2+
 signalling in the CO2-induced effect on 
cAMP-regulated HCO3
-
 transport in Calu-3 cells, with the possibility that hypercapnia 
elicited an IP3-dependent Ca
2+
 release which, not only could crosstalk with cAMP signalling 
pathways, but was also important for pHi recovery from CO2-induced acidosis. To ascertain 
whether hypercapnia induced a rise in intracellular Ca
2+
, Calu-3 cells were grown on glass 
coverslips and loaded with the Ca
2+
-sensitive dye, Fura-2-AM. To show that changes in 
[Ca
2+
]i could be detected in non-polarised Calu-3 cells, cells were stimulated with ATP in the 
presence of 1mM Ca
2+
 and thapsigargin in the absence of extracellular Ca
2+
 and both agents 
induced an increase in the 340/380 ratios, indicative of elevated [Ca
2+
]i (fig 4.09A). 
Furthermore, reintroduction of extracellular Ca
2+
 after thapsigargin treatment induced a large 
rise in 340/380 ratio, indicative of store-operated Ca
2+
 entry (fig. 4.09A). Calu-3 cells were 
next perfused with high Cl
-
 Krebs solution gassed with either 5% CO2/95% O2 (v/v) or 10% 
CO2/90% O2 (v/v). As shown in figure 4.09B, there appeared to be a slow increase in [Ca
2+
]i 
and therefore a liner regression was performed over the data points collected in 5% and 10% 
CO2 to monitor whether CO2 had any effect on this apparent increase in intracellular Ca
2+
. In 
normocapnia, the 340/380 ratio increased by 0.005 ± 0.002 units/min (n=5; fig. 4.09D). 
However, in hypercapnia, there was no significant difference in the rate of 340/380 ratio 
increase; here ratio increased by 0.006 ± 0.003 units/min (p>0.05 vs. normocapnia; n=5; fig. 
4.09D). Therefore, these data suggested that hypercapnia did not induce an increase in total 
intracellular Ca
2+
. To confirm that the slow increase in 340/380 ratio was a feature of these 
experiments, cells were perfused with high Cl
-
 Krebs solution gassed with 5% CO2/95% O2 
over an equivalent time course (fig. 4.09C). Again, a slow increase in 340/380 ratio was 
observed which was calculated as 0.001 ± 0.0002 units/min (n=3) which, although smaller 
than that observed in previous experiments in which the effects of hypercapnia was 
investigated, was not statistically significantly different (p>0.05), suggesting that the 
observed slow rise in 340/380 counts was a common feature of these experiments. To 
confirm that non-polarized Calu-3 cells responded to hypercapnia in a similar fashion to 
polarized cells, Calu-3 cells were grown on coverslips and pHi was measured in response to 
10% CO2 (fig. 4.09E). Cells displayed a pHi decrease of 0.19 ± 0.04 in response to 
hypercapnia (n=3; fig. 4.09F) which recovered by 110 ± 42.9% after 20 minutes (n=3; fig. 
4.09G). These responses to hypercapnia were not different to those observed in polarized 
 130 
 
monolayers of Calu-3 cells (figs. 4.09F and 4.09G) suggesting similar responses to 
hypercapnia exist between polarized and non-polarized Calu-3 cells 
 
 131 
 
 
 
 
Figure 4.09: Acute hypercapnia does not cause an increase in intracellular Ca
2+
 in Calu-3 cells. 
Cells were grown as a non-polarised monolayer on glass coverslips and loaded with the Ca
2+
-sensitive 
dye Fura-2-AM (10µM). (A) shows a representative experiment in which cells were stimulated with 
ATP (100µM) and thapsigargin (200nM) in the absence of extracellular Ca
2+
 before extracellular Ca
2+
 
was reintroduced as indicated. These experiments were performed by my colleague Waseema Patel. 
(B) shows an example experiment in which cells were  perfused with high Cl
-
 Krebs solution gassed 
with either 5% CO2/95% O2 (v/v) or 10% CO2/90% O2 (v/v). (C) shows an example experiment in 
which cells were  perfused with high Cl
-
 Krebs solution gassed with either 5% CO2/95% O2 (v/v). (D) 
summarizes the rate of increase in 340/380 ratio in normocapnia, hypercapnia and in normocapnia 
over a longer time course. Data represents mean ± S.E.M., n numbers are displayed in parenthesis. (E) 
shows a representative experiment in which the effect of 10% CO2 on pHi of Calu-3 cells grown on 
glass coverslips was assessed. The magnitude of the pHi decrease in response to hypercapnia and the 
extent of the recovery of pHi are summarized in (F) and (G) respectively. Data represents mean ± 
S.E.M., n numbers are displayed in parenthesis.   
 
4.2.3. Activation of intracellular Ca
2+
 signalling 
Although my experiments revealed that hypercapnia did not induce an increase in 
intracellular Ca
2+
, the fact that these experiments were performed on non-polarised 
monolayers did limit the data and as a result, it cannot be concluded that CO2 does not induce 
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a Ca
2+
 release in polarised monolayers of Calu-3 cells. Should CO2 mediate its effects on 
cAMP-regulated HCO3
-
 transport by mobilization of intracellular Ca
2+
, it would be predicted 
that increasing intracellular Ca
2+
 in normocapnia may mimic the effect of hypercapnia. To 
investigate this possibility, cells were stimulated with forskolin in the absence or presence of 
Ca
2+
 elevating agonists that increase intracellular Ca
2+
 via two distinctly different 
mechanisms. Thapsigargin was used to inhibit SERCA to prevent Ca
2+
 reuptake into the 
endoplasmic reticulum and carbachol was used to activate cell surface cholinergic receptors 
and increase intracellular Ca
2+
 via phospholipase C-dependent IP3-mediated release from the 
ER. Figure 4.10A shows that addition of thapsigargin to Calu-3 cells grown on coverslips and 
loaded with the Ca
2+
-sensitive dye Fura-2 caused a large increase in the 340/380 ratio, 
indicative of a large increase in [Ca
2+
]i. To investigate whether an increase in [Ca
2+
]i 
mimicked the effect of hypercapnia on the forskolin-stimulated intracellular acidification, 
thapsigargin was added for 5 minutes prior to addition of forskolin in normocapnia as shown 
in figure 4.10B. Thapsigargin did not significantly alter the response to forskolin; the 
magnitude of the pHi change and the rate of HCO3
-
 flux was increased 1.1 ± 0.1 fold (p>0.05; 
n=3; fig 4.10C) and 1.4 ± 0.4 fold (p>0.05; n=3; fig. 4.10D) respectively by thapsigargin. 
These data show that increasing intracellular Ca
2+
 by thapsigargin did not mimic the effect of 
hypercapnia and suggests that if CO2 does modulate intracellular Ca
2+
, it is from 
thapsigargin-insensitive store. 
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Figure 4.10: Thapsigargin treatment does not mimic the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which the effects of 
thapsigargin (200nM) on [Ca
2+
]i was assessed in Calu-3 cells grown on coverslips. (B) shows a 
representative experiment in which pHi was measured in Calu-3 cells when stimulated with 5µM 
forskolin or 5µM forskolin in the presence of 200nM thapsigargin in normocapnia. The delta pH (C) 
and HCO3
-
 flux (D) resulting from agonist stimulation are summarized. Data represents mean ± 
S.E.M.; n=3 for each. 
 
In contrast to thapsigargin, carbachol had an effect at both membranes but basolateral 
carbachol had the most pronounced effect on the forskolin-stimulated intracellular 
acidification. Apical carbachol increased the magnitude of the forskolin-stimulated 
intracellular acidification 1.0 ± 0.1 fold (p>0.05; n=4; fig. 4.11B) and increased the rate of 
forskolin-induced HCO3
-
 flux 2.1 ± 0.2 fold (p<0.01; n=4; fig. 4.11C). Basolateral carbachol 
increased the magnitude of the forskolin-stimulated intracellular acidification 1.4 ± 0.02 fold 
(p<0.01 vs. forskolin alone; p<0.01 vs. forskolin + apical carbachol; n=4; fig. 4.11B) and 
increased the rate of forskolin-induced HCO3
-
 flux 3.9 ± 0.2 fold (p<0.001 vs. forskolin 
alone; p<0.01 vs. forskolin + apical carbachol; n=4; fig. 4.11C). Furthermore, the effect of 
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basolateral carbachol was blocked by atropine verifying that the effect of carbachol was due 
to signalling via cholinergic receptors and subsequent activation of the PLC/IP3 signalling 
pathway (fig. 4.11D). Therefore, activation of the phospholipase C pathway and IP3-
dependent Ca
2+
 mobilization by carbachol mimics the effect of hypercapnia. This supports 
the findings that showed the effect of hypercapnia was dependent on PLC activity and also 
supports the findings by Cook et al. (2012) that showed hypercapnia affected cAMP 
signalling due to IP3-dependent Ca
2+
 release. 
 
 
Figure 4.11: Basolateral carbachol mimics the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 5µM forskolin, 5µM forskolin + apical  carbachol (20µM) or 5µM forskolin + 
basolateral  carbachol (20µM). The delta pH (B) and HCO3
-
 flux (C) resulting from agonist 
stimulation are summarized. The sensitivity of the effect of carbachol to atropine (10µM) is 
summarized in (D). * = significant effect of carbachol (p<0.05; ** = p<0.01; *** = p<0.001); † = 
significant difference between apical carbachol and basolateral carbachol (p<0.05). Data represents 
mean ± S.E.M.; n=4 for each 
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4.3. The effect of exogenous ATP 
Given that hypercapnia has been shown to induce ATP release in brain tissue (Huckstepp et 
al., 2010b) and that ATP signals via purinergic receptors to mobilize intracellular Ca
2+
 and 
regulate ion transport in airway epithelia (Homolya et al., 2000; Son et al., 2004), it was 
possible that CO2 may induce ATP release from Calu-3 cells to activate purinergic receptors 
via an autocrine signalling mechanism and induce elevations in [Ca
2+
]i. If this was the case, 
addition of exogenous ATP in normocapnia should mimic the effect of hypercapnia. 
Carbachol was able to somewhat mimic the effect of hypercapnia, thus implicating activation 
of Gq-coupled receptors may underlie the effects of hypercapnia on cAMP-regulated HCO3
-
 
transport. Before the effects of ATP on the forskolin-stimulated intracellular acidification 
were assessed, the effect of ATP alone was first measured. As shown in figure 4.12A, 
addition of exogenous ATP caused a fast, transient acidification. In normocapnia, the 
magnitude of the acidification was 0.16 ± 0.03 (n=4) and was 0.22 ± 0.04 in hypercapnia 
(p>0.05; n=4; fig. 4.12C). Interestingly, the rate of ATP-stimulated HCO3
-
 flux was 
significantly enhanced 6.8 ± 2.6 fold from 16.0 ± 6.8mM HCO3
-
 min
-1
 (n=4) in normocapnia 
to 60.0 ± 15.3mM HCO3
-
 min
-1
 in hypercapnia (p<0.05; n=4; fig. 4.12D). Further 
investigations revealed that the ATP-induced intracellular acidification was almost 
completely abolished by BAPTA-AM, as shown in figs 4.12B, C and D. Therefore, ATP 
utilizes Ca
2+
 signalling in order to mediate its effects in Calu-3 cells which is supported by 
figure 4.09A which showed a small but detectable Ca
2+
 transient after stimulation of Calu-3 
cells with exogenous ATP. 
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Figure 4.12: Exogenous ATP induces a Ca
2+
-dependent, transient intracellular acidification 
which is modulated by acute hypercapnia. (A) and (B) show representative experiments in which 
Calu-3 cells were stimulated with bilateral ATP (100µM) in normocapnia and hypercapnia in control 
and BAPTA-AM (50µM) loaded cells respectively. The delta pH (C) and HCO3
-
 flux (D) resulting 
from ATP stimulation are summarized. * = significant effect of hypercapnia (p<0.05); † = significant 
effect of BAPTA-AM (p<0.05). Data represents mean ± S.E.M.; n=4 for each. 
 
To assess how ATP-induced elevations in Ca
2+
 affected the forskolin-stimulated intracellular 
acidification, cells were stimulated with either forskolin alone or forskolin and bilateral ATP 
simultaneously in normocapnia and hypercapnia (fig. 4.13A). In normocapnia, ATP increased 
the magnitude of the forskolin-stimulated intracellular acidification 1.5 ± 0.1 fold (p<0.001 
vs. forskolin alone; n=6; fig. 4.13B) which was similar, but significantly smaller, than 
hypercapnia, which increased the magnitude of the forskolin-stimulated intracellular 
acidification 2.2 ± 0.1 fold (p<0.001 vs. normocapnia; p<0.001 vs. ATP in normocapnia; n=6; 
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fig. 4.13B). Furthermore, ATP increased the rate of the forskolin-stimulated HCO3
-
 flux 4.3 ± 
0.5 fold in normocapnia (p<0.01 vs. forskolin alone; n=6; fig. 4.13C) which again was similar 
but significantly smaller than the 6.9 ± 0.8 fold increase in the forskolin-stimulated HCO3
-
 
flux observed in hypercapnia (p<0.001 vs. normocapnia; p<0.05 vs. ATP in normocapnia; 
n=6; fig. 4.13C). The effect of exogenous ATP in hypercapnia was also assessed. ATP 
induced a non-significant 1.0 ± 0.1 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification in hypercapnia (p>0.05 vs. forskolin alone; n=6; fig. 4.13B) but did 
induce a 1.9 ± 0.2 fold increase in the rate of forskolin-stimulated HCO3
-
 flux in hypercapnia 
(p<0.01 vs. forskolin alone; n=6; fig. 4.13C). Together, these data imply that (i) exogenous 
ATP mimics the effect of hypercapnia but does not modulate the cAMP-regulated HCO3
-
 
transport to the same extent as CO2 and (ii) ATP and hypercapnia together are able to further 
enhance forskolin-stimulated HCO3
-
 transport and suggests that if hypercapnia is mediating 
its effects by causing an ATP release, the ATP levels released by 10% CO2 are not high 
enough to saturate the purinergic receptors. 
  
Figure 4.13: Exogenous ATP mimics the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with either 5µM forskolin or 5µM forskolin + 100µM bilateral ATP  in normocapnia and 
hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from agonist stimulation are summarized. 
* = significant effect of hypercapnia (p<0.05; ** = p<0.01). † = significant effect of ATP. Data 
represents mean ± S.E.M.; n=6 for each. 
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To determine whether exogenous ATP was mediating its effects on either apical or 
basolateral purinergic receptors, exogenous ATP was applied unilaterally. Figure 4.14A 
shows an example experiment in which ATP was added apically and figure 4.15A shows an 
example experiment in which ATP was added basolaterally. Apical ATP increased the 
magnitude of the forskolin-stimulated intracellular acidification 1.2 ± 0.1 fold (p>0.05 vs. 
forskolin alone; n=3) compared to hypercapnia which induced a 1.6 ± 0.1 fold increase in the 
magnitude of the forskolin-stimulated intracellular acidification (p<0.01 vs. normocapnia; 
n=3; fig. 4.14B). However, although apical ATP significantly enhanced the rate of forskolin-
stimulated HCO3
-
 flux 2.0 ± 0.1 fold (p<0.05 vs. forskolin alone; n=3), this was significantly 
lower than the 4.7 ± 0.8 fold increase in forskolin-stimulated HCO3
-
 flux induced by 
hypercapnia (p<0.05 vs. normocapnia; p<0.05 vs. apical ATP; n=3; fig. 4.14C). Basolateral 
ATP increased the magnitude of the forskolin-stimulated intracellular acidification 1.3 ± 0.3 
fold (p>0.05 vs. forskolin alone; n=3) compared to hypercapnia which induced a 1.9 ± 0.2 
fold increase in the magnitude of the forskolin-stimulated intracellular acidification (p<0.05 
vs. normocapnia; n=3; fig. 4.15B). However, basolateral ATP appeared to have a greater 
effect than apical ATP on the rate of forskolin-stimulated HCO3
-
 flux as it significantly 
enhanced this parameter 3.8 ± 0.7 fold (p<0.01 vs. forskolin alone; n=3), which is not 
significantly different to the 5.4 ± 0.8 fold increase in forskolin-stimulated HCO3
-
 flux 
induced by hypercapnia (p<0.01 vs. normocapnia; p>0.05 vs. basolateral ATP; n=3; fig. 
4.15C). As summarized in figure 4.16, bilateral ATP has a significantly greater effect on the 
rate of forskolin-stimulated HCO3
-
 flux compared to apical ATP (p<0.05) but there was no 
difference between the effect of bilateral ATP compared to basolateral ATP. Together, these 
data suggested that although apical ATP did produce a small, but significant, effect on 
forskolin-stimulated HCO3
-
 transport, the more pronounced effect of basolateral ATP implied 
that any CO2-induced ATP release occurred predominantly across the basolateral membrane. 
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Figure 4.14: Exogenous apical ATP has a small effect on the forskolin-stimulated intracellular 
acidification. (A) shows a representative experiment in which Calu-3 cells were stimulated with 
either 5µM forskolin or 5µM forskolin + 100µM apical ATP  in normocapnia and hypercapnia. The 
delta pH (B) and HCO3
-
 flux (C) resulting from agonist stimulation are summarized. * = significant 
effect of hypercapnia (p<0.05; ** = p<0.01). † = significant effect of ATP. Data represents mean ± 
S.E.M.; n=3 for each. 
 
 140 
 
 
Figure 4.15: Exogenous basolateral ATP mimics the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were stimulated with either 5µM forskolin or 5µM forskolin + 100µM basolateral ATP in 
normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from agonist 
stimulation are summarized. * = significant effect of hypercapnia (p<0.05). † = significant effect of 
ATP. Data represents mean ± S.E.M.; n=3 for each. 
 
 
Figure 4.16: The effect of exogenous ATP on the forskolin-stimulated intracellular acidification 
is predominantly basolateral. * = significant effect of bilateral ATP vs apical ATP (p<0.05). Data 
represents mean ± S.E.M.; n=6 for bilateral ATP; n=3 for apical and basolateral ATP. 
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Next, the effect of ATP was tested for its Ca
2+
 dependence. Calu-3 cells were preincubated 
with BAPTA-AM for one hour before being stimulated with forskolin or forskolin + bilateral 
ATP simultaneously in normocapnia and hypercapnia. An example experiment is shown in 
figure 4.17A. In control experiments performed on the same day, exogenous ATP caused a 
1.5 ± 0.1 fold increase in the magnitude of the forskolin-stimulated intracellular acidification 
(p<0.01; n=3; figs 4.17B and D) and a 3.8 ± 0.3 fold increase in the rate of forskolin-
stimulated HCO3
-
 flux (p<0.01; n=3; figs. 4.17C and E). However, this effect of ATP was 
blocked in cells that had been treated with BAPTA-AM. Here, addition of exogenous ATP in 
normocapnia caused a 1.0 ± 0.1 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification (p>0.05; n=3; figs. 4.17B and D) and a 1.3 ± 0.04 fold increase in 
the rate of forskolin-stimulated HCO3
-
 flux (p>0.05; n=3; figs. 4.17C and E). These findings 
demonstrated that the effect of ATP is Ca
2+
-dependent and implicates G-protein coupled 
purinergic receptors in mediating the ATP effects. Given that the effect of hypercapnia is also 
Ca
2+
-dependent, it shows that ATP and CO2 are potentially signalling via the same common 
pathway and provides further indication that CO2 may elicit its effects via a release of ATP. 
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Figure 4.17: The effect of ATP on the forskolin-stimulated intracellular acidification is Ca
2+
-
dependent. (A) shows a representative experiment in which Calu-3 cells were preincubated with 
BAPTA-AM (50µM) for one hour before being stimulated with either 5µM forskolin or 5µM 
forskolin + 100µM ATP  in normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) 
resulting from agonist stimulation are summarized and compared to non-BAPTA-AM loaded control 
experiments performed on the same day. ** = significant effect of hypercapnia (p<0.01; *** = 
p<0.001). † = significant effect of ATP (p<0.05). The fold increase in the delta pH (D) and HCO3
-
 
flux (E) from the forskolin response in normocapnia are summarized. ** = significant of treatment vs 
forskolin alone (p<0.01; *** = p<0.001); † = significant effect of BAPTA-AM (p<0.05). Data 
represents mean ± S.E.M., n=3 for each. 
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To verify that exogenous ATP was signalling via purinergic receptors, the non-specific P2 
receptor antagonist, suramin, was used to block purinergic receptor activation and an example 
experiment is shown in figure 4.18A. Exogenous ATP increased the magnitude of the 
forskolin-stimulated intracellular acidification 1.7 ± 0.1 fold (p<0.01; n=4; fig. 4.18B) but 
this effect of ATP was abolished in the presence of suramin as, in these conditions, ATP only 
increased the magnitude of the forskolin-stimulated intracellular acidification 0.8 ± 0.1 fold 
(p>0.05 vs. forskolin alone; p<0.05 vs. forskolin + ATP; n=4; fig. 4.18B). Similarly, ATP 
increased the rate of forskolin-stimulated HCO3
-
 flux 3.1 ± 0.6 fold (p<0.05; n=4; fig. 4.18C) 
but this was reduced to a 1.5 ± 0.2 fold increase in the presence of suramin (p>0.05 vs. 
forskolin alone; p<0.05 vs. forskolin + ATP; n=4; fig. 4.18C). These findings imply that ATP 
elicits its effects on forskolin-stimulated HCO3
-
 transport due to activation of purinergic 
receptors. It is worth noting that suramin treatment alone induced a pHi decrease of 0.21 ± 
0.03 units (n=4) suggesting that suramin treatment alone modified HCO3
-
/H
+
 transport which 
does slightly complicate experiments in which this drug was used. 
 
Figure 4.18: Suramin prevents ATP-mediated augmentation of forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in Calu-3 cells were stimulated 
with 5µM forskolin + 100µM bilateral ATP +/- suramin  in normocapnia. The delta pH (B) and 
HCO3
-
 flux (C) resulting from agonist stimulation are summarized. * = significant effect of 
hypercapnia (p<0.05). Data represents mean ± S.E.M.; n=4 for each. 
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To determine whether the effect of ATP was specific or whether other nucleotides induced 
similar effects, the response to UTP was also assessed. UTP has been shown to act as a 
signalling molecule in the airways with both Namkung et al. (2010) and Bove et al. (2010) 
demonstrating UTP stimulated, Ca
2+ 
and CFTR-dependent increases in Isc in primary human 
bronchial epithelia and alveolar type II cells, respectively. Figure 4.19A shows an example 
experiment in which cells were stimulated with forskolin or forskolin and exogenous, 
bilateral UTP simultaneously in normocapnia and hypercapnia. In normocapnia, exogenous 
UTP increased the magnitude of the forskolin-stimulated intracellular acidification 1.5 ± 0.1 
fold (p<0.001 vs. forskolin alone; n=4) which was similar but significantly smaller than 
hypercapnia which increased the magnitude of the forskolin-stimulated intracellular 
acidification 2.1 ± 0.1 (p<0.001 vs. normocapnia; p<0.01 vs. UTP in normocapnia; n=4; fig. 
4.19B). Furthermore, UTP increased the rate of forskolin-stimulated HCO3
-
 flux 3.1 ± 0.9 
fold in normocapnia (p<0.05 vs. forskolin alone; n=4) which was significantly smaller than 
the 7.4 ± 0.2 fold increase in HCO3
-
 flux observed in hypercapnia (p<0.001 vs. normocapnia; 
p<0.01 vs. UTP in normocapnia; n=6; fig. 4.19C). These data suggested that UTP, like ATP, 
can also modulate forskolin-stimulated HCO3
-
 transport in a similar, but not as pronounced, 
fashion to hypercapnia. The UTP-induced 3.1 ± 0.9 fold (n=4) increase in the rate of 
forskolin-stimulated HCO3
-
 transport in normocapnia was not statistically different to the 4.3 
± 0.5 fold increase induced by bilateral ATP (p>0.05; n=6).  
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Figure 4.19: Exogenous UTP partially mimics the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were stimulated with either 5µM forskolin or 5µM forskolin + 100µM UTP  in normocapnia and 
hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from agonist stimulation are summarized. 
** = significant effect of hypercapnia (p<0.01); † = significant effect of UTP. Data represents mean ± 
S.E.M.; n=4 for each. 
 
Should hypercapnia induce a release of purinergic signalling molecules (i.e. ATP, UTP or 
both), inhibition of purinergic receptors would be predicted to prevent the effect of 
hypercapnia on cAMP-regulated HCO3
-
 transport. To this end, suramin was used to block 
purinergic receptor activation and the response of Calu-3 cells to forskolin in normocapnia 
and hypercapnia was assessed, as shown in figure 4.20A. Suramin treatment did not affect the 
response to forskolin in 5% CO2; in control conditions, the magnitude of the forskolin-
stimulated intracellular acidification was 0.17 ± 0.01 (n=3) and the rate of forskolin-
stimulated HCO3
-
 flux was 5.6 ± 1.0mM HCO3
-
 min
-1
 (n=3) whilst in the presence of 
suramin, the magnitude of the forskolin-stimulated intracellular acidification was 0.20 ± 0.02 
(p>0.05 vs. control; n=3; fig. 4.20B) and the rate of forskolin-stimulated HCO3
-
 flux was 9.1 
± 1.9mM HCO3
-
 min
-1
 (p>0.05 vs. control; fig. 4.20C). Importantly, suramin treatment did 
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not affect the response to forskolin in hypercapnia. In control experiments, hypercapnia 
induced a 2.1 ± 0.2 fold increase in the forskolin-stimulated intracellular acidification 
(p<0.01; n=4; fig. 4.20D) and a 7.9 ± 0.8 fold increase in the rate of forskolin-stimulated 
HCO3
-
 flux (p<0.001; n=4; fig. 4.20E). Similarly, in the presence of suramin, hypercapnia 
induced a 2.2 ± 0.2 fold increase in the forskolin- stimulated intracellular acidification 
(p<0.01; n=3; fig. 4.20D) and a 5.6 ± 0.6 fold increase in the rate of forskolin-stimulated 
HCO3
-
 flux (p<0.01; n=3; fig. 4.20E). These data suggest that if CO2 is inducing a release of 
ATP or UTP from Calu-3 cells, they are not signalling via purinergic receptors to induce 
changes in cAMP-regulated HCO3
-
 transport. 
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Figure 4.20: Suramin does not block the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 5µM forskolin alone or 5µM forskolin in the presence of 10µM suramin in 
normocapnia and hypercapnia. The effect of suramin on the delta pH (B) and HCO3
-
 flux (C) resulting 
from forskolin stimulation is summarized. *** = significant effect of hypercapnia (p<0.001). The 
effect of suramin on the delta pH and HCO3
-
 flux resulting from forskolin stimulation was also 
compared to control experiments performed on the same day as shown in (D) and (E) respectively. ** 
= significant effect of hypercapnia (p<0.01). Data represents mean ± S.E.M.; n=3 for each. 
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An alternative way to deduce whether release of ATP mediated the effects of hypercapnia 
was to stimulate ATP hydrolysis by adding exogenous apyrase. Should ATP be mediating the 
effects of hypercapnia, metabolism of ATP should eliminate the CO2 effect. Calu-3 cells 
were stimulated with forskolin in normocapnia and hypercapnia and then stimulated once 
more with forskolin in hypercapnia in the presence of apyrase (fig. 4.21A). Ideally, apyrase 
would have been added prior to exposing the cells to hypercapnia. However, perfusion of 
apyrase over a longer time frame was cost inefficient. Hypercapnia caused a 2.0 ± 0.2 fold 
increase in the magnitude of the forskolin- stimulated intracellular acidification (p<0.01; n=3; 
fig. 4.21B) and a 4.9 ± 1.8 fold increase in the rate of forskolin-stimulated HCO3
-
 flux 
(p<0.05; n=3; fig. 4.21C) This was unchanged in the presence of apyrase; here hypercapnia 
caused a 2.0 ± 0.2 fold increase in the magnitude of the forskolin- stimulated intracellular 
acidification (p<0.01 vs. normocpania; p>0.05 vs. hypercapnia; n=3; fig. 4.21B) and a 4.4 ± 
0.9 fold increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.01 vs. normocpania; 
p>0.05 vs. hypercapnia; n=3; fig. 4.21C). Therefore, these data suggested ATP was not 
mediating the effects of hypercapnia. 
 
Figure 4.21: Apyrase does not block the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 5µM forskolin in normocapnia and hypercapnia and 5µM forskolin in the presence of 
apyrase (1U/ml) in hypercapnia. The effect of hypercapnia on the delta pH (B) and HCO3
-
 flux (C) 
resulting from forskolin stimulation is summarized. * = significant effect of hypercapnia (p<0.05; ** 
= p<0.01). Data represents mean ± S.E.M.; n=3 for each. 
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Given that the data from experiments using suramin and apyrase implied ATP was not be 
signalling via purinergic receptors to mediate its effects, it was possible that ATP may have 
been broken down into adenosine by extracellular 5’ nucleotidases (Arch and Newsholme, 
1978) and that adenosine signalling could underlie the response in hypercapnia. Therefore, to 
assess whether adenosine signalling mediated the effect of hypercapnia, adenosine receptors 
were blocked using the non-specific adenosine receptor antagonist, CGS-15943. Figure 
4.22A shows that treatment of cells with CGS-15943, prevented the adenosine-induced 
intracellular acidification in a non-reversible manner. In control conditions, adenosine 
induced an intracellular acidification of 0.18 ± 0.03 pH units (n=3) and a HCO3
-
 flux of 5.9 ± 
1.3mM HCO3
-
 min
-1
 (n=3). However, in the presence of CGS-15943, the adenosine-
stimulated intracellular acidification was 0.01 ± 0.02 pH units (p<0.05; n=3) with no 
measureable HCO3
-
 flux (0 ± 0mM HCO3
-
 min
-1
 (p<0.05; n=3)). These data show that CGS-
15943 was an appropriate inhibitor to use when studying the effects of adenosine signalling 
in Calu-3 cells. Figure 4.22B shows an example experiment used to assess the effects of 
hypercapnia on the forskolin-stimulated intracellular acidification in the presence of CGS-
15943. CGS-15943 treatment alone did not affect the response to forskolin in normocapnia as 
shown in figs 4.22C and D. In control experiments performed on the same day, hypercapnia 
caused a 2.3 ± 0.1 fold increase in the magnitude of forskolin-stimulated intracellular 
acidification (p<0.05; n=3; fig. 4.22E) and a 5.0 ± 0.5 fold increase in the rate of forskolin-
stimulated HCO3
-
 flux (p<0.001; n=3; fig. 4.22F). In the presence of CGS-15943, 
hypercapnia caused a 2.4 ± 0.4 fold increase in the magnitude of forskolin-stimulated 
intracellular acidification (p<0.05; n=3; fig. 4.22D) and a 4.1 ± 0.1 fold increase in the rate of 
forskolin-stimulated HCO3
-
 flux (p<0.001; n=3; fig. 4.22E). Therefore, these data imply that 
the effect of hypercapnia was not due to increases in extracellular adenosine (as a result of 
ATP metabolism) signalling via adenosine receptors to modulate cAMP-dependent HCO3
-
 
transport. 
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Figure 4.22: CGS-15943 does not block the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 10µM adenosine alone or in the presence of 500nM CGS-15943 as shown in (A). 
Calu-3 cells were stimulated with 5µM forskolin alone or 5µM forskolin in the presence of 500nM 
CGS-15943 in normocapnia and hypercapnia as shown in (B). The effect of hypercapnia on the delta 
pH (B) and HCO3
-
 flux (C) resulting from forskolin stimulation is summarized. * = significant effect 
of hypercapnia (p<0.05; *** = p<0.001). The effect of CGS-15943 on the delta pH and HCO3
-
 flux 
resulting from forskolin stimulation was also compared to control experiments performed on the same 
day as shown in (D) and (E) respectively. * = significant effect of hypercapnia (p<0.05; *** = 
p<0.001). Data represents mean ± S.E.M.; n=3 for each. 
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4.4. Possible mechanisms for CO2-Induced ATP release 
4.4.1. Connexins 
The previously reported data suggests that exogenous ATP mimicked the effect of 
hypercapnia and implies CO2 may mediate its effects by causing a release of ATP. Although 
the evidence for ATP release at this stage was minimal, the hypothesis would support the 
work done by Huckstepp et al. (2010b) who attributed a CO2-induced ATP release as a 
mechanism for the regulation of ventilation in medulla oblongata of rats. Here, they showed 
the ATP release was due to CO2-induced opening of connexin hemichannels, specifically 
connexin 26. Connexins are proteins possessing four membrane spanning domains and two 
extracellular loops containing cysteine residues. 6 connexins associate to form a connexon 
which forms a channel on the cell membrane. The extracellular cysteine residues interact with 
connexins on neighbouring cells to form a gap junction, capable of shuttling small molecules 
between adjacent cells. For a review of connexin hemichannels, see Matsuuchi and Naus 
(2013). Calu-3 cells have been reported to express connexins 32 and 43 (Go et al., 2006; 
Scheckenbach et al., 2011; Losa et al., 2014) with Cx43 actually believed to be important in 
CFTR regulation by prostaglandins (Scheckenbach et al., 2011). Thus, to determine whether 
connexins were involved in transduction of the CO2 signal, the effect of hypercapnia on the 
forskolin-induced acidification was tested in the presence of the connexin inhibitors 
carbenoxolone, cobalt and proadifen.  
Carbenoxolone has been shown to inhibit connexins in a variety of cell types (Sagar and 
Larson, 2006; Huckstepp et al., 2010b) and figure 4.23A shows an example experiment of 
carbenoxolone treated cells. Interestingly, in conditions of normocapnia, carbenoxolone 
treatment alone increased both the magnitude of the forskolin-stimulated intracellular 
acidification and the rate of forskolin-stimulated HCO3
-
 flux compared to the response in the 
absence of carbenoxolone. This is summarized in figures 4.23B and C. This suggests 
carbenoxolone treatment alone is able to modulate cAMP-regulated HCO3
-
 transport.  In 
control experiments performed on the same day, hypercapnia increased the magnitude of the 
forskolin-stimulated intracellular acidification 2.1 ± 0.1 fold (p<0.001; n=4; fig. 4.23D) and 
the rate of forskolin-stimulated HCO3
-
 flux 5.8 ± 0.3 fold (p<0.001; n=4; fig. 4.23E). 
However, in the presence of carbenoxolone, hypercapnia was not able to significantly alter 
the forskolin-stimulated intracellular acidification. Here, hypercapnia increased the 
magnitude of the forskolin-stimulated intracellular acidification 0.8 ± 0.1 fold (p>0.05; n=4; 
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fig. 4.23D) and the rate of forskolin-stimulated HCO3
-
 flux 1.1 ± 0.3 fold (p>0.05; n=4; fig. 
4.23E). These data suggested that CO2 may alter cAMP-regulated HCO3
-
 transport by a 
modulation of connexin activity. Furthermore, cells treated with carbenoxolone were unable 
to recover their pHi in response to CO2-induced acidosis and actually displayed a -35.3 ± 
8.0% in pHi recovery (p<0.001 vs. control; n=4; fig. 4.26) demonstrating that cells actually 
further acidified after CO2-induced acidosis. Thus, connexins may also be important in the 
mechanisms of pHi recovery from CO2-induced acidosis. 
 
Figure 4.23: Carbenoxolone treatment blocks the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were stimulated with 5µM forskolin alone or 5µM forskolin in the presence of 100µM carbenoxlone  
in normocapnia and hypercapnia. The effect of carbenoxolone on the delta pH (B) and HCO3
-
 flux (C) 
resulting from forskolin stimulation is summarized. * = significant effect of carbenoxolone in 
normocapnia (p<0.05). The effect of carbenoxolone on the delta pH and HCO3
-
 flux resulting from 
forskolin stimulation was also compared to control experiments performed on the same day as shown 
in (D) and (E) respectively. *** = significant effect of hypercapnia (p<0.001); † = significant effect of 
carbenoxolone (p<0.05). Data represents mean ± S.E.M.; n=4 for each. 
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To verify that carbenoxolone was specifically targeting connexins, the effect of another 
reported connexin inhibitor was also tested. Cobalt has been shown to inhibit gap junctions in 
several studies performed on brain tissue (Huckstepp et al., 2010b; Wenker et al., 2012). 
Figure 4.24A shows an example experiment of cells treated with cobalt chloride. A notable 
difference between cobalt and carbenoxolone is the inability of cobalt to modulate the 
forskolin-stimulated intracellular acidification in normocapnia, as summarized in figures 
4.24B and 4.23C. Furthermore, cobalt had no effect on the pHi recovery from CO2-induced 
acidosis with cells demonstrating a 120.5 ± 40.6% recovery of pHi (p>0.05 vs. control; n=3; 
fig. 4.26). In control experiments performed on the same day, hypercapnia increased the 
magnitude of the forskolin-stimulated intracellular acidification 2.2 ± 0.1 fold (p<0.001; n=4; 
fig. 4.24D) and the rate of forskolin-stimulated HCO3
-
 flux 3.6 ± 0.5 fold (p<0.001; n=4; fig. 
4.24E). Unlike carbenoxolone, cobalt did not prevent the CO2-mediated increase of the 
forskolin-stimulated intracellular acidification. Here, hypercapnia increased the magnitude of 
the forskolin-stimulated intracellular acidification 2.1 ± 0.1 fold (p<0.01; n=4; fig. 4.24D) 
and the rate of forskolin-stimulated HCO3
-
 flux 5.0 ± 0.6 fold (p<0.001; n=4; fig. 4.24E). 
These data suggest that either the effects of carbenoxolone were off target or that 
carbenoxolone and cobalt inhibit different members of the connexin family of which only the 
carbenoxolone-sensitive ones were CO2-sensitive. 
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Figure 4.24: Cobalt chloride does not block the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were stimulated with 5µM forskolin alone or 5µM forskolin in the presence of cobalt chloride 
(500µM) in normocapnia and hypercapnia. The effect of cobalt chloride on the delta pH (B) and 
HCO3
-
 flux (C) resulting from forskolin stimulation is summarized. *** = significant effect of 
hypercapnia (p<0.05). The effect of cobalt chloride on the delta pH and HCO3
-
 flux resulting from 
forskolin stimulation was also compared to control experiments performed on the same day as shown 
in (D) and (E) respectively. * = significant effect of hypercapnia (p<0.05; ** = p<0.01; *** = 
p<0.001); † = significant effect of cobalt chloride (p<0.05). Data represents mean ± S.E.M.; n=4 for 
each. 
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Proadifen has also been reported to be an inhibitor of connexins and has been shown to 
prevent gap junction mediated dye uptake in the gerbil cochlea (Spiess et al., 2002; Zhao, 
2005) as well as ATP release via connexins in rat brain tissue (Huckstepp et al., 2010b). 
Figure 4.25A shows an example experiment of cells treated with proadifen. As with cobalt, 
proadifen also had no effect on the forskolin-stimulated intracellular acidification in 
normocapnia, as summarized in figures 4.25B and C. Furthermore, proadifen also had no 
effect on the pHi recovery from CO2-induced acidosis with cells demonstrating a 73.7 ± 7.6% 
recovery of pHi (p>0.05 vs. control; n=3; fig. 4.26). In control experiments performed on the 
same day, hypercapnia increased the magnitude of the forskolin-stimulated intracellular 
acidification 2.3 ± 0.1 fold (p<0.01; n=3; fig. 4.25D) and the rate of forskolin-stimulated 
HCO3
-
 flux 6.0 ± 0.3 fold (p<0.001; n=3; fig. 4.25E). Similar to cobalt, proadifen did not 
prevent the CO2-mediated increase of the forskolin-stimulated intracellular acidification. 
Here, hypercapnia increased the magnitude of the forskolin-stimulated intracellular 
acidification 2.0 ± 0.3 fold (p<0.05; n=3; fig. 4.25D) and the rate of forskolin-stimulated 
HCO3
-
 flux 3.7 ± 0.6 fold (p<0.01; n=3; fig. 4.25E). These data support the findings from the 
cobalt experiments and therefore imply that there is no role for connexins in mediating the 
response to hypercapnia. As a result, the effects of carbenoxolone are more likely to be an 
effect on an offsite target of the drug. 
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Figure 4.25: Proadifen does not block the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 5µM forskolin alone or 5µM forskolin in the presence of proadifen (200µM) in 
normocapnia and hypercapnia. The effect of proadifen on the delta pH (B) and HCO3
-
 flux (C) 
resulting from forskolin stimulation is summarized. * = significant effect of hypercapnia (p<0.05). 
The effect of cobalt chloride on the delta pH and HCO3
-
 flux resulting from forskolin stimulation was 
also compared to control experiments performed on the same day as shown in (D) and (E) 
respectively. * = significant effect of hypercapnia (p<0.05). Data represents mean ± S.E.M.; n=3 for 
each. 
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Figure 4.26: The effect of connexin inhibitors on the intracellular pH recovery in response to 
CO2-induced acidosis. % recovery of pHi calculated as described in chapter 3, section 3.3. *** = 
significant effect of carbenoxolone (p<0.001). Data represents mean ± S.E.M.; n numbers displayed in 
parenthesis. 
 
4.4.2. Pannexins 
Pannexins are proteins that are structurally very similar to connexins but pannexins function 
as a channel as opposed to having the ability to form gap junctions with neighbouring cells. 
These channels have been implicated in mediating ATP release in pannexin-1 expressing 
oocytes (Wang et al., 2013) as well as in primary airway epithelia (Ransford et al., 2009) and 
Calu-3 cells (Seminario-Vidal et al., 2011) in which it was found that pharmacological 
inhibition or genetic knockdown of pannexin-1 reduced ATP release. Therefore, pannexins 
could mediate the proposed CO2-induced ATP release in Calu-3 cells. Firstly, it was 
necessary to test whether pannexins were expressed in Calu-3 cells. End-Point PCR revealed 
a band of expected size (133bp) for pannexin-1 but the product size for pannexin-2 was much 
larger than expected and suggested the amplified product was not pannexin-2 (fig. 4.27). 
Thus it appeared only pannexin-1 was expressed in Calu-3 cells.  
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Figure 4.27: Panx-1, but not Panx-2, is expressed in Calu-3 cells. End-point PCR on RNA samples 
extracted from Calu-3 cells grown as a polarised monolayer were analysed for the expression of 
members of the pannexin family. CFTR expression was also analysed as a positive control. 
 
To test for a role of pannexins in mediating a possible CO2-induced ATP release, cells were 
treated with the pannexin inhibitor probenecid (Silverman et al., 2008).  An example 
experiment is shown in figure 4.28A. As shown in figures 4.28B and C, probenecid treatment 
alone did not alter the response to forskolin in normocapnic conditions. Furthermore, in the 
presence of probenecid, hypercapnia caused a 2.2 ± 0.2 fold increase in the magnitude of the 
forskolin-stimulated intracellular acidification (p<0.01; n=4; fig. 4.28D) and a 3.7 ± 0.5 fold 
increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.05; n=4; fig. 4.28E). However, in 
control experiments performed on the same day, although hypercapnia caused a similar 2.5 ± 
0.1 fold increase in the magnitude of the forskolin-stimulated intracellular acidification 
(p<0.001; n=4; fig. 4.28D), it caused a markedly higher 6.6 ± 0.8 fold increase in the rate of 
forskolin-stimulated HCO3
-
 flux (p<0.01 vs. normocapnia; p<0.05 vs. probenecid treated 
cells; n=4; fig. 4.28E). These data suggest that the effect of hypercapnia was significantly 
diminished when compared to untreated cells and indicates pannexins signalling may have a 
role in mediating the effects of hypercapnia on cAMP-regulated HCO3
-
 transport in Calu-3 
cells.  
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Figure 4.28: Probenecid reduces the effect of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
stimulated with 5µM forskolin alone or in the presence of probenecid (500µM) in normocapnia and 
hypercapnia. The effect of probenecid on the delta pH (B) and HCO3
-
 flux (C) resulting from 
forskolin stimulation is summarized. *** = significant effect of hypercapnia (p<0.001). The effect of 
probenecid on the delta pH and HCO3
-
 flux resulting from forskolin stimulation was also compared to 
control experiments performed on the same day as shown in (D) and (E) respectively. *** = 
significant effect of hypercapnia (p<0.001); † = significant effect of probenecid (p<0.05). Data 
represents mean ± S.E.M.; n=4 for each. 
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Interestingly, carbenoxolone has also been reported to inhibit pannexins and as such may 
explain why carbenoxolone, but not cobalt or proadifen, was able to block the effect of 
hypercapnia on the forskolin-stimulated intracellular acidification if CO2 was signalling via 
pannexins as opposed to connexins. Pannexins are more sensitive to carbenoxolone than 
connexins, with Bruzzone et al. (2005) demonstrating 10µM carbenoxolone inhibited 
pannexin-1-mediated currents but not Cx46-mediated currents when expressed in Xenopus 
oocytes. A representative experiment showing the effects of 10µM carbenoxolone on the 
forskolin-stimulated intracellular acidification in normocapnia and hypercapnia is shown in 
figure 4.29A. Figure 4.29C shows that, like for 100µM carbenoxolone, 10µM carbenoxolone 
also increased the rate of forskolin-stimulated HCO3
-
 flux in normocapnia from 4.9 ± 0.7mM 
HCO3
-
 min
-1
 to 11.4 ± 1.0mM HCO3
-
 min
-1
 (p<0.05; n=3) suggesting carbenoxolone 
modulates cAMP-regulated HCO3
-
 transport either directly, or via offsite targets. In the 
presence of carbenoxolone, hypercapnia caused a 1.8 ± 0.2 fold increase in the magnitude of 
the forskolin-stimulated intracellular acidification (p<0.05; n=3; figs. 4.29B and D) and a 2.9 
± 0.2 fold increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.05; n=3; figs. 4.29C 
and E). However, in control experiments performed on the same day, hypercapnia caused a 
significantly greater 2.5 ± 0.2 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification (p<0.001 vs. normocapnia; p<0.05 vs. carbenoxolone treated cells; 
n=3; fig. 4.29D), and a significantly greater 7.1 ± 0.7 fold increase in the rate of forskolin-
stimulated HCO3
-
 flux (p<0.001 vs. normocapnia; p<0.001 vs. carbenoxolone treated cells; 
n=3; fig. 4.29E). These results are very similar to those experiments which used probenecid 
to inhibit pannexins. Although hypercapnia was able to augment HCO3
-
 flux in 
carbenoxolone treated cells, the effect of hypercapnia has been significantly diminished when 
compared to untreated cells. This supports the hypothesis that panx-1 expressed in Calu-3 
cells may be sensitive to changes in CO2 and therefore may induce the release of signalling 
molecules, such as ATP, that mediate the  effects of hypercapnia on cAMP-regulated HCO3
-
 
transport in Calu-3 cells. 
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Figure 4.29: A low concentration of carbenxolone reduces the extent by which hypercapnia 
enhances the forskolin-stimulated intracellular acidification. (A) shows a representative 
experiment in which Calu-3 cells were stimulated with 5µM forskolin alone or 5µM forskolin in the 
presence of carbenoxolone (10µM) in normocapnia and hypercapnia. The effect of carbenoxolone on 
the delta pH (B) and HCO3
-
 flux (C) resulting from forskolin stimulation is summarized. ** = 
significant effect of hypercapnia (p<0.01; *** = p<0.001); † = significant effect of carbenoxolone 
(p<0.05). The effect of carbenoxolone on the delta pH and HCO3
-
 flux resulting from forskolin 
stimulation was also compared to control experiments performed on the same day as shown in (D) 
and (E) respectively. ** = significant effect of hypercapnia (p<0.01; *** = p<0.001). Data represents 
mean ± S.E.M.; n=3 for each. 
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Seminario-Vidal et al. (2011) showed that hypotonicity-induced ATP release in airway 
epithelia occurred via pannexin-1 and was dependent on activation of the mechanosensitive 
channel TRPV4 and activation of Rho Kinase, implying TRPV4 channels activated Rho 
Kinase to induce downstream activation of pannexin-1. To determine whether hypercapnia 
may elicit a pannexin-1-dependent ATP release via a similar signalling mechanism, cells 
were preincubated and perfused with either the TRPV4 inhibitor HC067047 or the Rho 
Kinase inhibitor H-1152. However, as shown in figure 4.30, neither of these inhibitors 
prevented the CO2-mediated increase in either the magnitude of forskolin-stimulated 
intracellular acidification, or the rate of forskolin-stimulated HCO3
-
 flux. Thus, if hypercapnia 
does activate pannexin-1-dependent ATP release, it is not via a TRPV4/Rho kinase signalling 
pathway. 
  
Figure 4.30: Hypercapnia does not mediate its effects on via activation of TRPV4 channels and 
Rho Kinase signalling. Calu-3 cells were stimulated with 5µM forskolin in the presence or absence 
of H-1152 (1µM) or HC067047 (10µM) in normocapnia and hypercapnia. The delta pH (A) and 
HCO3
-
 flux (B) resulting from forskolin stimulation are summarized. *** = significant effect of 
hypercapnia (p<0.001); Data represents mean ± S.E.M.; n=3 for each. 
 
4.4.3. Exocytosis of ATP-containing vesicles 
Next, other reported ATP release pathways were also investigated to assess whether these had 
a role in the proposed CO2-induced ATP release in Calu-3 cells. O'Grady et al. (2013), 
demonstrated that exposure of human bronchial epithelial cells to the spores of the allergen 
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Alternaria alternata caused an ATP release due to Ca
2+
-dependent exocytosis of ATP-
containing vesicles. This study showed brefeldin A, an agent which has been reported to 
disrupt the microtubule cytoskeleton network (Alvarez and Sztul, 1999) prevented vesicle 
trafficking and consequentially ATP release in response to Alternaria exposure. Therefore, 
the effect of hypercapnia on the forskolin-stimulated intracellular acidification was assessed 
in cells which had been preincubated with brefeldin A and an example experiment of 
brefeldin A treated cells is shown in figure 4.31A. In control experiments performed on the 
same day, hypercapnia increased the magnitude of the forskolin-stimulated intracellular 
acidification 1.9 ± 0.1 fold (p<0.001; n=3; fig. 4.31B) and the rate of forskolin-stimulated 
HCO3
-
 flux 5.0 ± 0.4 fold (p<0.001; n=3; fig. 4.31C). Pretreatment with brefeldin A did not 
prevent the CO2-mediated increase of the forskolin-stimulated intracellular acidification. In 
these experiments, hypercapnia increased the magnitude of the forskolin-stimulated 
intracellular acidification 2.1 ± 0.1 fold (p<0.001; n=3; fig. 4.31B) and the rate of forskolin-
stimulated HCO3
-
 flux 4.7 ± 0.2 fold (p<0.001; n=3; fig. 4.31C). These data suggest that if 
CO2 does induce an ATP release from Calu-3 cells, it is not via exocytosis of ATP-containing 
vesicles. 
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Figure 4.31: Brefeldin A does not block the effects of hypercapnia on the forskolin-stimulated 
intracellular acidification. (A) shows a representative experiment in which Calu-3 cells were 
preincubated for one hour with Brefeldin A (5µg/ml) and stimulated with 5µM forskolin in 
normocapnia and hypercapnia. The delta pH (B) and HCO3
-
 flux (C) resulting from forskolin 
stimulation are summarized. ** = significant effect of hypercapnia (p<0.01; *** = p<0.001); Data 
represents mean ± S.E.M.; n=3 for each. 
 
5.4.4. P-glycoproteins 
P-glycoprotein-1 - also known as multidrug resistance protein 1 (MDR1) or ABC subfamily 
B member 1 (ABCB1) - is an ABC transporter with a primary role of transporting 
xenobiotics out of cells. However, they have also been reported to have ATP transporting 
capacities (Abraham et al., 1993; Roman et al., 1997). Thus if hypercapnia does stimulate 
ATP release in Calu-3 cells, it is possible it is via activation of P-glycoproteins. Therefore, 
cells were treated with elacridar, a P-glycoprotein inhibitor which is unable to inhibit MRP 
transporters (Evers et al., 2000), and the response to forskolin was assessed in normocapnia 
and hypercapnia as shown in figure 4.32A. Elacridar treatment had no effect on the response 
to forskolin in normocapnia as shown in figures 4.32B and 4.32C. In control experiments, 
hypercapnia caused a 2.0 ± 0.2 fold increase in the magnitude of the forskolin-stimulated 
intracellular acidification (p<0.001; n=3; fig. 4.32D) and increased the rate of forskolin-
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stimulated HCO3
-
 flux 5.6 ± 1.0 fold (p<0.001; n=3; fig. 4.32E). Elacridar treatment had no 
effect on the CO2-mediated change in forskolin-stimulated intracellular acidification. In the 
presence of elacridar, hypercapnia caused a 1.8 ± 0.1 fold increase in the magnitude of the 
forskolin-stimulated intracellular acidification (p<0.001; n=4; fig. 4.32D) and increased the 
rate of forskolin-stimulated HCO3
-
 flux 3.5 ± 0.4 fold (p<0.05; n=4; fig. 4.32E). Therefore, 
these data show that any putative CO2-induced ATP release was not mediated via P-
glycoproteins.  
  
Figure 4.32: Inhibition of P-glycoproteins does not block the effects of hypercapnia on the 
forskolin-stimulated intracellular acidification. (A) shows a representative experiment in which 
Calu-3 cells were stimulated with 5µM forskolin alone or 5µM forskolin in the presence of elacradir 
(500nM) in normocapnia and hypercapnia. The effect of elacradir on the delta pH (B) and HCO3
-
 flux 
(C) resulting from forskolin stimulation is summarized. * = significant effect of hypercapnia (p<0.05; 
*** = p<0.001). The effect of elacradir on the delta pH and HCO3
-
 flux resulting from forskolin 
stimulation was also compared to control experiments performed on the same day as shown in (D) 
and (E) respectively. * = significant effect of hypercapnia (p<0.05; *** = p<0.001). Data represents 
mean ± S.E.M.; n=3 for controls and n=4 for elacradir treated cells. 
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In an attempt to measure extracellular ATP to assess whether hypercapnia induced an ATP 
release in Calu-3 cells, cells were incubated in pregassed, modified high Cl
-
 Krebs solution in 
which NaCl, KCl, MgCl2 and CaCl2 were replaced with equimolar mannitol. The reason for 
this modification was because the luciferase assay used to detect ATP was highly sensitive to 
salt. After 20 minutes incubation, the apical and basolateral solutions were collected and ATP 
content in the fluid was measured. Figure 4.33 summarizes the data. In normocapnia, the 
amount of ATP in the apical and basolateral solutions was 23.4 ± 11.3nM (n=3) and 73.0 ± 
45.8nM (n=3) respectively. These levels were unaffected by probenecid treatment (apical 
ATP = 43.6 ± 25.1nM (p>0.05; n=3); basolateral ATP = 143.3 ± 106.9nM (p>0.05; n=3)). In 
hypercapnia, the amount of apical ATP was 11.6 ± 2.7nM (p>0.05 vs normocapnia; n=3) and 
the amount of basolateral ATP was 8.0 ± 2.0nM (p>0.05 vs normocapnia). Again there was 
no effect of probenecid on the ATP measured in hypercapnic conditions. Together, these data 
suggest hypercapnia does not elicit an ATP release from probenecid-sensitive transporters in 
Calu-3 cells. 
 
Figure 4.33: Acute hypercapnia does not increase the extracellular concentration of ATP. Calu-3 
cells were incubated in modified Krebs solutions that were buffered to pH 7.4 for each CO2 
concentration and contained either 0.05% DMSO or 500µM probenecid. After 20 minutes incubation, 
the apical and basolateral fluid was collected and ATP concentration measured using a luciferase 
assay. Data represents mean ± S.E.M., n=3 for each. 
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4.5. Other potential targets for CO2 signalling 
4.5.4. NADPH Oxidase 
It has been shown that dual oxidase, a member of the NAPPH Oxidase family, is activated by 
an acid load (i.e. hypercapnia) via a Ca
2+
-dependent mechanism (Seidler, 2013). Activation 
of dual oxidase causes an increased production of H2O2 (Ameziane-El-Hassani et al., 2005) 
which may impact upon cAMP-regulated HCO3
-
 transport. To test the role of dual oxidase in 
mediating the response to hypercapnia, Calu-3 cells were treated with the dual oxidase 
inhibitor DPI as shown in figure 4.34A. DPI treatment caused no significant changes to the 
forskolin-stimulated intracellular acidification in normocapnia as shown in figs 4.34B and C. 
In control experiments, hypercapnia caused a 1.9 ± 0.1 fold increase in the magnitude of the 
forskolin-induced acidification (p<0.01; n=3; fig. 4.34D) and increased the rate of forskolin-
stimulated HCO3
-
 flux 6.6 ± 0.5 fold (p<0.01; n=3; fig. 4.34E). In DPI treated cells, 
hypercapnia caused a 1.6 ± 0.1 fold increase in the magnitude of the forskolin-induced 
acidification (p<0.05; n=3; fig. 4.34B and D). However, although hypercapnia induced a 3.0 
± 0.5 fold increase in the rate of forskolin-stimulated HCO3
-
 flux (p<0.05; n=3; fig. 4.34E), 
this was significantly lower than seen in control experiments (p<0.01; n=3) and suggests that 
dual oxidase inhibition may prevent the effects of hypercapnia on cAMP-regulated HCO3
-
 
transport.  
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Figure 4.34: Dual oxidase inhibition reduces the effects of hypercapnia on the forskolin-
stimulated intracellular acidification. (A) shows a representative experiment in which Calu-3 cells 
were stimulated with 5µM forskolin alone or 5µM forskolin in the presence of DPI (10µM) in 
normocapnia and hypercapnia. The effect of DPI on the delta pH (B) and HCO3
-
 flux (C) resulting 
from forskolin stimulation is summarized. * = significant effect of hypercapnia (p<0.05). The effect 
of DPI on the delta pH and HCO3
-
 flux resulting from forskolin stimulation was also compared to 
control experiments performed on the same day as shown in (D) and (E) respectively. * = significant 
effect of hypercapnia (p<0.05; ** = p<0.01 *** = p<0.001). Data represents mean ± S.E.M.; n=3 for 
each. 
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4.6. Discussion 
4.6.1. Indications that acute hypercapnia induced an IP3-dependent Ca
2+
 release to 
modulate cAMP signalling in Calu-3 cells 
As described in chapter 3, hypercapnia altered cAMP-dependent HCO3
-
 transport in Calu-3 
cells but this was not due to a change in the activity in cAMP-stimulated CFTR or NBC, but 
appeared to be due to CO2-modulation of basal NBC activity and/or basolateral Na
+
/K
+
-
ATPase. The present chapter aimed to investigate whether there were upstream signalling 
mechanisms involved in transduction of the CO2 signal to modulate cAMP signalling. The 
particular emphasis was on the role of Ca
2+
 signalling, given that CO2 has been found to alter 
intracellular Ca
2+
 levels to mediate effects on Na
+
/K
+
-ATPase activity in rat alveolar type II 
cells (Briva et al., 2007; Vadasz et al., 2008) and cAMP signalling in renal epithelia (Cook et 
al., 2012). Here, I have shown that the effects of hypercapnia on cAMP-dependent HCO3
-
 
transport was dependent on PLC-mediated mobilization of intracellular Ca
2+
 as the effect of 
hypercapnia on cAMP-regulated HCO3
-
 transport was eliminated in the presence of BAPTA-
AM, the PLC inhibitor U73122 and the IP3R inhibitor, 2-APB. Furthermore, BAPTA-AM 
and 2-APB also abolished the effect of hypercapnia on forskolin-stimulated elevations in 
[cAMP]i suggesting IP3-dependent Ca
2+
 release mediates the effect of hypercapnia on tmAC 
and/or MRPs to reduce [cAMP]i. These findings support a similar mechanism to that already 
described by our laboratory (Cook et al., 2012). The effect of BAPTA-AM and 2-APB on 
[cAMP]i was interesting in that these agents did not alleviate the CO2-induced reduction in 
[cAMP]i but rather appeared to bring down [cAMP]i in normocapnia to that of the level seen 
in hypercapnia. These data perhaps imply that intracellular Ca
2+
 signalling is required to 
generate maximal increases in forskolin-stimulated [cAMP]i and would support findings by 
Tian and Laychock (2001) who demonstrated that BAPTA-AM reduced forskolin-stimulated 
cAMP levels in rat islet β cells. Lee and Foskett (2010) have also shown that forskolin 
stimulated an increase in [Ca
2+
]i in pig serous cells which may underlie a mechanism by 
which tmAC are able to become fully activate by forskolin. The effects of BAPTA-AM on 
forskolin-stimulated HCO3
-
 transport were similar in that  BAPTA-AM did not simply bring 
the values measured in 10% CO2 down to the 5% CO2 level; rather BAPTA-AM increased 
the magnitude of the pH change measured in 5% to the 10% level. Furthermore, as well as 
reducing the rate of forskolin-stimulated HCO3
-
 flux in 10% CO2, BAPTA-AM also 
increased the rate of forskolin-stimulated HCO3
-
 flux in normocapnia so that the two values 
in BAPTA-AM treated cells were effectively at an intermediate level between 5% and 10% 
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control values (although these values were not statistically significantly different to control 
values). Unfortunately, it wasn’t tested whether BAPTA-AM, U73122 or 2-APB were able to 
eliminate the effect of hypercapnia on forskolin-stimulated Isc and these would be useful 
experiments to perform to further establish whether CO2 mediates its effects on cAMP 
signalling via changes in [Ca
2+
]i. Hypercapnia was still able to modulate forskolin-stimulated 
intracellular acidification in the absence of extracellular Ca
2+
 thus demonstrating that the 
CO2-induced changes in intracellular Ca
2+
 were due to mobilization of intracellular Ca
2+
 and 
not dependent on extracellular Ca
2+
. This supports findings from Bouyer et al. (2003) who 
also showed no requirement for extracellular Ca
2+
 in CO2-induced changes in intracellular 
Ca
2+
.  
Further evidence that the effect of hypercapnia on the cAMP-stimulated intracellular 
acidification is dependent on changes in intracellular Ca
2+
 were from the findings that 
increasing intracellular Ca
2+
 in normocapnia mimicked the effect of hypercapnia. The Ca
2+
 
agonists carbachol, ATP and UTP all significantly enhanced the magnitude and the rate of the 
forskolin-stimulated intracellular acidification in normocapnia although this was not quite as 
pronounced as the effect of acute hypercapnia. Inhibition of cholinergic receptors or 
purinergic receptors prevented the effect of carbachol and ATP respectively. These findings 
suggested that increases in intracellular Ca
2+
 due to activation of Gq coupled receptors and 
subsequent PLC-dependent IP3-mediated Ca
2+
 release underlied the effect of hypercapnia. 
The effects of carbachol and ATP were both dependent on the membrane on to which they 
were applied with basolateral carbachol or basolateral ATP producing a much greater effect 
than apical carbachol or apical ATP. These findings imply that either Calu-3 cells express 
cholinergic and purinergic receptors predominantly at the basolateral membrane or that only 
increases in Ca
2+
 at the basolateral pole is able to mimic the effect of hypercapnia, possibly 
due to the fact that the apparent CO2-sensitive transporters, the Na
+
/K
+
-ATPase and NBC, are 
also expressed at the basolateral membrane and may be affected by a localized increase in 
Ca
2+
.  A common finding in experiments in which either intracellular or extracellular Ca
2+
 
was reduced was the inability of Calu-3 cells to recover intracellular pH from CO2-induced 
acidosis. As discussed in chapter 3, hypercapnia caused an upregulation of NBC and a 
reduction in AE2 activity to favour an increase in HCO3
-
 accumulation across the basolateral 
membrane. This appears to be the mechanism for pHi recovery in Calu-3 cells after acidosis. 
Therefore, these results suggest that CO2-induced upregulation of NBC activity is Ca
2+
 
dependent. Consistent with this hypothesis, Thornell et al. (2012) demonstrated that NBCe1 
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activity was enhanced by both PIP2 and IP3 injection into Xenopus oocytes with PIP2-induced 
NBCe1 activation blocked by PLC inhibition with U73122. Furthermore, upregulation of 
NBCe1 activity was also sensitive to BAPTA-AM. Therefore, NBCe1 activity appears to be 
regulated by [Ca
2+
]i and, as discussed in chapter 3, CO2-induced upregulation of NBC 
activity under basal conditions may underlie the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. Therefore, should CO2 regulate basal NBC activity due 
to increases in [Ca
2+
]i, it would explain why inhibition of Ca
2+
 signalling negates the effect of 
hypercapnia on forskolin-stimulated intracellular acidification. Furthermore, it would also 
explain why, in conditions where changes in [Ca
2+
]i were prevented, recovery of pHi from 
CO2-induced acidosis was impaired.  
In a similar fashion, the Ca
2+
 mobilizing agonists endothelin, angiotensin II and 5-HT have 
all been shown to activate Na
+
/K
+
-ATPase in a variety of cell types whilst addition of 
exogenous phospholipase C also upregulated Na
+
/K
+
-ATPase activity in rat hepatic cells 
(Lynch et al., 1986; Middleton et al., 1990; Gupta et al., 1991). Yuan et al. (2005) have also 
shown that Na
+
/K
+
-ATPase can physically interact with both PLC and IP3 receptors implying 
any Ca
2+
-mediated modulation of Na
+
/K
+
-ATPase is highly localized in a subcellular 
microdomain. Thus we can speculate that hypercapnia increases IP3-dependent Ca
2+
 release 
at the basolateral pole of Calu-3 cells to activate Na
+
/K
+
-ATPase which, with its reported H
+
 
transporting capacities, can contribute to changes in cytosolic pH. Thus, inhibition of 
increases in Ca
2+
 with BAPTA-AM, U73122 and 2-APB, or Na
+
/K
+
-ATPase with ouabain, 
eliminates the effect of hypercapnia. It is worth noting that it has been reported that ouabain 
can increase intracellular Ca
2+
 in cardiac myocytes (Tian et al., 2001) although this appears to 
be via a MAPK-dependent pathway, which would not be predicted to mimic the effect of 
hypercapnia. In summary, these findings suggest acute hypercapnia induces the release of Gq 
coupled receptor agonists, potentially either ATP, UTP or both, which signal to alter cAMP-
regulated HCO3
-
 transport. However, it is possible that CO2 may not induce the release of 
either agents and simply the effect of ATP and UTP is due to a purinergic signalling pathway 
that modulates HCO3
-
 transport via a different mechanism to hypercapnia. Indeed, addition of 
ATP alone does produce a Ca
2+
-dependent, transient acidification and therefore what simply 
may be being observed is an additive effect of ATP and forskolin such that the resulting 
acidification is augmented and therefore appears to mimic the effect of acute hypercapnia.  
My work is the first work to assess the effects of hypercapnia on the expression of IRBIT, a 
recently discovered regulator of HCO3- transport. Acute hypercapnia appeared to reduce the 
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expression of p-IRBIT, therefore implying that the amount of IRBIT capable of binding to 
IP3 receptors was reduced, suggesting elevations in IP3 may have displaced some of the IP3R-
bound IRBIT. This, therefore, supports the hypothesis that hypercapnia can induce a PLC-
dependent increase in IP3 in Calu-3 cells of which one major effect would be to increase the 
amount of unbound IRBIT to contribute to CO2-induced changes in HCO3
-
 transport. 
However, acute hypercapnia did not increase the amount of non-phosphorylated IRBIT 
suggesting hypercapnia may induce degradation of p-IRBIT rather than dephosphorylation. 
Thus, although CO2 may reduce p-IRBIT due to an elevation in IP3, this does not translate to 
an increased expression of IRBIT capable of binding to and regulating cAMP-regulated 
HCO3
-
 transporters.  Further investigations into the role of IRBIT in cAMP-regulated HCO3- 
secretion in Calu-3 cells is important and generation of IRBIT KO cells should provide 
valuable insights into the role of this protein in coordinating HCO3
-
 transport in these cells as 
well as its sensitivity to altered CO2 environments. 
 
4.6.2. How do potential modulations of Ca
2+
 affect cAMP signalling? 
Should hypercapnia stimulate an IP3-dependent Ca
2+
 release in Calu-3 cells, the link between 
CO2-induced elevations in [Ca
2+
]i and CO2-induced reduction in [cAMP]i and subsequent 
modulation of cAMP-regulated HCO3
-
 transport must be determined. The data from chapter 3 
implicated CO2 caused a reduction in forskolin-stimulated cAMP levels due to reductions in 
tmAC activity and/or activation of MRP-mediated cAMP efflux. Thus, one must consider 
that tmAC and MRPs are regulated by Ca
2+
 and thus sensitive to CO2-induced changes in 
[Ca
2+
]i. Of the 9 isoforms of tmACs, it has been shown that AC5 and AC6 are primarily 
inhibited by elevations in [Ca
2+
]i (Cooper et al., 1998; Hu et al., 2002) and therefore a 
depression of the activity of these enzymes by Ca
2+
 could underlie the effect of acute 
hypercapnia on forskolin-stimulated elevations in [cAMP]i. For comprehensive reviews of 
AC regulation see Hanoune and Defer (2001) and Cooper (2003). Therefore, determining 
which tmAC isoforms are expressed in Calu-3 cells will be important to understand further 
the influence of Ca
2+
 signalling on tmAC-dependent cAMP production. The regulation of 
tmAC by Ca
2+
 has been well described but what is less well understood is the regulation of 
MRPs by Ca
2+
. Very little evidence exists on the regulation of MRPs directly by Ca
2+
 but 
Gekeler et al. (1995) describe that inhibition of PKC inhibits MRP in MRP overexpressing 
human leukaemia cells suggesting that PKC is able to regulate MRPs. Therefore, should CO2 
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activate PLC-dependent PIP2 hydrolysis to induce IP3-dependent Ca
2+
 release and activation 
of DAG, the resulting activation of PKC may modulate MRPs in Calu-3 cells such that 
cAMP efflux is enhanced. 
 
4.6.3. Indications that acute hypercapnia does not induce an IP3-dependent Ca
2+
 
release to modulate cAMP signalling in Calu-3 cells 
Although the effects of hypercapnia on cAMP-regulated HCO3
-
 transport were inhibited by 
BAPTA-AM, U73122 and 2-APB, and therefore suggested a CO2-induced IP3-dependent 
Ca
2+
 release was involved in mediating the effects of hypercapnia, several experiments 
provided evidence that this wasn’t the case. Perhaps most importantly, depletion of the ER 
Ca
2+
 stores by exposing cells to thapsigargin in the absence of extracellular Ca
2+
, did not 
eliminate the effect of hypercapnia, thus implying IP3-dependent Ca
2+
 release was not 
involved in mediating the CO2 effect. Therefore, should hypercapnia induce a rise in [Ca
2+
]i, 
this appears to be from a thapsigargin-insensitive store and thus cannot be the ER. 
Interestingly, under these conditions, one must consider that socAMPs, as proposed by 
Lefkimmiatis et al. (2009), may be activated should Calu-3 cells be capable of signalling in 
this fashion, which may contribute to changes in cAMP-regulated HCO3
-
 transport and 
potentially mask an effect of ER depletion of Ca
2+
. However, when attempting to measure 
intracellular Ca
2+
 by loading cells with the Ca
2+
-sensitive dye Fura-2-AM, it was found that 
hypercapnia did not increase intracellular Ca
2+
 and thus argued against a CO2-induced IP3-
dependent Ca
2+
 release. Therefore, how does one explain the findings from experiments 
involving BAPTA-AM, U73122 and 2-APB? As with any pharmacological inhibitors, it is 
always difficult to be certain of their targets. Although U73122 is widely reported as an 
inhibitor of PLC (Bleasdale et al., 1990; Jin et al., 1994), Klein et al. (2011) demonstrated 
that U73122 actually enhanced PIP2 hydrolysis by human PLCβ and γ whilst Mogami et al. 
(1997) have shown U73122 caused a Ca
2+
 release in pancreatic acinar cells arguing against 
its function as an inhibitor of PLC-dependent Ca
2+
 mobilization. Similarly, 2-APB has been 
suggested to be an ineffective inhibitor of IP3R with Gregory et al. (2001) demonstrating 2-
APB was unable to prevent IP3-induced Ca
2+
 release in rat hepatocytes whilst offsite effects, 
including inhibition of Ca
2+
 release activated current (ICRAC) (Prakriya and Lewis, 2001) and 
inhibition of Cx26 and 32 (Tao and Harris, 2007) have also been reported. Therefore, one 
must consider that U73122 and 2-APB may not be having the desired effect on Ca
2+
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homeostasis and consequentially, genetic ablation of either PLC or IP3Rs need to be 
performed to assess whether hypercapnia still mediates its effects in these genetically 
modified cells. It is worth noting that the cells used for intracellular Ca
2+
 measurements were 
grown non-polarised on glass as opposed to a polarised monolayer on plastic which will 
likely affect the cell properties, protein expression profile and thus potentially impair their 
CO2 sensitivity and/or Ca
2+
 release mechanisms. I have shown that Calu-3 cells grown on 
coverslips exhibit identical recovery in pHi from CO2-induced acidosis as polarized cells 
suggesting that non-polarized cells do respond to acute hypercapnia in a similar fashion to 
polarized cells yet whether the molecular signalling mechanisms remain the same is yet to be 
determined. Furthermore, should CO2 induce a highly localized increase in intracellular Ca
2+
, 
this assay may not be sensitive enough to detect this increase. Therefore, although the data 
from these experiments imply elevations in CO2 did not cause Ca
2+
 mobilization in Calu-3 
cells, more experiments are needed to ensure this is the case; primarily being able to measure 
changes in intracellular Ca
2+
 on polarized Calu-3 cells.  
As discussed previously, addition of exogenous ATP was found to mimic the effect of 
hypercapnia and suggested CO2 may induce a release of ATP to activate IP3-dependent Ca
2+
 
release via activation of purinergic receptors – a mechanism that has already been reported by 
Huckstepp et al. (2010b) in rat brain tissue. However, several experiments suggested this was 
not the case. Firstly, a non-specific purinergic receptor, suramin, was unable to block the 
effect of hypercapnia on the forskolin-stimulated intracellular acidification implying that the 
purinergic receptors were not involved in transducing the CO2 signal. Secondly, addition of 
exogenous apyrase to break down ATP into ADP + Pi also was unable to block the effect of 
hypercapnia on the forskolin-stimulated intracellular acidification, implying that extracellular 
ATP is not required for transducing the CO2 signal. One limitation of this experiment, 
however, was that apyrase was added over 20 minutes after cells had been exposed to 
hypercapnia due to limited availability of the enzyme. If an ATP release was occurring in 
response to hypercapnia, it would be likely that, after several minutes in hypercapnia, a high 
amount of ATP would have already been released into the extracellular medium and as a 
result addition of apyrase at this point may not be sufficient to markedly reduce total 
extracellular ATP levels. Thus, it would be interesting to see the effects of adding apyrase 
prior to exposing the cells to hypercapnia as these conditions would likely favour greater 
ATP metabolism. Finally, an ATP luciferase assay revealed that there was no measureable 
increase in extracellular ATP in cells exposed to acute hypercapnia. Again, these experiments 
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were limited due to the fact that the assay was highly sensitive to high salt concentrations 
and, as a result, the high Cl
-
 Krebs solution had to be modified to eliminate NaCl, KCl, 
CaCl2, and MgCl2 to be replaced with mannitol. This non-physiological solution could have 
implications for the cells ability to respond to CO2 and/or release ATP into the extracellular 
medium. Furthermore, extra care had to be taken when handling the plate in which the cells 
were located. Movement of fluid flowing over the surface of the cells does induce a 
mechanosensitive ATP release (Button et al., 2007) and it is highly unlikely that the degree 
of mechanical stimulation would have been identical for all samples. Therefore the large 
variation in ATP levels measured, particularly in normocapnia, could be attributed to 
mechanostimualation of cells during handling of the plate. 
Although exogenous ATP mimicked the effect of hypercapnia in normocapnia, there was 
little evidence to suggest that ATP release was occurring from these cells. One alternative 
was that CO2 was inducing an ATP release but it was being rapidly broken down into 
adenosine by extracellular 5’-nucleotidases and it was adenosine signalling that was actually 
stimulating changes in cAMP-regulated HCO3
-
 transport in hypercapnia. This would explain 
the lack of effect of apyrase and suramin on the effects of hypercapnia. However, inhibition 
of adenosine receptors using CGS-15943 was also unable to block the effect of hypercapnia 
on the forskolin-stimulated intracellular acidification, suggesting that adenosine signalling 
also does not underlie the effects of hypercapnia. 
Experiments in which known release pathways of ATP were inhibited provided further 
insights into whether CO2 induced an ATP release. Of the three connexin inhibitors tested, 
only carbenoxolone (100µM) had an effect on cAMP-regulated HCO3
-
 transport. 
Carbenoxolone abolished the effect of hypercapnia on the forskolin-stimulated intracellular 
acidification though, interestingly, similar to what was observed in BAPTA-AM treated cells, 
carbenoxolone increased both the forskolin-stimulated intracellular acidification in 
normocapnia and reduced the forskolin-stimulated intracellular acidification in hypercapnia 
to produce an intermediate value between the control values measured in normocapnia and 
hypercapnia. Also similar to BAPTA-AM was that carbenoxolone prevented pHi recovery 
from CO2-induced acidosis. Neither CoCl2 nor proadifen had the same effects as 
carbenoxolone which suggested that CO2 was not inducing an ATP release via connexin 
hemichannels and the effect of carbenoxolone was actually an offsite target. Given the similar 
effects of BAPTA-AM, it suggests that carbenoxolone may be able to influence intracellular 
Ca
2+
 levels which would support findings from both Bramley et al. (2011) who reported that 
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100µM carbenoxolone blocked increases in intracellular Ca
2+
 in retinal ganglion cells and 
Rouach et al. (2003) who demonstrated that carbenoxolone prevented Ca
2+
 oscillations in 
neuronal cells isolated from rat hippocampus. In Calu-3 cells, it has been reported that both 
Cx32 and Cx43 are expressed. Interestingly, Huckstepp et al. (2010a) identified that Cx43 is 
actually insensitive to CO2 and therefore suggest that CO2-induced activation of connexin-
dependent ATP release may be unlikely in Calu-3 cells given the members of the connexin 
family expressed in these cells. 
Similar to connexins, the related family of proteins, the pannexins, have also been implicated 
in ATP transport. End-point PCR experiments revealed Calu-3 cells expressed pannexin-1 
and therefore possessed another potentially CO2-sensitive transporter. Although hypercapnia 
still significantly increased the rate of forskolin-stimulated HCO3
-
 flux in the presence of the 
non-specific pannexin inhibitor, probenecid, or a low concentration of carbenoxolone 
(10µM), the extent of this increase was significantly smaller than in control experiments and 
suggested pannexins may have a minor role in mediating the CO2 effect. However, more 
specific inhibitors of pannexins are needed before this can be fully concluded. I have already 
discussed potential offsite targets of carbenoxolone and these may still occur at the lower 
concentration of the drug. Probenecid has numerous offsite targets including the multidrug 
resistance proteins (MRPs) (Gollapudi et al., 1997) and, in chapter 3, it was shown that 
inhibition of MRPs blocked the effect of hypercapnia and therefore probenecid may be 
inducing similar but less potent effects here. Experiments on cells that have had panx-1 
genetically knocked out would provide further insights into whether panx-1 is CO2-sensitive 
and is involved in the effect of acute hypercapnia on cAMP-regulated HCO3
-
 transport. 
 
In summary, the transduction of the CO2 signal to modulate cAMP-regulated HCO3
-
 transport 
appears to be dependent on PLC-induced Ca
2+
 mobilization. Yet how CO2 is able to do this 
still remains unresolved. The data suggests CO2 may induce the release of a Gq coupled 
receptor agonist in order to stimulate Ca
2+
 mobilization at the basolateral pole but the 
evidence for the release of the prime candidate, ATP, is minimal. As a result, investigations 
into whether hypercapnia can stimulate the release of other endogenous cell signalling 
molecules need to be performed. For example, hypercapnia has been shown to trigger the 
release of prostaglandin E2 (PGE2) from human endothelial cells (Kovecs 2001) and Palmer 
et al., (2006) have demonstrated increases in Isc in Calu-3 cells in response PGE2 treatment, as 
 177 
 
well as expression of prostaglandin receptors at the mRNA level showing extracellular 
prostaglandins elicit physiological responses in Calu-3 cells. Interestingly, the PGE2 receptor 
EP3 has been shown to regulate adenylyl cyclase activity via activation of the PLC/Ca
2+
 
signalling pathway (Yamaoka et al., 2009) and indicating prostaglandins can mediate 
crosstalk between cAMP and Ca
2+
 signalling. Similarly, Scheckenbach et al. (2011) 
demonstrated that Calu-3 cells express the PGE2 receptor EP4 and that adenosine-stimulated 
CFTR activity was dependent on PGE2 signalling, mediated, in part, by activation of gap 
junctional intercellular communication. Also of interest is that prostaglandins are transported 
by MRP transporters (Reid et al., 2003), which may explain why inhibition of these 
transporters using MK-571 is able to prevent the effect of hypercapnia on the forskolin-
stimulated intracellular acidification. Thus, investigations into whether hypercapnia can 
stimulate the release of other endogenous Ca
2+
 mobilizing agents should form the basis of 
future work into this area. 
The major findings of this chapter are summarized below and in figure 4.35. 
 The effects of acute hypercapnia on cAMP-regulated HCO3
-
 transport were dependent 
on PLC-dependent mobilization of intracellular Ca
2+
. 
 The effects of acute hypercapnia were mimicked by the Ca2+ elevating agonists 
carbachol, ATP and UTP but there was little evidence to suggest CO2 is inducing an 
ATP release to signal to cells as suggested in other tissue (Huckstepp et al., 2010b). 
 Potentially, CO2 may induce the release of an unidentified endogenous Ca
2+
 elevating 
agent with pannexins possibly being involved in this release process. 
 Acute hypercapnia appeared to reduce expression of p-IRBIT suggesting a reduction 
in IRBIT binding to IP3 receptors which could be a result of elevated levels of 
cytosolic IP3. 
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Figure 4.35: Proposed mechanism for CO2-induced mobilization of Ca
2+
 and the potential 
effects this has on cAMP-regulated HCO3
-
 transport. CO2 potentially causes a pannexin-dependent 
release of an endogenous Ca
2+
 elevating agent which activates cell surface receptors to increase IP3 
formation and induce Ca
2+
 release via activation of IP3Rs. Elevations in intracellular Ca
2+
 may impact 
upon cAMP signalling due to inhibition of tmAC and/or activation of MRP-dependent cAMP efflux 
as well as modulating the activity of Na
+
/K
+
-ATPase, contributing to observed effects on cAMP-
regulated HCO3
-
 transport. 
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Chapter 5:  The effects of chronic hypercapnia on Calu-3 cells 
5.1.  Introduction 
The previous chapters focussed on the effects of acute hypercapnia (20-30 minutes) on Calu-
3 cell physiology, in particular cAMP-regulated HCO3
-
 transport. Over this time frame, one 
would predict that the effects of hypercapnia were a direct effect on key cell signalling 
components, as opposed to more long term effects such as CO2-induced changes in gene 
expression. Given a large body of evidence focuses on the role of CO2 impacting upon cell 
signalling pathways, less is understood on the effect of chronic hypercapnia on animal 
physiology. Older studies have revealed that chronic hypercapnia affected body electrolyte 
homeostasis in dogs with 11-13% CO2 causing an increase in blood [HCO3
-
], a decrease in 
[Cl
-
] and an increased [NH4
+
] in urine; mechanisms to compensate for the respiratory acidosis 
(Polak et al., 1961). Studies on guinea pigs have shown that chronic hypercapnia (15% CO2) 
caused a drop in body temperature due to an increased vasodilation of peripheral blood 
vessels and increased body weight, blood corticosteroids and blood fatty acids concentration 
as well a decrease in the number of lymphocytes, demonstrating that chronic CO2 can induce 
a whole host of different physiological changes in mammals (Schaefer et al., 1968; Schaefer 
et al., 1975). At the molecular level, Vohwinkel et al. (2011) demonstrated that exposure of 
A549 cells or N12 lung fibroblasts to prolonged 60mmHg CO2 (~8% CO2) or 120mmHg CO2 
(~16% CO2) caused a significant reduction in cell proliferation due to a slower cell cycle, 
implicating chronic hypercapnia can impair an important aspect of cell physiology. In the 
lungs, Das et al. (2009) showed chronic hypercapnia increased the expression of α smooth 
muscle actin which the researchers suggested was involved in the formation of the higher 
number of alveolar buds observed in hypercapnic animals. This perhaps suggests at a 
mechanism by which animals increase their rate of ventilation during hypercapnia. With 
relevance to HCO3
-
 transport, de Seigneux et al. (2007) found expression of NBCe1 and 
pendrin were upregulated and downregulated respectively in renal cells of rats exposed to 
chronic hypercapnia and hypoxia. Therefore, whether this is an effect of elevated CO2 or a 
reduction in oxygen is difficult to determine but it does highlight the role of gases in 
regulation of acid/base transporters. Insights into the effect of chronic hypercapnia on ion 
transport have been provided by Gu et al. (2004) who measured neurone excitability in rat 
neuronal cells isolated from the hippocampus. Here, they showed that in rats exposed to 8% 
CO2 for 14 days had higher neurone excitability due to an increased Na
+
 conductance 
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mediated, in part, by an increased expression of surface Na
+
 channels. Therefore, these 
studies provide insights into the effects of chronic hypercapnia on the expression and/or 
activity of ion transporters in animal cells. It has been postulated that hypercapnia can 
downregulate NF-κB activity to reduce airway inflammation – a process which may underlie 
the benefits of permissive hypercapnia arising in ARDS/ALI treatment (Laffey et al., 2000). 
However, this reduction in NF-κB activity has been attributed to the hypercapnia causing a 
reduction in wound healing in both A549 cells and HBE cells. These findings suggest that 
elevated CO2 could be detrimental in airway disease in which efficient tissue repair was 
needed (O'Toole et al., 2009). Therefore, this chapter  aims to assess the effects of chronic 
hypercapnia (24 hours) on cAMP-regulated ion transport as well as wound repair in Calu-3 
cells.  
 
5.2.  Calu-3 transepithelial electrical resistance is unaffected by chronic hypercapnia 
A useful indicator of whether epithelial cells are affected by changed environmental 
conditions is to assess their bioelectrical properties. Measurement of transepithelial electrical 
resistance (TEER) gave indications as to whether chronic hypercapnia affected the integrity 
of the epithelial monolayer. Thus, TEER measurements were performed on Calu-3 cells 
which had been incubated in 10% CO2 (v/v) in air for 24 hours prior to being studied. TEER 
was not significantly different between normocapnic controls (682 ± 28 Ω cm-2; n=6) and 
cells exposed to chronic hypercapnia (681 ± 6 Ω cm-2; p>0.05; n=6). This indicates that 
chronic hypercapnia does not affect processes involved in tight junction formation and 
suggests that any changes in ion and fluid transport that may occur in chronic hypercapnia are 
unlikely due to a change in paracellular transport. 
 
5.3.  Chronic hypercapnia reduces the volume of forskolin-stimulated fluid secretion 
but has no effect on the composition on secreted fluid 
The findings from chapters 3 and 4 suggest that acute hypercapnia can modulate cAMP-
regulated HCO3
-
 transport in a Ca
2+
-dependent manner with a possible involvement of the 
Na
+
/K
+
-ATPase. To study Calu-3 cell physiology over a longer time course, cAMP-regulated 
fluid and HCO3
-
 secretion can be assessed using fluid secretion assays. Garnett et al. (2011) 
demonstrated that treatment of Calu-3 cells for 24 hours with forskolin induced a ~20% 
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increase in the amount of fluid secreted compared to unstimulated control cells. This increase 
in secretion was both Cl
-
 and HCO3
-
 dependent and was blocked by GlyH-101 and reduced in 
CFTR KD cells. This implies forskolin activated CFTR-dependent Cl
-
 and HCO3
-
 secretion to 
achieve an increase in fluid secretion. Furthemore, forskolin treatment also increased the pH 
of secreted fluid relative to unstimulated control cells. Interestingly, the change in pH was 
unaffacted by GlyH-101 or CFTR KD. These data imply cAMP stimulates HCO3
-
 secretion 
which is seemingly not directly via CFTR but likely to be through pendrin. To study how 
chronic hypercapnia impacted upon cAMP-regulated fluid and HCO3
-
 secretion, cells were 
stimulated with 5µM forskolin and incubated in either 5% CO2 (v/v) in air or 10% CO2 (v/v) 
in air for 24 hours before the amount of secreted fluid was measured and its composition 
analysed. In normocapnic conditions, unstimulated cells secreted 12 ± 4µl  (n=3) fluid over 
24 hours which was significantly enhanced to 49 ± 3µl by forskolin stimulation (p<0.01; n=3; 
fig. 5.01A). This was calculated as a 17.1 ± 2.6% increase in the volume of fluid secreted in 
cells stimulated with forskolin relative to unstimulated control cells (p<0.01; n=3; fig 5.01B). 
In hypercapnic conditions, unstimulated cells secreted 12 ± 1µl fluid over 24 hours which 
was almost identical to that seen in normocapnia (p>0.05; n=3). However, although forskolin 
increased fluid secretion to 32 ± 1µl over 24 hours (p<0.01; n=3; fig. 5.01A), this 9.5 ± 0.9% 
increase in the volume of forskolin-stimulated fluid secretion was significantly lower than 
that observed in normocapnia (p<0.05; n=3; figs 5.01A and B). This suggests chronic 
hypercapnia acts to impair cAMP-regulated CFTR-dependent Cl
-
 secretion in airway 
epithelia. The pH of the secreted fluid was also measured. In normocapnia, the pH of secreted 
fluid increased from 7.52 ± 0.01 to 7.82 ± 0.06 (p<0.01; n=3) indicative of a greater [HCO3
-
] 
in the forskolin-stimulated secreted fluid. This pH increase of 0.31 ± 0.01 was not different to 
the pH increase of 0.30 ± 0.01 observed in hypercapnia (7.21 ± 0.04 to 7.51 ± 0.02; p<0.01 
vs. unstimulated controls; p>0.05 vs. normocapnia; n=3; fig. 5.01C) with the lower pH values 
observed due to acidosis induced by elevated CO2. Using the Henderson-Hasselbalch 
equation to calculate [HCO3
-
] in the secreted fluid revealed that, in normocapnia, the 
forskolin-stimulated fluid contained 61.6 ± 9.5mM HCO3
-
 which was not significantly 
different to the 58.2 ± 2.4mM HCO3
-
 in the forskolin-stimulated fluid in hypercapnia 
(p>0.05; n=3). The glycoprotein content of the secreted fluid was also analysed by the PAS 
assay in order to give indications as to whether mucin secretion had been altered by 
treatment. In normocapnia, forskolin did not increase the amount of glycoproteins detected 
relative to unstimulated cells (18.5µg/ml ± 0.5 vs. 18.2µg/ml ± 1.0  respectively; p>0.05; 
n=3; fig. 5.01D) but may have stimulated an increase in mucus secretion due to the larger 
 182 
 
volume of secreted fluid in forskolin-treated cells. Furthermore, hypercapnia had no effect on 
glycoprotein secretion from Calu-3 cells. Unstimulated cells secreted 19.2µg/ml ± 0.1 
glycoprotein (p>0.05 vs. unstimulated cells in normocapnia; n=3) which was not affected by 
forskolin stimulation (24.0µg/ml ± 4.0; p>0.05 vs. unstimulated cells; n=3; fig 5.01D). 
 
Figure 5.01: Chronic hypercapnia reduces forskolin-stimulated fluid secretion in Calu-3 cells. 
Cells were stimulated with 5µM forskolin and incubated for 24 hours in either 5% CO2 (v/v) in air or 
10% CO2 (v/v) in air in high Cl
-
 Krebs solution at 37˚C. (A) shows the effect of chronic hypercapnia 
on the volume of fluid secreted over 24 hours. (B) displays the relative increase in the volume of fluid 
secreted by forskolin when normalized to non-stimulated controls. * = significant effect of forskolin 
stimulation compared to unstimulated control cells (p<0.01); † = significant effect of 10% CO2 
(p<0.05). Data represents mean ± S.E.M.; n = 3 for each. (C) displays the increase in pH of forskolin-
stimulated secreted fluid relative to unstimulated control cells. Data represents mean ± S.E.M.; n = 3 
for each. (C) displays the effects of forskolin and hypercapnia on the amount of glycoprotein present 
in the secreted fluid, quantified by the PAS assay. Data represents mean ± S.E.M.; n = 3 for each. 
 
As shown in section in chapter 3, the effects of acute hypercapnia on cAMP-regulated HCO3
-
 
transport were dependent on the cAMP-elevating agonist used. Hypercapnia modulated both 
forskolin and adenosine-stimulated HCO3
-
 transport but it did not affect IBMX-stimulated 
HCO3
-
 transport, implying that CO2 had specific effects on cAMP signalling, depending on 
how intracellular cAMP levels were elevated. Whether the same phenomenon existed in 
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chronic hypercapnia was determined by treating cells with 1mM IBMX for 24 hours and 
measuring the volume and composition of the secreted fluid. The data is displayed in figure 
5.02. In normocapnia, IBMX significantly increased the volume of fluid secreted by 16.8 ± 
3.1% (p<0.01; n=3) compared to non-stimulated control cells. The increase in fluid secretion 
in IBMX-stimulated cells compared to non-stimulated cells in hypercapnia was 11.8 ± 2.9% 
(p<0.01; n=3; fig. 5.02A) which was not significantly different to normocapnic conditions 
(p>0.05). These findings suggest that, like acute hypercapnia, CO2 was only able to modulate 
cAMP signalling via an effect upon cAMP synthesis via tmAC, as opposed to cAMP 
breakdown via phosphodiesterases. The increase in the pH of the secreted fluid was, like 
forskolin-stimulated cells, unaffected by chronic hypercapnia. pH increased by 0.25 ± 0.03 in 
normocapnia (p<0.05 vs. non-stimulated cells; n=3) and 0.18 ± 0.01 in hypercapnia (p<0.05 
vs. non-stimulated cells; p>0.05 vs. normocapnia; n=3; fig. 5.02B) and shows hypercapnia 
does not affect cAMP-regulated HCO3
-
 secretion over 24 hours. 
 
 
Figure 5.02: Chronic hypercapnia has no effect on IBMX-stimulated fluid secretion in Calu-3 
cells. Cells were stimulated with 1mM IBMX and incubated for 24 hours in either 5% CO2 (v/v) in air 
or 10% CO2 (v/v) in air in high Cl
-
 Krebs solution at 37˚C. (A) shows the effect of chronic 
hypercapnia on the volume of fluid secreted over 24 hours; * = significant effect of IBMX stimulation 
compared to unstimulated control cells (p<0.01). Data represents mean ± S.E.M.; n = 3 for each. (B) 
displays the increase in pH of IBMX-stimulated secreted fluid relative to unstimulated control cells. 
Data represents mean ± S.E.M.; n = 3 for each.  
 
Having shown that acute hypercapnia reduced the volume of forskolin-stimulated fluid 
secretion but had no effect on the volume of IBMX-stimulated fluid secretion, it was 
interesting to observe the effects of acute hypercapnia when both agonists were added at the 
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same time. Figure 5.03 shows that, in normocapnia, forskolin + IBMX stimulated a 24.3 ± 
2.7% increase in the volume of fluid secreted compared to non-stimulated controls (p<0.001; 
n=3). This was significantly higher than the 17.0 ± 1.2% increase in forskolin + IBMX-
stimulated fluid secretion observed in hypercapnia (p<0.001 vs. unstimulated controls; 
p<0.01 vs. normocapnia; n=3; fig. 5.03A). However, there was no significant difference in 
the increase in pH of the secreted fluid with pH increasing by 0.41 ± 0.03 units in 
normocapnia (p<0.001; n=3) and by 0.32 ± 0.07 in hypercapnia (p<0.05 vs. non-stimulated 
controls; p>0.05 vs. normocapnia; n=3; fig. 5.03B). 
 
 
Figure 5.03: Chronic hypercapnia reduces forskolin + IBMX-stimulated fluid secretion in Calu-
3 cells. Cells were stimulated with 5µM forskolin and 1mM IBMX and incubated for 24 hours in 
either 5% CO2 (v/v) in air or 10% CO2 (v/v) in air in high Cl
-
 Krebs solution at 37˚C. (A) shows the 
effect of chronic hypercapnia on the volume of fluid secreted over 24 hours; * = significant effect of 
forskolin + IBMX stimulation compared to unstimulated control cells (p<0.001). Data represents 
mean ± S.E.M.; n = 3 for each. (B) displays the increase in pH of IBMX-stimulated secreted fluid 
relative to unstimulated control cells. Data represents mean ± S.E.M.; n = 3 for each.  
 
In order to understand the role of intracellular Ca
2+
 signalling in cAMP-stimulated fluid 
secretion, Calu-3 cells were treated with 50µM BAPTA-AM and incubated for 24 hours in 
5% CO2 (v/v) in air for 24 hours. In non-stimulated conditions, BAPTA-AM reduced fluid 
secretion by 3.5 ± 0.6% (p<0.05; n=3; fig. 5.04A) implying that there is a small Ca
2+
 
component to the basal level of secretion that occurs over 24 hours. Forskolin increased the 
volume of fluid secreted by 8.9 ± 0.7% (n=3; p<0.05) compared to unstimulated cells  whilst 
in BAPTA-AM treated cells, forskolin stimulated a 6.5 ± 1.2% (n=3; p<0.05; fig. 5.04A) 
increase in fluid secretion. Although BAPTA-AM caused a significant reduction in the 
volume of forskolin-stimulated fluid secretion (p<0.01; n=3) the % increase in the volume of  
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forskolin-stimulated fluid secretion was not statistically significantly different between 
control and BAPTA-AM loaded cells (p>0.05; n=3) and indicates that there is no role for  
Ca
2+
 in cAMP-stimulated fluid transport. The pH of secreted fluid in basal conditions was 
7.42 ± 0.07 (n=3) and this was unaffected by BAPTA-AM treatment in which it was 7.35 ± 
0.04 (p>0.05; n=3; fig. 5.04B). Forskolin increased the pH of secreted fluid by 0.25 ± 0.09 
(n=3) in control cells and by 0.28 ± 0.07 in BAPTA-AM-loaded cells (p>0.05; n=3 fig. 
5.04B) demonstrating that chelation of intracellular Ca
2+
 did not affect cAMP-stimulated 
HCO3
-
 secretion in Calu-3 cells. 
 
 
Figure 5.04: BAPTA-AM reduces basal fluid secretion in Calu-3 cells but does not prevent the 
increase in fluid secretion stimulated by forskolin. Cells were treated with 50µM BAPTA-in the 
presence of 5µM forskolin and incubated for 24 hours in high Cl
-
 Krebs solution in 5% CO2 (v/v) in 
air at 37˚C. (A) shows the volume of fluid secreted over 24 hours; * = significant effect of forskolin 
relative to non-stimulated cells (p<0.05); ‡ = significant effect of BAPTA-AM compared to non-
BAPTA-AM treated cells (p<0.05). Data represents mean ± S.E.M.; n = 3 for each. (B) displays the 
pH of the secreted fluid; * = significant effect of forskolin realtive to non-stimulated cells (p<0.05). 
Data represents mean ± S.E.M.; n = 3 for each. 
 
The findings from chapter 4 showed that there appears to be a Ca
2+
 component to the effects 
of acute hypercapnia on cAMP-regulated HCO3
-
 transport. Having shown there is a role for 
Ca
2+
 in maintaining a basal level of fluid secretion in Calu-3 cells (fig. 5.04A), it was 
important to investigate whether the effect of hypercapnia on cAMP-regulated fluid secretion 
required changes in intracellular Ca
2+
. Calu-3 cells were treated with 50µM BAPTA-AM and 
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incubated in either 5% CO2 (v/v) in air or 10% CO2 (v/v) in air for 24 hours before the 
volume of secreted fluid was measured. Forskolin significantly increased the volume of fluid 
secreted in both normocapnic (12.5 ± 1.1%; p<0.05 vs. unstimulated cells; n=3) and 
hypercapnic conditions (19.9 ± 7.9%; p<0.05 vs. unstimulated cells; n=3; fig. 5.05). Unlike in 
non-BAPTA-AM loaded cells (fig 5.01), this stimulation of the volume of fluid secreted by 
forskolin was not significantly different between normocapnia and hypercapnia (p>0.05; n=3) 
and therefore shows that BAPTA-AM abolished the effect of hypercapnia on cAMP-
regulated fluid secretion. These data implied that in order for CO2 to mediate its effects on 
cAMP-regulated fluid secretion, it utilized a Ca
2+
 signalling pathway, similar to what is 
observed in acute hypercapnia. 
 
Figure 5.05: BAPTA-AM prevents the effect of hypercapnia on forskolin-stimulated fluid 
secretion in Calu-3 cells. Cells were treated with 50µM BAPTA-AM in the presence of 5µM 
forskolin and incubated for 24 hours in high Cl
-
 Krebs solution in either 5% CO2 (v/v) in air or 10% 
CO2 (v/v) in air at 37˚C. * = significant effect of forskolin vs. non-stimulated cells (p<0.05). Data 
represents mean ± S.E.M.; n=3 for each. 
 
5.4.  Chronic hypercapnia has no effect on Isc in Calu-3 cells 
The results from the fluid secretion assays imply that chronic hypercapnia reduces CFTR-
dependent fluid secretion likely due to a reduction in CFTR-mediated Cl
-
 secretion. 
Therefore, the effects of chronic hypercapnia on electrogenic Cl
-
 transport was assessed by 
measuring Isc using an Ussing chamber. Calu-3 cells were incubated for 24 hours in 10% CO2 
(v/v) at 37˚C prior to being studied. To measure electrogenic Cl- secretion, cells were 
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stimulated with 5µM forskolin in the presence of a basolateral to apical Cl
-
 gradient, achieved 
by reducing apical Cl
-
 to 40mM (by removal of 84mM NaCl and adding equimolar Na 
Gluconate) whilst maintaining basolateral Cl
-
 at 124mM. The effects of both apical CFTRinh 
172 (20µM) and basolateral bumetanide (25µM) on forskolin-stimulated changes in Isc were 
also assessed. Representative Isc measurements recorded from cells grown in normocapnia 
and cells exposed to hypercapnia for 24 hours are shown in figures 5.06A and 5.06B 
respectively. The basal Isc in normocapnia was 4.6 ± 0.8µA cm
-2
 (n=4) whilst in cells exposed 
to chronic hypercapnia, basal Isc was 5.3 ± 0.7µA cm
-2
 (n=4; p>0.05; fig. 5.06C). These 
findings suggest chronic hypercapnia does not affect the basal electrogenic ion transport in 
non-stimulated conditions. Forskolin produced a maximal increase of 24.8 ± 1.8µA cm
-2
 in 
normocapnia (n=4) and 26.4
 
± 2.8µA cm
-2
 in chronic hypercapnia (n=4; p>0.05; fig. 5.06D). 
Furthemore, the rate of this forskolin-induced increase in Isc was 12.5 ± 1.3µA cm
-2
 min
-1
 in 
normocapnia (n=4) and 9.2 ± 1.7µA cm
-2
 min
-1
  in hypercapnia (n=4; p>0.05; fig. 5.06E). 
These data suggest that chronic hypercapnia does not affect cAMP-regulated CFTR-
dependent Cl
-
 secretion which is in stark contrast to the results from the fluid secretion 
assays. Furthermore, given that acute hypercapnia modulated forskolin-induced increases in 
Isc, shows a distinct difference between cAMP regulated signalling in the acute and chronic 
setting. 
 
 
 
 
 
 188 
 
 
 
Figure 5.06. Chronic hypercapnia has no effect on forskolin-stimulated changes in Isc in Calu-3 
cells. Calu-3 cells were grown on permeable snapwell supports and forskolin-stimulated electrogenic 
Cl
-
 secretion was measured using an Ussing Chamber. Representative traces of control experiments 
(A) or experiments in which cells had been exposed to hypercapnia for 24 hours prior to study (B) are 
shown. The inset shows that a 2 second 10mV pulse was applied across the cells every 30 seconds to 
monitor transepithelial electrical resistance (TEER) but these pulses were removed from the trace in 
order to display the effects of treatment more clearly. The basal Isc (C), the maximal forskolin-
stimulated increase in Isc (D) and the rate of increase in forskolin-stimulated Isc (E) are displayed. Data 
represents mean ± S.E.M.; n = 4. 
 
It was puzzling as to why such different effects on Cl
-
 secretion were observed in the fluid 
secretion assays relative to the Isc measurements. One explanation could be that in the Isc 
measurements, a basolateral to apical Cl
-
 gradient exists which is not present in the fluid 
secretion assays. This Cl
-
 gradient will increase the driving force for Cl
-
 secretion and may 
mask any subtle effects of hypercapnia that exist when apical and basolateral [Cl
-
] was equal. 
Therefore, the effects of chronic hypercapnia on fluid secretion were tested on cells in which 
apical Cl
-
 was reduced to 40mM (by removal of 84mM NaCl and replacement with equimolar 
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Na Gluconate) and basolateral Cl
- 
was maintained at 124mM. The presence of a basolateral to 
apical Cl
-
 gradient caused an expected overall increase in the amount of fluid secreted over 
24 hours. For example, in normocapnia, under basal conditions, 49 ± 2µl of fluid was 
secreted over 24 hours which was significantly higher than the 12 ± 4µl secreted when apical 
Cl
-
 and basolateral Cl
-
 were equal (p<0.001; n=3). In normocapnia, forskolin stimulated 80 ± 
2µl fluid to be secreted over 24 hours which was calculated as a 12.6 ± 2.0% increase in the 
volume of fluid secreted compared to unstimulated controls (p<0.001; n=3; fig. 5.07B). 
However, in hypercapnia, forskolin elicted a 7.1 ± 2.2% increase in fluid secretion (p<0.05; 
n=3) which was significantly lower than that observed in normocapnia (p<0.05; fig. 5.07B). 
Therefore, even in the presence of a basolateral to apical Cl
-
 gradient, chronic hypercapnia 
signficantly reduces the volume of forskolin-stimulated fluid secretion in Calu-3 cells. Such 
disparity with the Isc measurements, in which chronic hypercapnia appears to not effect 
electrogenic Cl
-
 secretion, are, at this stage, confusing and highlights that different 
experimental approaches may yield different results due to the nature of the measurements 
being made. 
 
 
Figure 5.07: Chronic hypercapnia reduces  forskolin-stimulated fluid secretion in Calu-3 cells in 
the presence of a basolateral to apical Cl
-
 gradient. Cells were stimulated with 5µM forskolin and 
incubated for 24 hours in either 5% CO2 (v/v) in air or 10% CO2 (v/v) in air. Apical Cl
-
 was reduced 
to 40mM and basolateral Cl
-
 was maintained at 124mM Cl
-
. (A) shows the effect of chronic 
hypercapnia on the volume of fluid secreted over 24 hours. (B) displays the relative increase in the 
volume of fluid secreted by forskolin when normalized to non-stimulated controls. * = significant 
effect of forskolin stimulation compared to unstimulated control cells (p<0.01; *** = p<0.001); † = 
significant effect of 10% CO2 (p<0.05). Data represents mean ± S.E.M.; n = 3 for each.  
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5.5. Chronic hypercapnia reduces the expression of  CFTR in Calu-3 cells 
Figure 3.04 in chapter 3 showed that acute hypercapnia caused an apparent reduction in the 
expression of CFTR protein in Calu-3 cells although whether this correlated with a decreased 
expression of CFTR at the apical membrane still remains to be determined. Here, the effect of 
chronic hypercapnia on total CFTR expression was assessed. Cells were incubated for 24 
hours in high Cl
-
 Krebs solution containing either DMSO (control) or forskolin in either 5% 
CO2 (v/v) in air or 10% CO2 (v/v) in air. After 24 hours, cells were lysed and the expression 
of CFTR was measured and normalized to the expression of β-actin. As shown in fig. 5.08, 
forskolin has no effect on the expression of CFTR in either normocapnia or hypercapnia. 
However, it appears that chronic hypercapnia reduces total CFTR expression which is the 
opposite of what is observed in acute hypercapnia and this may suggest at a mechanism by 
which chronic hypercapnia can reduce the volume of forskolin-stimulated fluid secretion. 
 
Figure 5.08: Chronic hypercapnia reduces CFTR expression in Calu-3 cells. (A) shows the results 
from a Western Blot in which the effect of forskolin and chronic hypercapnia on CFTR protein 
expression was assessed and normalized to β-actin expression. The data is summarized in (B). For 
each experimental condition, 3 lysates were generated from 3 separate transwell. These lysates were 
combined to produce one lysate for each experimental condition; thus data represents mean of n=1. 
 
5.6. CFTR-dependent anion exchange activity is unaffected by chronic hypercapnia 
To further investigate the effects of chronic hypercapnia on cAMP-regulated CFTR-
dependent HCO3
-
 transport, intracellular pH measurements were made on Calu-3 cells. These 
experiments allow for the measurement of CFTR-dependent anion exchange activity as 
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described by Garnett et al., (2009). Cells were incubated in either 5% CO2 (v/v) in air 
(control) or in 10% CO2 (v/v) in air for 24 hours prior to being studied (chronic hypercapnia). 
As previously described in chapter 3, section 3.14.1, to measure CFTR-dependent anion 
exchange activity, cells were perfused with an apical Cl
-
 free Krebs solution to reverse the 
anion exchanger and stimulate Cl
-
 efflux and consequentially HCO3
-
 influx. Reintroduction of 
Cl
-
 to the apical perfusate causes the anion exchanger to function in its normal direction and 
the subsequent intracellular acidification that occurs provides a measure for CFTR-dependent 
HCO3
-
 secretion. Representative experiments for normocapnia (fig. 5.09A) and chronic 
hypercapnia (fig 5.09B) are shown. The initial intracellular pH of cells in normocapnia was 
7.41 ± 0.04 (n=4) which was unchanged in cells exposed to chronic hypercapnia (7.48 ± 0.03; 
n=3; p>0.05 vs. normocapnia; fig 5.09C). This shows that Calu-3 cells are able to maintain a 
normal intracellular pH even after prolonged exposure to hypercapnia and is unsurprising 
given it has been shown these cells can recover intracellular pH from CO2-induced acidosis 
within 20 minutes. As discussed at length in chapter 4, addition of forskolin induces an 
intracellular acidification which is significantly augmented by acute hypercapnia. In cells 
exposed to chronic hypercapnia, forskolin causes pHi to decrease by 0.16 ± 0.02 (n=3) at a 
rate of 10.7 ± 2.0mM HCO3
-
 min
-1
 (n=3). These findings are comparable to the forskolin-
induced acidification observed in normocapnic cells. Here, pHi decreased by 0.15 ± 0.01 
(n=4; p>0.05 vs. hypercapnia; fig 5.09D) at a rate of 5.9 ± 0.7mM HCO3
-
 min
-1
 (p>0.05 vs. 
hypercapnia; n=4; fig 5.09E). These data show that, unlike acute hypercapnia, chronic 
hypercapnia does not affect forskolin-stimulated HCO3
-
 transport. In the presence of 
forskolin, removal of apical Cl
-
 causes an alkalization of pHi of 0.78 ± 0.04 (n=4) in 
normocapnia and 0.90 ± 0.04 in hypercapnia (p<0.05; n=3). Reintroduction of apical Cl
-
 
causes a HCO3
-
 influx of 232.7 ± 83.8mM HCO3
-
 min
-1
 (n=4) in normocapnia and 
371.3mM/min ± 38.0mM HCO3
-
 min
-1
 in hypercapnia (p>0.05; n=3). Thus, chronic 
hypercapnia does not affect CFTR-dependent anion exchange activity in Calu-3 cells which 
implies that cells are able to adapt to chronic hypercapnia and thus only acute hypercapnia 
can affect the pathways and components involved in HCO3
-
 transport in airway epithelia.  
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Figure 5.09: Chronic hypercapnia does not alter CFTR-dependent HCO3
-
 transport in Calu-3 
cells. (A) shows a representative experiment in normocapnia in which cAMP-regulated CFTR-
dependent HCO3
-
 transport was assessed by exposing cells to an apical 0Cl
-
 solution in the presence of 
5µM forskolin. (B) shows the same experiment but after cells had been incubated in 10% CO2 (v/v) in 
air for 24 hours prior to being studied. (C) shows the intial pHi of cells whilst (D) displays the delta 
pHi that occurs after forskolin-stimulation and after removal of apical Cl
-
. (E) displays the HCO3
-
 flux 
that occurs after forskolin stimulation and after reintroduction of apical Cl
-
. * = significant effect of 
chronic hypercapnia (p<0.05). Data represents mean ± S.E.M.; n = 4 for each. 
 
5.7.  Chronic hypercapnia elicits highly variable effects on wound healing of Calu-3 
cells 
As already discussed, hypercapnia has been shown to reduce wound healing airway epithelial 
cells lines due to a downregulation of NF-κB-dependent repair mechanisms (O'Toole et al., 
2009). Given that airway disease can cause fibrosis of lung tissue and thus the requirement 
for efficient wound healing, it was of interest to investigate whether the hypercapnia resulting 
from airway disease would modulate wound healing of a Calu-3 cell monlayer. Calu-3 cells 
 193 
 
were wounded by administering a single scratch using a P200 pipette tip before cells were 
and imaged every 4 hours using a Nikon BioStation in which ambient CO2 could be altered. 
Three separate experiments were performed on three different Calu-3 cell cultures and the 
results for each separate experiment are shown in figues 5.11, 5.12 ad 5.13. Figure 5.10 
shows example screen shots of the wound size of Calu-3 cells incubated in normocapnia, 
taken at 0, 12, 24 and 36 hours after the cells were scratched. The size of the wound at t=0 
hours was 2.22 ± 0.06mm
2
 (n=40). Figure 5.11 shows that in one experiment, when cells 
were incubated in high Cl
-
 Krebs solution, hypercapnia significantly accelerated the ability of 
Calu-3 cells to reheal after wounding. This was also observed in another, separate experiment 
which also investigated whether cells incubated in growth medium as opposed to Krebs 
solution displayed any differences in their wound healing ability (fig 5.12). Interestingly, 
growth media significantly slowed wound healing in both normocapnia and hypercapnia 
compared to Krebs solution. This finding is surprising as it would be expected that in serum-
containing conditions, cells would be able to proliferate as well as migrate, and thus increase 
the rate of wound healing. The final experiment aimed to assess whether the increased wound 
healing rate seen in hypercapnia was due to CO2 per se or was due to differences in pHe. 
Therefore, Calu-3 cells were incubated in either high Cl
-
 Krebs solution (control),  high Cl
-
 
Krebs + 10mM HEPES, 0.6mM NaOH and 15mM Mannitol (pH 7.4 when gassed with 5% 
CO2 (v/v) / 95% O2 (v/v)) or high Cl
-
 Krebs + 10mM HEPES and 10mM NaOH (pH 7.4 
when gassed with 10% CO2 (v/v) / 90% O2 (v/v)). The data is displayed in figure 5.13. Here, 
there is no effect of hypercapnia on wound healing, even in control conditions. These 
findings do not replicate the previous experiments and therefore highlights a large variability 
in wound healing between different cell cultures. Furthermore, from these findings, it is 
impossible to ascertain whether the effects of hypercapnia observed previously are due to 
CO2 per se or CO2-induced acidosis of extracellular pH.  
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Figure 5.10: Representative images showing the wound administered to Calu-3 cells at 0, 12, 24 
and 36 hours post-scratch. Images were generated at x4 magnification using a Nikon BioStation and 
analysed using ImageJ. 
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Figure 5.11: Hypercapnia increases the rate of wound healing in Calu-3 cells incubated in high 
Cl
-
 Krebs solution. Cells were scratched with a P200 pipette tip and imaged every 4 hours at 3 
different fields of view per transwell at x4 magnification using a Nikon BoStation. The mean wound 
surface area for each field of view was calculated and each data point is representative of mean ± 
S.E.M. of n = 6 transwells. ** = significant effect of hypercapnia (p<0.01; *** = p<0.001). 
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Figure 5.12: Growth medium reduces the rate of wound healing in Calu-3 cells in both 
normocapnia and hypercapnia. Cells were scratched with a P200 pipette tip, incubated in either 
high Cl
-
 Krebs solution or growth medium and imaged every 4 hours at 3 different fields of view per 
transwell at x4 magnification using a Nikon BioStation. The mean wound surface area for each field 
of view was calculated and each data point is representative of mean ± S.E.M. of n = 4 transwells. *** 
= significant effect of hypercapnia in cells incubated in Krebs solution (p<0.001); # = significant 
effect of hypercapnia in cells incubated in growth medium (p<0.01); † = significant difference 
between high Cl
-
 Krebs and growth medium in normocapnia (p<0.01); ‡ = significant difference 
between high Cl
-
 Krebs and growth medium in hypercapnia (p<0.01). 
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Figure 5.13: Hypercapnia has no effect on the rate of wound healing in Calu-3 cells. Cells were 
scratched with a P200 pipette tip, incubated in high Cl
-
 Krebs solution (control) or modified Krebs 
solution (pHe) and imaged every 4 hours at 3 different fields of view per transwell at x4 magnification 
using a Nikon BioStation. The mean wound surface area for each field of view was calculated and 
each data point is representative of mean ± S.E.M. of n = 4 transwells. No significant differences were 
found. 
 
Due to the apparent differences in variability that exist between different cell cultures, the 
data from all three experiments in which cells had been incubated in high Cl
-
 Krebs solution 
was combined (fig 5.14). Combining the data shows that hypercapnia does significantly 
accelerate wound healing in monolayers of Calu-3 cells. 
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Figure 5.14: Grouping the data from three separate experiments shows that hypercapnia 
increases the rate of wound healing in Calu-3 cells. Cells were scratched with a P200 pipette tip 
and imaged every 4 hours at 3 different fields of view per transwell at x4 magnification using a Nikon 
BioStation and the mean wound surface area for each field of view was calculated. Each data point is 
representative of mean ± S.E.M. of n = 14 transwells combined from 3 independent experiments. * = 
significant effect of hypercapnia (p<0.05; ** = p<0.01; *** = p<0.001). 
 
5.6. Discussion 
5.6.1. The effect of chronic hypercapnia on cAMP-regulated ion and fluid transport – 
similar mechanisms to acute hypercapnia? 
The data presented in this chapter investigated the effect of chronic hypercapnia on cAMP-
regulated ion and fluid transport in Calu-3 cells as well as the effect of chronic hypercapnia 
on Calu-3 cell wound healing. Incubating cells for 24 hours in hypercapnia did not affect the 
amount of fluid secreted under basal conditions but did cause a significant reduction in the 
amount of fluid secreted when cells were stimulated with forskolin. Interestingly, the 
composition of forskolin-stimulated fluid secretion was unaffected by chronic hypercapnia. 
Although forskolin caused an increase in the pH of the secreted fluid, indicative of a greater 
[HCO3
-
] in the fluid, the extent of the pH increase and the calculated [HCO3
-
] was equivalent 
in normocapnia and hypercapnia. Garnett et al. (2011) demonstrated that the volume of 
secreted fluid from Calu-3 cells was directly regulated by CFTR given that GlyH-101 
significantly reduced the volume of forskolin-stimulated fluid secreted over 24 hours. 
However, it was somewhat surprisingly found that GlyH-101 did not block the forskolin-
stimulated increase in pH of secreted fluid, suggesting that a GlyH-101-insensitive apical 
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HCO3
-
 transporter was responsible for the increased HCO3
-
 secretion, which the researchers 
concluded to be pendrin. Thus, it appears that chronic hypercapnia reduced CFTR-dependent 
Cl
-
 secretion to reduce the driving force for fluid transport, but did not affect pendrin-
mediated HCO3
-
 secretion. Although measured over a different time course, these findings 
are very similar to what was observed when measuring CFTR-dependent anion transport and 
pendrin activity in acute hypercapnia. Here, I showed that forskolin-stimulated, CFTR-
dependent increases in Isc were reduced by acute hypercapnia, yet pendrin-mediated Cl
-
/HCO3
-
 exchange was insensitive to acute hypercapnia. It is also interesting that the 36 ± 9% 
inhibition of forskolin-stimulated increase in [cAMP]i by acute hypercapnia, closely 
resembles the 35 ± 5% inhibition of forskolin-stimulated fluid secretion by chronic 
hypercapnia. These findings suggest that chronic hypercapnia may induce similar reductions 
in [cAMP]i to reduce CFTR-dependent Cl
-
 secretion and consequentially reduce the volume 
of fluid secreted. However, the reduction in CFTR activity may not be sufficient to reduce 
pendrin activity, hence efficient HCO3
-
 secretion is maintained. Furthermore, the lack of 
effect of chronic hypercapnia under basal conditions is also similar to what is observed when 
measuring [cAMP]i in acute hypercapnia. I discussed that CO2 may modulate the activity of 
tmAC to reduce [cAMP]i but, in order to do this, tmAC needed to in a “forskolin-bound” 
conformation – hence the lack of effect of hypercapnia on basal levels of [cAMP]i. As such, a 
similar mechanism may be in evident here whereby chronic CO2 reduced forskolin-
stimulated [cAMP]i by reducing the activity of tmAC held in a “forskolin-bound” 
conformation. To further verify this, it will be important to measure [cAMP]i in cells exposed 
to hypercapnia for 24 hours to see whether the effect of CO2 on [cAMP]i is also present over 
a longer time course. 
An alternative explanation for the reduced volume of forskolin-stimulated fluid secretion is 
from the finding that chronic hypercapnia appeared to reduce CFTR expression. These 
findings are in stark contrast to the effects of acute hypercapnia, in which it was found CFTR 
expression appeared to increase over this time frame. However, given that chronic 
hypercapnia reduced CFTR expression in both basal and forskolin-stimulated conditions 
would suggest that, if this did underlie the effects of chronic hypercapnia on fluid secretion, 
the basal level of fluid secretion would be reduced also. 
There was also other similarities between the effects of acute and chronic hypercapnia on 
cAMP-regulated ion transport. The volume of IBMX-stimulated fluid secretion was 
unaffected by chronic hypercapnia, similar to the finding that IBMX-stimulated intracellular 
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acidification was insensitive to acute hypercapnia. However, when fluid secretion was 
stimulated by both forskolin and IBMX, hypercapnia reduced fluid secretion. The absence of 
an effect of CO2 when [cAMP]i levels are raised independently of tmAC activity suggested 
that, if chronic CO2 is having effects on [cAMP]i, this is due to modulation of tmAC-
dependent cAMP production as opposed to phosphodiesterase-dependent cAMP breakdown. 
BAPTA-AM also abolished the effect of chronic hypercapnia on forskolin-stimulated fluid 
secretion, similar to the finding that BAPTA-AM blocked the effect of acute hypercapnia on 
the forskolin-stimulated intracellular acidification. These findings suggest that chronic 
hypercapnia also elicits Ca
2+
-dependent effects on cAMP-regulated ion transport. As 
discussed at great length in chapter 4, there was some evidence that CO2 mediated its effects 
via an IP3-dependent Ca
2+
 release which may impact upon Ca
2+
-sensitive tmAC or cAMP-
regulated transporters. 
 
5.6.2. The effect of chronic hypercapnia on cAMP-regulated ion and fluid transport – 
differences to acute hypercapnia?  
There were also notable differences between the effects of acute and chronic hypercapnia on 
cAMP-regulated ion transport in Calu-3 cells. Isc measurements revealed that chronic 
hypercapnia had no effect on two parameters that were reduced by acute hypercapnia: basal 
Isc and the rate of forskolin-stimulated increases in Isc. Therefore, this suggests that, unlike the 
findings from fluid secretion assays, CFTR-dependent ion transport was not affected by 
chronic hypercapnia. This disparity was not due to the fact that Isc measurements were made 
in the presence of a basolateral to apical Cl
-
 gradient, as hypercapnia still reduced forskolin-
stimulated fluid secretion in these conditions. Notably, in the presence of a basolateral to 
apical Cl
-
 gradient, the amount of fluid secreted under basal and forskolin-stimulated 
conditions were significantly enhanced compared to fluid secretion assays in which 
basolateral and apical Cl
-
 were equal, which was expected given that the driving force for Cl
-
 
efflux, and consequentially fluid secretion, were enhanced. The most likely explanation for 
the disparity between fluid secretion measurements and Isc measurements is that the Isc 
measurements were performed when the cells were in short-circuit conditions as opposed to, 
essentially, open-circuit conditions for fluid secretion assays. This could underlie the 
differences in the responses to hypercapnia and therefore repeating Isc measurements in open 
circuit conditions is important. An odd finding of the Isc measurements was in the profile of 
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the response, particularly after the addition of CFTRinh 172. In both normocapnia and 
hypercapnia, CFTRinh 172 caused an intial reduction in the forskolin-stimulated increase in 
Isc, but there appeared to be a “rebound” in which Isc increased again before the addition of 
bumetanide. This was not observed in previous experiments that aimed to investigate the 
effect of acute hypercapnia on Isc and indicated there was some kind of reversal/wash-off of 
CFTRinh 172. Why this should only arise in one set of experiments and not others is a mystery 
but the fact that it was observed in both normocapnia and hypercapnia suggested that it was 
not a CO2-dependent effect. 
 
5.6.3. Applying the effects of hypercapnia to a more clinical setting by investigating 
Calu-3 cell wound repair 
A slightly different angle to investigate the effects of hypercapnia on Calu-3 cells was to 
establish the role of hypercapnia in wound repair. By monitoring the rate of wound closure 
following the administration of a single scratch, it was found that in two of three independent 
experiments, hypercapnia increased the rate of wound healing in Calu-3 cells. However, in 
one experiment, no effect of hypercapnia was found, thus highlighting the large amount of 
variability that exists between different batches of cells. However, when grouping the data 
from all three experiments, it was found that hypercapnia did significantly increase the rate of 
wound healing, although whether this was an effect of acidosis or CO2 per se was unable to 
be deduced. Such findings would suggest that permissive hypercapnia resulting from the 
treatment of ARDS/ALI patients may have additional protective effects aside from the 
reported anti-inflammatory effects of CO2 (Laffey et al., 2000; Li et al., 2006; Contreras et 
al., 2012). In one experiment, it was surprisingly found that, in both normocapnia and 
hypercapnia, serum-containing media actually slowed wound healing compared to serum-free 
media. These findings suggest that serum-containing media, in which increased cell 
proliferation would be favoured, actually impaired wound healing and may imply that Calu-3 
cells only repair via increased cell migration. Therefore, in serum-free media, cells can utilize 
all of their energy stores into migration and repair faster than if some energy was used during 
cell division. Interestingly, these findings are in contrast to Schiller et al. (2010) who 
observed no effect of serum on wound repair of Calu-3 cells with possible differences being 
due to the way in which a wound was induced into the monolayer, with Schiller et al. (2010) 
inducing a circular wound using a electroporation approach as opposed to a scratch-induced 
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linear wound used in the present study. The effect of chronic hypercapnia on CFTR 
expression also suggest major differences between my findings and those reported by Schiller 
et al. (2010) who showed that repair of Calu-3 cells was slowed in the presence of  CFTRinh 
172 or genetic knockdown of CFTR, suggesting CFTR activity was required for efficeint 
wound repair. However, given hypercapnia reduced CFTR expression yet accelerated wound 
healing implies that a loss of CFTR in Calu-3 cells is not a major factor in wound repair and 
again differences may lie in the technique for administeration of the wound. 
How CO2 is able to modulate wound repair is an area of some debate within the field. There 
exists conflicting reports into the effect of hypercapnia on wound healing in human cells and, 
indeed whether these effects were dependent on CO2-induced acidosis. In agreement with the 
current findings, Tsuji et al. (2013) demonstrated that hypoxia significantly slowed wound 
healing in human umbilical venous endothelial cells (HUVECs), but this was rescued in the 
presence of hypercapnia. This effect of CO2 was independent of acidosis and was a result of 
increased proliferation of the cells, showing CO2 per se accelerated human cell repair. 
However, this study failed to assess the role of hypercapnia on wound healing in normoxia 
and therefore the effect of CO2 may only be seen because the cells are hypoxic and may not 
happen in a more physiological environment. Contrasting this, it was found that in HBE and 
A549 cells, CO2 per se induced a decrease in wound healing due to a CO2-mediated reduction 
in NF-κB activity and inhibition of cell migration (O'Toole et al., 2009). Given that, in the 
current study, the effect of hypercapnia was present in both serum-free and serum-containing 
media suggested that hypercapnia caused an increase in cell migration as opposed to 
proliferation and therefore suggests Calu-3 cells display a marked difference in sensitivity to 
CO2 compared to HBE and A549 cells. It would be of interest to assess whether the effects of 
CO2 on wound healing in Calu-3 cells were also dependent on NF-κB signalling to further 
establish the mechanism behind the difference in the effects of hypercapnia on wound healing 
in different airway epithelia. Finally, Caples et al. (2009) has shown that hypercapnia slowed 
wound healing in A549 cells. However, increasing the pH of the media from 7.12 ± 0.18 to 
7.40 ± 0.06 by the addition of HCO3
-
 reversed the inhibitory effect of hypercapnia, 
suggesting that the effects were due to hypercapnic acidosis as opposed to CO2 per se. Thus, 
it is clear there are conflicting ideas as to the role of CO2 in human cell repair from injury and 
further investigations into this area are of high interest, particularly for hypercapnic lung 
disease patients.  
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The major findings of this chapter are summarized below and in figure 5.15. 
 Chronic hypercapnia reduced forskolin-stimulated fluid secretion in Calu-3 cells but 
did not affect the composition of secreted fluid suggesting CFTR activity was reduced 
but was sufficient to maintain pendrin activity. 
 The effect of CO2 on forskolin-stimulated fluid secretion was abolished by BAPTA-
AM but maintained in the presence of IBMX, suggesting hypercapnia affected Ca
2+
-
dependent production of cAMP. 
 Chronic hypercapnia accelerated wound healing in Calu-3 cells due to increased cell 
migration. How it does this still remains to be determined but it could involve a CO2-
dependent regulation of NK-κB. 
 
 
Figure 5.15: Summary of the key effects of chronic hypercapnia on cAMP-regulated ion and 
fluid transport in Calu-3 cells. In normocapnia, elevations in [cAMP]i activate CFTR-dependent Cl
-
 
secretion creating an osmotic driving force for fluid secretion. CFTR-dependent activation of pendrin 
causes the secreted fluid to contain ~60mM HCO3
-
. In hypercapnia, potential Ca
2+
-dependent 
decreases in [cAMP]i and reduced CFTR expression reduces the volume of forskolin-stiumulated 
fluid secretion but pendrin activity is maintained, such that secreted HCO3
-
 is not impaired. CO2 may 
also modulate NF-κB to elicit changes in the ability of cell to repair following injury. 
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Chapter 6:  Discussion 
6.1. Summary of main findings 
This work has been the first to investigate the effects of hypercapnia on cAMP signalling in 
airway epithelia. Using a model of human serous cells, which secrete a HCO3
-
 rich fluid in 
response to elevations in [cAMP]i, the effects of both acute and chronic hypercapnia on 
cAMP-regulated ion and fluid transport were investigated. The majority of experiments 
performed in this work allowed for the study of vectorial ion and fluid transport in a polarized 
monolayer of airway epithelia in a dynamic, non-invasive way. Thus, the experimental set up 
is representative of physiological conditions and thus makes the findings easily transferable 
to an in vivo setting. It was found that acute hypercapnia blunted forskolin-stimulated 
increases in [cAMP]i which was abolished in the presence of BAPTA-AM and 2-APB, 
suggesting CO2 modulated [cAMP]i in a Ca
2+
-dependent manner. This adds to the body of 
growing evidence that CO2 acts as a cell signalling molecule in human cells by modulating 
the levels of important cell second messengers (Bouyer et al., 2003; Briva et al., 2007; 
Vadasz et al., 2008; Townsend et al., 2009; Cook et al., 2012). Acute hypercapnia also 
caused reductions in CFTR-dependent basal Isc as well as forskolin-stimulated increase in Isc, 
suggesting that the CO2-induced reduction in forskolin-stimulated [cAMP]i was sufficient to 
reduce CFTR-dependent ion transport.  
Interestingly, acute hypercapnia caused a significant increase in forskolin/adenosine-
stimulated intracellular acidification, suggesting that CO2 could augment the net difference in 
HCO3
-
 efflux relative to HCO3
-
 influx. However, there was no effect of hypercapnia on 
CFTR-regulated, pendrin-dependent HCO3
-
 transport across the apical membrane, and  
although acute hypercapnia did not significantly affect the activity of cAMP-stimulated NBC 
activity per se, it was found that hypercapnia increased basal NBC activity, such that a 
subsequent elevation in cAMP was unable to further upregulate NBC activity. This 
dysregulation of HCO3
-
 uptake across the basolateral membrane, under cAMP-stimulated 
conditions, could underlie the effects of hypercapnia in that, after addition of forskolin, apical 
HCO3
-
 efflux would be stimulated to a much greater extent than basolateral HCO3
-
 influx and 
contribute to the enhanced forskolin-stimulated intracellular acidification observed in 
hypercapnic conditions. It was also found that the effect of hypercapnia was blocked by 
ouabain suggesting that the Na
+
/K
+
-ATPase was a target of CO2, possibly contributing to the 
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enhanced intracellular acidification via increased H
+
 influx the transporter has been reported 
to be capable of (Vedovato and Gadsby, 2014). 
The effects of acute hypercapnia on cAMP-stimulated HCO3
-
 transport were blocked by 
BAPTA-AM, 2-APB and U73122 and mimicked by the Ca
2+
 elevating agonist ATP and, to a 
lesser extent, by carbachol and UTP. These results suggest that hypercapnia mediated its 
effects via an IP3-dependent Ca
2+
 release, stimulated by a CO2-induced release of ATP from 
airway cells to signal via an autocrine signalling mechanism. However, the effect of 
hypercapnia remained even when the ER stores were depleted of Ca
2+
 and there was little 
evidence to suggest that CO2 induced an ATP release from the cells. Further experiments are 
therefore required to fully deduce the role of Ca
2+
 signalling in underlying the effects of 
hypercapnia on cAMP-regulated HCO3
-
 transport. Inhibition of pannexins, by two reported 
pannexin inhibitors, caused a significant reduction in the extent by which acute hypercapnia 
could modulate cAMP-regulated HCO3
-
 transport. This suggests that CO2 may activate the 
efflux of an endogenous Ca
2+
-elevating agonist via pannexin channels which activates Gq 
coupled receptors to trigger increases in [Ca
2+
]i. This change in [Ca
2+
]i could then influence 
[cAMP]i due to modulation of the activity of Ca
2+
-dependent tmACs or MRPs, or alter the 
activity of transporters seemingly involved in underlying the effect of acute hypercapnia on 
HCO3
-
/H
+
 transport i.e. NBC and Na
+
/K
+
-ATPase. 
The effects of chronic hypercapnia were also investigated. Here, it was found that chronic 
hypercapnia reduced the volume of forskolin-stimulated, but not IBMX-stimulated, fluid 
secretion over 24 hours in a mechanism that required changes in [Ca
2+
]i. However, chronic 
hypercapnia had no effect on the change in the HCO3
-
 concentration or mucus content of 
secreted fluid, suggesting that transporters involved in transepithelial fluid secretion and 
transporters involved in regulating the composition of the secreted fluid have different 
sensitivities to CO2. Interestingly, chronic hypercapnia had no effect on forskolin-stimulated 
ion transport measured using an Ussing chamber. This may be due to the fact that Isc 
measurements are performed in closed-circuit conditions and therefore highlights that 
different experimental approaches used to measure cAMP-stimulated ion transport can lead 
to contrasting results. Chronic hypercapnia also appeared to accelerate the rate of wound 
healing of Calu-3 cell monolayers, although the data was highly variable with the effect of 
hypercapnia only being observed in two out of three independent experiments.  
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6.2. Clinical relevance of findings to hypercapnic lung disease patients 
Several lung diseases lead to hypercapnia in humans with hypercapnia arising from the 
pathology of the disease (e.g. COPD) or as a result of treatment of the diseases (ARDS/ALI) 
(Lourenco and Miranda, 1968; Prin et al., 2002). My findings may provide an explanation 
into how CO2 can act as a cell signalling molecule to modulate cAMP-regulated ion and fluid 
transport in Calu-3 cells and therefore, should the same effects of CO2 occur in vivo, CO2 
would be predicted to impair ion and fluid transport in serous cells of the submucosal glands. 
Efficient secretion of Cl
-
 and HCO3
-
 from serous cells is crucial to maintain the properties 
and pH of the airway surface liquid and studies have found that a reduction in ASL pH 
reduces the killing of the airway pathogen Pseudomonas aeruginosa (Pezzulo et al., 2012) 
which contributes to the increased airway colonization of bacteria in the airways of CF 
patients. I found that hypercapnia altered cAMP-regulated ion and fluid transport in Calu-3 
cells suggesting that hypercapnia may impact upon the secretion of ASL from submucosal 
glands and thus compromise the innate defence mechanisms of the lung. Although the 
majority of experiments in the present study have focussed on the effects of acute 
hypercapnia, in terms of a clinical relevance, the most applicable findings come from those 
done on chronic hypercapnia, given that it would be highly unlikely for respiratory disease 
patients to only be hypercapnic for 20-30 minutes. Therefore, given that chronic hypercapnia 
caused a reduction in cAMP-stimulated fluid secretion from Calu-3 cells, it suggests that 
hypercapnic patients may be at risk from dehydration of the ASL. ASL dehydration would 
reduce the volume of the periciliary layer of the ASL and could lead to the cilia becoming 
clogged in the overlaying mucus layer which would impair mucociliary clearance of inhaled 
pathogens – a phenotype similar to that observed in CF patients (Randell et al., 2006; 
Boucher, 2007). Therefore, aside from the underlying lung disease that causes hypercapnia, 
patients may then become more susceptible to airway infection and therefore further 
complications would ensue. However, in ARDS patients, who suffer from pulmonary edema 
due to increased permeability of the alveolar epithelium (Grommes and Soehnlein, 2011), a 
decrease in cAMP-stimulated fluid secretion would actually be of benefit to the patient as it 
would help minimize the extent of the edema. Therefore, this may underlie an additional 
protective effect of the permissive hypercapnia resulting from treatment of the disease. 
Another potential benefit of the permissive hypercapnia in ARDS/ALI patients, could be 
from the accelerated wound healing hypercapnia appears to induce in airway epithelia. It has 
been reported that the high degree of inflammation in ARDS patients damages surrounding 
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tissue (Tomashefski et al., 1983; Meduri et al., 2007; Ito et al., 2014)) and therefore 
permissive hypercapnia may act to help repair tissue damage. Ito et al. (2014) reported that 
ARDS/ALI patients suffer from alveolar epithelial cell injury and demonstrated that alveolar 
epithelial cell repair was enhanced by secretion of human growth factor from lung fibroblasts. 
Thus, a possible explanation for the increase in the rate of wound healing of Calu-3 cells 
exposed to chronic hypercapnia may be due to enhanced secretion of growth factors which 
would contribute to the protective effects of permissive hypercapnia in the treatment of 
ARDS/ALI. 
 
6.3. Future experiments 
Inevitably, there are a wide range of future experiments that should be performed in order to 
strengthen the conclusions made from the current study and to provide further insights into 
the effect of hypercapnia on cAMP signalling in airway epithelia. Interpreting data from an 
immortalised cell line can be problematic given that human cell lines are only models of 
native cells and thus findings from experiments may not reflect what happens physiologically 
in vivo. Calu-3 cells are reported to have abnormalities in chromosomes 1, 13, 15 and 17 
(Ballard and Inglis, 2004) which would likely alter the genome of these cells relative to 
native human serous cells. These changes in gene expression could induce changes in the 
amino acid sequence or overall protein structure of translated proteins that may alter their 
CO2 sensitivity relative to proteins expressed in native tissue. Repeating studies on primary 
airway epithelia is important in order to establish whether native serous cells respond to acute 
hypercapnia in a similar way. It is worth noting that Professor Steve Ballard (University of 
South Alabama, USA) performed experiments in which the amount of fluid secreted from 
isolated porcine bronchi was measured in normocapnia and hypercapnia. These results 
showed that there was no effect of hypercapnia on the amount of forskolin-stimulated fluid 
secreted and therefore contradicted the findings from Calu-3 cells (Ballard, 2013 – personal 
communication). Ballard et al. (2006) have shown that removal of surface epithelium from 
porcine trachea has no effect on the fluid secreted suggesting that the submucosal glands 
secrete ASL in porcine airways thus suggesting porcine serous cells are insensitive to CO2. 
The pig is widely accepted as a good model for investigations into CFTR-dependent ion and 
fluid transport in the airways given that CF pigs exhibit similar defects to CF humans, 
including impaired Cl
-
 transport across airway epithelia (Rogers et al., 2008). CFTR-deficient 
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pigs have also been shown to have a reduced rate of fluid secretion from submucosal glands 
in response to forskolin and carbachol – similar to what is found in humans (Choi et al., 
2007; Joo et al., 2010) whilst comparisons between pig serous cells and human nasal cells 
show that the molecular mechanisms underlying VIP-stimulated Cl
-
 and fluid secretion in 
each species was highly similar (Lee and Foskett, 2010). Therefore, the literature suggests the 
pig is an appropriate model for studying CFTR-dependent ion and fluid transport in humans 
and thus further studies into the effects of hypercapnia on this process in pigs are important.   
The results obtained in the present work mostly involved the use of pharmacological agents. 
These can be problematic due to potential off target effects that many drugs possess. For 
instance, the PKA inhibitor H-89 affects a host of other kinases including protein kinase B, 
ribosomal protein s6 kinase and mitogen and stress-activated kinase (Murray, 2008) and 
therefore deducing whether the effects of H-89 were due to PKA inhibition or due to 
inhibition of another kinase is difficult. Similarly, it was difficult to interpret the data from 
experiments in which carbenoxolone was used given the many offsite targets this drug 
possesses. Therefore, it would be important to repeat some experiments in genetically 
modified Calu-3 cells in which the target protein had been knocked out.  Specifically, 
knockdown of IP3 receptors would provide further insights into the role of IP3-dependent 
Ca
2+
 release in response to hypercapnia. DT40-K/O cells, in which IP3R1, R2 and R3 have all 
been genetically disrupted display no IP3-dependent Ca
2+
 release (Sugawara et al., 1997) and 
were used by Cook et al. (2012) to demonstrate that hypercapnia-induced reductions in 
[cAMP]i required IP3-dependent Ca
2+
 release. It would be of interest to attempt to knockdown 
IP3R expression in Calu-3 cells given that DT40 cells are actually chicken lymphocyte cells 
and therefore may respond differently to CO2 than human airway epithelia. I provided some 
evidence that pannexins were involved in transducing the CO2 signal in Calu-3 cells given 
that non-specific pharmacological inhibition of pannexin-1 using probenecid or 
carbenoxolone significantly reduced the effect of hypercapnia on forskolin-stimulated HCO3
-
 
transport. Thus, pannexin-1 knockdown Calu-3 cells could be used to determine the role of 
pannexins in the effects of hypercapnia. Seminario-Vidal et al. (2011) used a short hairpin 
RNA lentiviral approach to knockdown pannexin-1 expression by 66% in Calu-3 cells and 
demonstrated this caused a marked reduction in the amount of ATP released from these cells. 
Therefore, it would be interesting to adopt the same approach to assess whether hypercapnia 
modulates cAMP-regulated HCO3
-
 transport in pannexin-1 knockdown Calu-3 cells. It is 
worth noting that RNA interference approaches to silence gene expression have variable 
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success rates in Calu-3 cells and future strategies for efficient knockout studies could involve 
the recently described CRISPR-Cas9 technology, in which clustered regulatory interspaced 
short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas proteins), 
endogenous to prokaryotes, are transfected into eukaryotic cells (Mali et al., 2013; Qi et al., 
2013). Under the direction of guide RNA, targeted to a specific DNA sequence, Cas proteins 
unwind and cleave the targeted DNA sequences, thus inhibiting gene expression. This 
powerful tool appears to be the future for manipulation of gene expression in human cells 
(Zhou et al., 2014) and has already been used to good effect to knockout expression of the 
vWF gene in pigs (Hai et al., 2014).  
CO2 has been shown to reduce forskolin-stimulated [cAMP]i in Calu-3 cells with effects 
seemingly mediated via inhibition of tmAC and/or activation of cAMP efflux via MRPs. 
With this in mind, it would be interesting to identify the isoforms of tmAC expressed in Calu-
3 cells using PCR and to determine whether only a subset of these (for instance, only the 
Ca
2+
-sensitive isoforms) are CO2-sensitive. Once the CO2-sensitive tmAC isoforms had been 
identified, they could be expressed in a heterologous expression system and mutations within 
the amino acid sequence could be introduced to help identify CO2-sensitive residues or 
potential carbamylation (post-translational modification of amino acids by CO2) sites within 
the protein. Regulation of connexin 26 by CO2 has been suggested to be a result of 
carbamylation of a specific motif in the protein that caused an interaction between a lysine 
residue and a nearby arginine residue to facilitate channel opening (Meigh et al., 2013) and 
investigations into protein carbamylation will form a significant part of future work into CO2 
signalling in human cells. It would also be of interest to repeat the [cAMP]i assay in the 
presence of MK-571 to establish whether the CO2-induced reduction in forskolin-stimulated 
cAMP is dependent on MRP activity. Similarly, expression of MRPs into cells that do not 
endogenously express these proteins would establish whether these proteins are CO2 sensitive 
and whether they are involved in mediating CO2-induced reductions in forskolin-stimulated 
[cAMP]i. 
This study has focussed predominantly on the effect of two different CO2 concentrations: 5% 
CO2, used as a representative normocapnic level and 10% CO2 used to induce hypercapnia. It 
would be worth investigating whether increasing CO2 to an even higher level caused further 
modulations to cAMP-regulated ion and fluid transport and a dose-response curve to CO2 
would be illuminating to establish which concentration of CO2 induces the most pronounced 
effects on cAMP-regulated ion and fluid transport. 
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It is important to note that two important experiments were performed when cells were grown 
as a non-polarized monolayer. The radiolabelled [cAMP]i assay were performed on cells 
grown on 12 well plates whilst measurements on [Ca
2+
]i were performed on cells grown on 
glass coverslips. Therefore, the non-polarized nature of these cells are not representative of 
an in vivo setting and therefore responses to hypercapnia in these conditions may not be 
representative of what occurs physiologically. Therefore, it will be important to repeat these 
experiments on polarized Calu-3 cells. Furthermore, my data showed there existed high levels 
of variability between batches and passages of Calu-3 cells. Indeed, this variability was so 
pronounced that when observing the effect of wound healing in Calu-3 cells, it was found that 
hypercapnia significantly accelerated wound healing in one batch of cells but there was no 
effect of hypercapnia when the experiment was repeated two weeks later on a different batch 
of cells. In addition, when measuring the hypercapnia-induced fold increase in the rate of 
forskolin-stimulated HCO3
-
 flux, this ranged from ~2 fold to ~8 fold between different 
passages of cells. Therefore, when testing the effects of pharmacological agents, it was 
important to perform control experiments at the same time to get a measure of the extent of 
the effect of hypercapnia on that particular batch of cells. The fact that control experiments 
were always run in parallel enabled me to conclude that any effects of pharmacological 
agents were real and not due to variability between batches of cells, but it would still be 
important to repeat important experiments on more than one batch of Calu-3 cells. Such 
variability between batches and passages of Calu-3 cells could stem from the fact that Calu-3 
cells are a mixed population of both CFTR-expressing, non-mucus cells and mucus-secreting 
goblet-like cells (Shen et al., 1994; Kreda et al., 2007) and the relative population of each cell 
type in each separate culture was unknown. It is possible that only the CFTR-expressing cells 
were CO2-sensitive and therefore the more pronounced effects of hypercapnia were observed 
when there was a higher proportion of these cells in the culture relative to the number of 
mucus-secreting cells. 
To gain further insights into the effects of hypercapnia on Calu-3 cells on a more global 
scale, high throughput investigations into gene expression and post-translational protein 
modifications in response to CO2 should be performed. Microarray analysis would identify 
genes in which expression had been altered by hypercapnia which could lead to further 
research into the potential roles these genes may have in mediating effects of hypercapnia on 
cAMP-signalling, amongst other effects. Microarray studies were used by Ross et al. (2007) 
and Pezzulo et al. (2011) to investigate the mechanisms behind the differentiation of human 
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bronchial epithelia when grown at an air-liquid interface (ALI) and to compare gene 
expression between in vivo and in vitro primary airway epithelial cells grown at ALI as well 
as Calu-3 cells grown at ALI. These studies provided important information about gene 
expression changes during airway epithelial cell differentiation and the differences that exist 
between primary airway epithelia when obtained from healthy individuals in vivo or cultured 
in vitro. These experiments uncovered a whole host of genes that were upregulated during 
differentiation which will pave the way for future studies into the roles of these genes in 
airway epithelia differentiation.  
My data suggested that hypercapnia modulates both cAMP and PLC signalling pathways 
which would be predicted to have effects on both PKA and PKC activity. With this in mind, 
it would be interesting to assess the effect of hypercapnia on the phosphorylation profiles of 
proteins using a phosphoproteomics approach. This method has been used by Gunaratne et al. 
(2010) to investigate the proteins that became phosphorylated in response to elevations in 
[cAMP]i in renal cells and provided further insights into the role of vasopressin signalling in 
the kidney. A reduction in the phosphorylation states of PKA-regulated proteins in 
hypercapnia would provide further evidence of a CO2-induced reduction in [cAMP]i and may 
uncover other potential CO2-sensitive proteins in which further studies into CO2 signalling 
can be built upon. 
 
6.4. Final conclusions 
The present work has shown that both acute and chronic hypercapnia have significant effects 
of cAMP-regulated ion and fluid transport in Calu-3 cells. These findings provide further 
evidence and insights into how CO2 behaves as a cell signalling molecule in human cells and 
suggests that in hypercapnic lung disease patients, potential dysregulation of the ASL may 
provide important information into the underlying pathology of the elevated PaCO2. Further 
research into this area should focus on a better understanding of the molecular mechanisms 
underlying the effect of CO2 on cAMP signalling, particularly the role of Ca
2+
 signalling. 
Repeating these experiments in primary human or other mammalian tissue is important to 
observe whether the reported effects of hypercapnia occur in a more physiological setting.
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